the 19th Annual Scientific Sessions

Transcription

the 19th Annual Scientific Sessions
Society for Cardiovascular Magnetic Resonance
19th Annual Scientific Sessions
From Innovation to Impact in Cardiovascular Care
FINAL PROGRAM
January 27-30, 2016
Hyatt Regency
Century Plaza
Los Angeles,
California USA
www.scmr.org
2015 Best Image Contest Winner,
Lilia Sierra-Galan, MD, FACC,FSCCT
(American British Cowdray Medical Center)
SCMR 19th Annual Scientific Sessions
Hyatt Regency Century Plaza
Los Angeles, CA
January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
S C H E D U L E AT A G L A N C E
WEDNESDAY, JANUARY 27, 2016
SCMR/ISMRM Co-Provided Workshop - Quantitative CMR: From Technique Development to Practical Implementation (Location: Westside)
8:00 AM - 6:00 PM
THURSDAY, JANUARY 28, 2016
LOCATION
Los Angeles
8:00 AM - 1:00 PM
Constellation
Pacific Palisades
Olympic
Westwood
Westside
Physician's Pre-Conference Course
Congenital Pre-Conference Course
Clinical Trials Workshop
Interventional CMR Workshop
SCMR/ISMRM Co-Provided Workshop
1:00 PM - 2:00 PM
2:00 PM - 3:45 PM
4:00 PM - 5:20 PM
Lunch (on own) - Exhibits and Poster Hall Open for Viewing
Opening Plenary Session
Invited Lecture Session 1: Big Data Oral Abstract Session 1: CAD and
Enabling Healthcare Research or
ACS
Expensive Distraction?
Case Review 1: Physiology or
Pathology? Questions in Sports
Oral Abstract Session 2:
Translational
5:30 PM - 6:00 PM
CMR Technology Update
6:00 PM - 7:00 PM
Welcome Reception, Poster Group P1 and Exhibits (California Showroom)
FRIDAY, JANUARY 29, 2016
LOCATION
Los Angeles
Constellation
7:30 AM - 8:30 AM
Physics for Physicians: What Your
Technologist Wants You to Know
8:40 AM - 10:00 AM
Invited Lecture Session 2: Game
Changers in CMR
Olympic
Oral Abstract Session 3
(ECA Basic Science)
Invited Lecture Session 3: CMR
Practice Models Around the World
12:00 PM - 12:30 PM
SCMR Business Meeting
Oral Abstract Session 5
(ECA Clinical)
Case Review 4: The Patient Referred
for Vascular Imaging
12:30 PM - 1:30 PM
Westwood
Technologist Track
Invited Lecture Session 4:
Congenital Scanning Beyond
Structure and Function
Walking Poster Session 2: CMR in
Coronary Artery Disease
Technologist Track
Lunch (on own)/Exhibits/Poster Group P2 (California Showroom)
Invited Lecture Session 5:
Multimodality Imaging to Guide
Surgical and Transcatheter Repair
Oral Abstract Session 6: Tissue
Characterization
Case review 5: The Adult Patient
Referred for Evaluation of
Congenital Heart Disease
Oral Abstract Session 7
New Techniques
Walking Poster Session 3: Clinical
Outcome and Prognosis
Technologist Track
Walking Poster Session 4:
Mechanisms in Cardiovascular
Disease
Technologist Track
Walking Poster Session 5: CMR in
Myocardial Disease
Technologist Track
Refreshment Break/Exhibits
2:50 PM - 3:40 PM
5:10 PM - 6:30 PM
Santa Monica
Refreshment Break/Exhibits (California Showroom)
10:40 AM - 12:00 PM
3:40 PM - 5:00 PM
Plaza Foyer
Careers in CMR: Aligning Your Path
Across Opportunities
Case Review 3: The Patient Referred
Walking Poster Session 1: Methods
for a Cardiac Mass with Pathologic Oral Abstract Session 4: Congenital I
to Analyze Tissue and Function
Correlation
10:00 AM - 10:30 AM
1:30 PM - 2:50 PM
Westside
Cardiology for Non-Clinicians: What Case Review 2: The Patient Referred
the Sick Patient in the Scanner
for Evaluation of Ischemic Heart
Needs You to Know
Disease
Invited Lecture Session 6: Reducing
Case review 6: The Patient Referred Invited Lecture Session 7: Diffusion
Oral Abstract Session 8: Outcomes
Cost, Increasing Value, and
for Evaluation of Cardiomyopathy
CMR
Allocating One's Time
Invited Lecture Session 8: CMR in
Tarnslational Science: From
Pathways to Protocols
Oral Abstract Session 9
(ECA Translational)
Oral Abstract Session 10: Systolic
and Diastolic Function
Oral Abstract Session 11: Postprocessing and Modeling
CMR Outreach Dinner Program
(Special Registration)
6:30 PM - 8:30 PM
SATURDAY, JANUARY 30, 2016
LOCATION
Los Angeles
Constellation
7:30 AM - 8:50 AM
Invited Lecture Session 9: CMR in
Multisystem Disorders
8:50 AM - 10:00 AM
CMR Outreach Plenary Session:
Cardiovascular Disease in Women CMR's Essential Role
Pediatric and Congenital
The Experts
Olympic
CMR: Ask
10:00 AM - 10:40 AM
10:40 AM - 12:00 PM
2
Plaza Foyer
Santa Monica
Westwood
LIVE CASE
Refreshment Break/Exhibits (California Showroom)
Invited Lecture Session 10:
Translating Advances in CMR to the
Community
Oral Abstract Session 13:
Inflammatory Cardiomyopathy
Invited Lecture Session 11: What Is
Case Review 8: Potpourri Cases and
This Congenital Patient Doing On My
Best Web Case of the Week
Schedule?
Walking Poster Session 7: Novel
CMR Strategies
Technologist Track
Lunch (on own)/Exhibits/Poster Group P3 (California Showroom)
12:00 PM - 1:00 PM
1:10 PM - 2:30 PM
Invited Lecture Session 12: CMRGuided Management of Sudden
Cardiac Death in Nonischemic
Disease
2:40 PM - 4:00 PM
Invited Lecture Session 15: Past,
Present and Future Assessment of
Myocardial Mechanics
4:15 PM - 5:30 PM
CMR World Cup, A Joint
SCMR/EuroCMR Event
& Closing Plenary Session
5:30 PM - 6:00 PM
Awards Ceremony
6:00 PM - 7:00 PM
Westside
Oral Abstract Session 12: Flow and Case review 7: Patients Referred for Walking Poster Session 6: Advances
Hemodynamics
Evaluation of Acute Chest Pain
in CMR Methods
Oral Abstract Session 14: Rapid
Efficient Imaging
Oral Abstract Session 15:
Congenital II
Invited Lecture
Invited Lecture Session 13: CMR in
CAD
Best of Walking Posters
Technologist Track
Oral Abstract Session 16:
Arrhythmia
Case Review 9:
The Pediatric Patient Referred for
the Evaluation of the Congenital
Heart Disease
Oral Abstract Session 17: Clinical
Trials
Invited Lecture Session 14:
Parametric Mapping
Technologist Track
Awards Reception (California Lounge)
19th Annual Scientific Sessions • January 27-30, 2016
TABLE OF CONTENTS
D E A R D I S T I N G U I S H E D C O L L E AG U E S ,
Welcome to sunny Los Angeles for the 19th Annual Scientific Sessions of the Society
for Cardiovascular Magnetic Resonance! This premier global CMR meeting brings
together in one convenient venue the best in technology development, translational
research and clinical science. Our all-star program committee and staff deserve
a heartfelt Thank You for their remarkable efforts in making this year’s program
a reality. Special kudos to those involved in submitting, reviewing, and organizing
the best science into high-impact Abstract sessions. We thank our program’s
supporters who are eager to share with you via their exhibitions ideas on how to
deliver on the promise of CMR. We are especially grateful to partnering groups
such as the EACVI’s Heart Imagers of Tomorrow who helped create Thursday’s
session on “Training and Certification in CMR” and EuroCMR for their support of
Saturday’s “World Cup: A Joint SCMR/EuroCMR Event”. Other joint endeavors
such as the ISMRM/SCMR Joint Workshop “Quantitative CMR: From Technique
Development to Practical Implementation” and Friday’s ESCR co-provided session
“Reducing Cost, Increasing Value, and Allocating One’s Time” are designed to help
you translate today’s innovations to tomorrow’s research and practice.
New this year is a special Outreach Program conducted with the help of the
California Chapter of the ACC and EACVI’s Cardiovascular Imaging section. The
combined Friday evening dinner session and Saturday morning Outreach Plenary
is a great place to engage with practitioners outside of our field to positively impact
human health, focusing this year on CMR to advance women’s cardiovascular
health. Our first-ever Live Case on Saturday morning complements thematicallyorganized Case Sessions, and the Technologist Track highlights the essential team
approach needed to deliver on the promise of CMR. Popular preconference
sessions address Congenital and Interventional CMR, and the Clinical Trials
Workshop will empower attendees with critical knowledge to advance patientoriented research to improve cardiovascular outcomes.
Schedule at a Glance ..........................2
Welcome .............................................3
About SCMR ........................................4
Conference Goals/Accreditation .........5
General Information ...........................7
PRE-CONFERENCE COURSES
Physicians Pre-conference
Course .........................................8
Congenital/Pediatric
Pre-conference Course ................9
Thursday Program .............................13
Friday Program ..................................17
Saturday Program .............................30
Technologist Track .............................41
This is your meeting – we look forward to your engagement! Please participate
in the many audience response queries and discussions embedded throughout
the sessions, and follow us on Twitter (@SCMRorg, #SCMR2016) for breaking
communications during the meeting. We hope you find this program useful as you
help our society advance the science and practice of CMR around the world.
Poster Directory ................................44
Sincerely,
Exhibit Hall Floor Plan .......................79
Subha V. Raman, MD, MSEE
Program Chair
Daniel Messroghli, MD
Abstract Chair
Victor Ferrari, MD
SCMR President
www.scmr.org
Author Index .....................................55
Exhibitor Directory ............................77
Hotel Floor Plan ................................80
3
From Innovation to Impact in Cardiovascular Care
SC M R V I S I O N STATEM ENT
The Society for Cardiovascular Magnetic Resonance (SCMR) will be the leading international representative and advocate for all physicians, scientists,
and technologists working in CMR to improve patient outcomes through excellence in education, training, standards, research and development.
TH E M I S S I O N O F SC M R I S TO:
• Be the premier international model and provider of CMR education, training, standards development, and accreditation.
• Maximize clinical effectiveness of CMR through coordinated comparative effectiveness research efforts resulting in evidence-based
guidelines to enhance patient care and outcomes.
• Continually enhance the accuracy, efficiency, and effectiveness of CMR in cardiovascular healthcare through technological advances.
• Promote scientific exchange through organization of an annual international scientific conference, publication of the Journal of
Cardiovascular Magnetic Resonance, and interactive internet-enabled tools including the SCMR website.
• Build an expanding global membership of physicians, scientists, technologists, and interested healthcare partners focused on clinical
applications and research in CMR.
• Develop and advance close working alliances with related societies, industry partners, and governmental and regulatory agencies
to more effectively integrate and elevate the use of CMR within cardiovascular healthcare.
OFFICERS/
EXECUTIVE COMMITTEE
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, USA
Vice-President
Jeanette Schulz-Menger, MD
Charite Universitatsmedizin and HELIOS Clinics
Berlin, Germany
Secretary-Treasurer
Matthias G. Friedrich, MD
McGill University Health Centre
Montreal, Canada
Ruchira Garg, MD
Colin Berry, MD
Nadine Kawel-Boehm, MD
Chiara Bucciarelli-Ducci, MD
Dara Kraitchman, DVM, PhD
Carmen Chan, MBBS
Daniel Lee, MD
Stephen Cheung, MBBS
J. Ronald Mikolich, MD
Rohan Dharmakumar, PhD
Steffen Petersen, MD
Christopher Dyke, MD
Michael Salerno, MD, PhD
Robert Edelman, MD
David Sosnovik, MD
Daniel Ennis, PhD
M. Barbara Srichai-Parsia, MD
Victor Ferrari, MD
Daniel Thomas, MD
Alison Fletcher, RT
Anne Marie Valente, MD
University of Glasgow
Bristol Heart Institute
Brigham & Women’s Hospital
Queen Mary Hospital
Cedars-Sinai MC
Alaska Heart Institute
University of Pennsylvania Medical Center
Past President
Orlando P. Simonetti, PhD
The Ohio State University
Columbus, Ohio, USA
Papworth Hospital
Sohrab Fratz, MD, PhD, FESC
German Heart Centre Munich
University of Virginia
Cedars-Sinai Medical Center
University of Basel Hospital
Johns Hopkins University, School of Medicine
Northwestern University, Feinberg School of Medicine
Northeast Ohio Medical University
Queen Mary, University of London
University of Virginia Health System
Massachusetts General Hospital
Medstar Georgetown University Hospital
University of Bonn
Children’s Hospital Boston
Brigham & Women’s Hospital
Mark Westwood, MD
The London Chest Hospital
Program Committee Chair
Subha V. Raman, MD, MSEE
4
Andrew Arai, MD
UCLA School of Medicine
Lausanne University
Lausanne, Switzerland
German Heart Institute Berlin
Berlin, Germany
Brent French, PhD
Lund University Hospital
Evanston Hospital
Vice Secretary-Treasurer
Matthias Stuber, PhD
Program Committee Co-Chair
Daniel Messroghli, MD
Anthony Aletras, PhD
NHLBI - National Institutes of Health
President
Victor A. Ferrari, MD
The Ohio State University
Columbus, Ohio, USA
PROGR AM COMMITTEE MEMBERS
STAFF
Executive Director
Deborah Berkowitz
Meeting Manager
Maria Ramos, CMP
Chief Operating Officer
Pete Pomilio
Meeting Coordinator
Stephanie Moyer
Headquarters Assistant
Kearstin Rehmann
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
TH E G OA L S O F TH E SC I ENTI FI C S ES S I O N S A R E TO:
• Deliver state-of-the-art information on the translational science and clinical impact of CMR
• Provide a forum for the presentation of advances in CMR
• Demonstrate CMR-based solutions to unmet needs in cardiovascular care and after care enhance patient care and outcomes
AT TH E CO N C LU S I O N O F TH E SC I ENTI FI C S ES S I O N S ,
PA RTI C I PA NT S S H O U LD B E B ET TER A BLE TO:
• Implement CMR services to improve cardiovascular care
• Develop CMR-facilitated clinical and translational research
• Apply relevant MR principles to improve image quality, data reliability and patient safety
CO NTI N U I N G M EDI C A L EDUC ATI O N
C R ED IT I N FO R M ATI O N – SC I ENTI FI C S ES S I O N S
The SCMR 19th Annual Scientific Sessions designates this educational activity for a maximum of 24 hours of External CME credits. Each
participant should claim only those hours of credit that have actually been spent in the educational activity.
The Society for Cardiovascular Magnetic Resonance designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The evaluation link will be sent at the conclusion of the meeting. There will be a CME tracking worksheet at the end of the overall
evaluation to request CME credits. To access the CME tracking worksheet, you will need to complete the overall evaluation. Once you
have completed the worksheet, be sure to click “done” so your certificate can be processed. Your certificate will be sent via email on
or before February 12.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals who participate in this CME activity may submit their Statements of Attendance to their appropriate
accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity
meets the requirements for acceptable continuing education.
TEC H N O LOG I ST WO R K S H O P
This activity has been approved for credit by the American Society of Radiologic Technology (ASRT) for a maximum of 10 CE credits.
Each technologist should claim only those hours of credit actually spent in this activity.
www.scmr.org
5
From Innovation to Impact in Cardiovascular Care
PA ST SC M R G O LD
M EDA L AWA R D EES
2015 AWA R D EES
Christopher M. Kramer, MD
Raymond J. Kim, MD
Robert M. Judd, PhD
2016 SCMR GOLD MEDAL AWARDS
The Board of Trustees of the Society for Cardiovascular Magnetic Resonance (SCMR) is
pleased to announce the 2016 Gold Medal Award recipients are Joao A.C. Lima, MD, MBA,
Professor of Medicine, Radiology and Epidemiology at Johns Hopkins University and Eike
Nagel, MD, PhD, Director of the Institute for Experimental and Translational Cardiovascular
Imaging, DZHK Centre for Cardiovascular Imaging, at Goethe University Frankfurt. The award
is presented annually by the SCMR for outstanding achievement in the field of CMR as well as
exemplary service to the Society.
2014 AWA R D EE:
Warren J. Manning, MD
2013 AWA R D EE:
Stefan Neubauer, MD
2012 AWA R D EE:
Dudley Pennell, MD
2011 AWA R D EES:
Charles Higgins, MD
Gerald Pohost, MD
Joao Lima
Eike Nagel
Dr. Lima is very well known to the field of CMR, as a leader over the past 25 years. He has
a strong history of service to the SCMR, beginning with the very first organizational meeting
hosted by Gerald Pohost, extending through his service on the SCMR Board of Trustees, and
including his tireless attendance and presentations at most if not all of the SCMR’s scientific
sessions. Dr. Lima has been a major contributor to the field. In particular among his research
contributions over the past two and half decades, marked by nearly 160 peer-reviewed
papers, those on myocardial function, late gadolinium enhancement, LV contractile function,
and delayed enhancement imaging and his many contributions from the 10-year, 7,000-patient
Multi-Ethnic Study of Atherosclerosis (MESA) study have been central to advances in our field.
This landmark epidemiology study has published over 1,000 papers over the past 15 years. The
CMR data has been the component of that study which has produced the most publications of
any single sub-unit within MESA. In addition, Dr. Lima has authored 39 high‐level editorials and
guidelines directly related to CMR. Perhaps most importantly, Dr. Lima has helped mentor and
guide numerous others in the field.
“From lectures to daily discussions and supervising research projects in CMR he was not only the most visionary researcher that I have ever known, but the
best mentor any fellow could ask for.” - Carlos Eduardo Rochitte, MD, PhD
Dr. Nagel has been deeply involved in SCMR for over two decades, including serving as President from 2008-2009. He has also been instrumental
in furthering CMR recognition by holding leadership positions within the American College of Cardiology, American Heart Association, European
Society of Cardiology, British Society of Cardiovascular Magnetic Resonance, German Society of Cardiovascular Magnetic Resonance, and as a
Founding Member of the Asian Society for Cardiovascular Imaging. From a scientific perspective, Dr. Nagel has been a distinguished leader bringing
recognition of the clinical applications of CMR across the spectrum of disease entities including left ventricular remodeling, viability, atherosclerosis,
quantitative myocardial perfusion, and dobutamine stress ischemia CMR. Most recently, Dr. Nagel has been the Global Chief Investigator of MRINFORM, a large international randomized controlled outcome study assessing whether patients with stable chest pain can be guided noninvasively
by CMR perfusion rather than invasive angiography supported by fractional flow reserve. These efforts have been critical in elevating CMR’s
diagnostic and prognostic role. Finally, Dr.Nagel has also been at the forefront of training/mentoring a large number of CMR clinician researchers, as
well as establishing multiple training programs throughout the world. It should be noted that many of his trainees have gone on to establish highly
productive and widely recognized CMR centers of their own.
“It is hard to find any aspect of the SCMR that has not been touched in some manner by Eike.” – Warren Manning, MD
The SCMR is honored to recognize both individuals for their invaluable contributions to CMR and to the Society. Each has contributed in their own
way, but all have made an indelible mark on the field deserving of the highest recognition.
6
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
G EN ER A L I N FO R M ATIO N
ADMISSION
PHOTOGRAPHY
Conference name badges are required for admission to all activities
related to the 19th Annual Scientific Sessions, including the exhibit hall and
social events.
Any photography, filming, taping, recording or reproduction in any medium
including via the use of tripod-based equipment of any of the programs
and/or posters presented at the 19th Annual Scientific Sessions without
the express written consent of the Society for Cardiovascular Magnetic
Resonance is strictly prohibited.
REGISTRATION HOURS
The Registration Desk is located in the California Lounge and will be open
and staffed during the following hours:
Wednesday, January 27 Thursday, January 28
Friday, January 29 Saturday, January 30 3:00 PM
7:00 AM
7:00 AM
7:00 AM
SPEAKER READY ROOM
The 2016 Program Committee is committed to providing attendees’ cutting
edge technology and coordinated presentations at the Scientific Sessions.
To be fully prepared for your session, each presenter is requested to visit
the Speaker Ready Room at least 24 hours prior to your presentation. The
Speaker Ready Room is located in the meeting room Sherman Oaks and
will be open the following days and times:
– 6:30 PM
– 6:00 PM
– 6:30 PM
– 4:30 PM
DISCLOSURE STATEMENT
It is the policy of the Society for Cardiovascular Magnetic Resonance to
insure balance, independence, objectivity and scientific rigor in all of its
sponsored educational activities. All participating speakers and moderators,
course directors, and planning committee members are required to
disclose to the program audience any financial relationships related to
the subject matter of this program. Relationships of spouse/partner with
proprietary entities producing healthcare goods or services should be
disclosed if they are of a nature that may influence the objectivity of the
individual in a position to control the content of the CME activity. Disclosure
information is reviewed in advance in order to manage and resolve any
possible conflicts of interest. Specific faculty disclosure information for each
speaker, course director, and planning committee member will be shared
with the audience prior to the speaker’s presentation. A complete list of
disclosures is available on the website.
Tuesday, January 26
Wednesday, January 27 Thursday, January 28
Friday, January 29 Saturday, January 30 The Society for Cardiovascular Magnetic Resonance gratefully
acknowledges the 2016 support of the following industry partners:
PL ATINUM LEVEL:
Siemens
GOLD LEVEL:
Philips
At the conclusion of the SCMR Scientific Sessions, you will receive an
invitation to complete the meeting survey. Please take the time to complete
this survey as it provides very important feedback for future programming.
Thank you, in advance, for completing the evaluation…your opinion and
feedback matter!
EXHIBITS
Educational and informational exhibits will be available in the California
Showroom during the Scientific Sessions. Exhibiting company
representatives will be available to answer your questions about their
products and services. Please visit the exhibits and thank the representatives
for their support. The complete list of exhibits can be found on pages XX.
Thursday, January 28
1:00 PM – 7:00 PM
Friday, January 29
10:00 AM – 10:30 AM
12:30 PM – 1:30 PM
2:50 PM – 3:40 PM
Saturday, January 30 10:00 AM – 10:30 AM
12:00 PM – 1:00 PM
– 8:00 PM
– 8:00 PM
– 6:00 PM
– 6:00 PM
– 5:00 PM
ACKNOWLEDGEMENTS
EVALUATIONS AND CME TRACKING FORMS
You must complete the CME Tracking Form in order to receive your CME
certificate. After completing the Tracking Form, please return it to the
Registration Desk or email it to [email protected].
5:00 PM
7:00 AM
7:00 AM
7:00 AM
7:00 AM
SILVER LEVEL:
General Electric
Heart Imaging Technologies
SOCIAL MEDIA
Continue the online conversation this year on Twitter with hashtag
#SCMR2016. Share your thoughts about the conference and see what
everyone is saying! Follow @SCMRorg on Twitter and Like Us on
Facebook, SCMRorg.
MOBILE DEVICES
As a courtesy to the speakers and your fellow attendees, please switch
your mobile device(s) to silent while attending sessions.
www.scmr.org
7
From Innovation to Impact in Cardiovascular Care
PR E- CO N FER EN C E S ES S IO N S
THURSDAY, JANUARY 28, 2016
PHYSICIAN’S PRE-CONFERENCE COURSE
Location: Constellation
Co-Chairs:Chiara Bucciarelli-Ducci, MD, FESC (Bristol Heart Institute) and Katherine Wu, MD (Johns Hopkins Medical Institutions)
SESSION 1:
:00 AM –10:00 AM Physics and How-to’s of CMR
8
Moderators: Robert Biederman, MD (Allegheny General Hospital)
Yuchi Han, MD (University of Pennsylvania)
At the conclusion of this session, participants will be better able to:
• Appreciate the key aspects of the Fourier Transform and other essential physics for CMR
• Recognize typical scanning techniques to image myocardium and cardiovascular structures
• Recognize typical scanning techniques to image functional and dynamic processes
8:00 AM Physics Made Easy and Fourier Transform for the Clinician
Anthony Aletras, PhD (University of Thessaly)
8:20 AM The Essential Techniques for Cardiac Structure and Function
Patrizia Pedrotti, MD (Niguarda Hospital)
8:40 AM Myocardial Tissue Characterization
Martin Ugander, MD, PhD (Karolinska Institute)
9:00 AM Blood Flow Imaging and Angiography
Robert Edelman, MD (Evanston Hospital)
9:20 AM How to Perform High Quality CMR Stress Imaging
Manish Motwani, MB ChB (University of Leeds)
9:40 AM How To Assess Cardiac Chamber Sizes and Global vs. Regional Function
Dipan Shah, MD (Methodist DeBakey Heart & Vascular Center)
10:00 AM
BREAK
SESSION 2:
10:20 AM–11:40 AM
Clinical Scenarios (Part 1)
Moderator: Ingo Eitel, MD (University Leipzig)
At the conclusion of this session, participants will be better able to:
• Recommend CMR vs. other diagnostic options
• Prescribe CMR approaches to common questions in myocardial and valvular disease
10:20 AM Choosing CMR in a Multi-modality Imaging Climate
Lilia M. Sierra-Galan, MD (ABC Medical Center) 10:40 AM
Detecting Causes of Acute Myocardial Injury
Erik Schelbert, MD, MS (University of Pittsburgh) 11:00 AM Assessment of New Onset Heart Failure or Cardiomyopathy of Unknown Cause
Vinayak Hegde, MD (Akron General Medical Center)
11:20 AM Comprehensive Assessment of Valvular Heart Disease
Clerio Azevedo, MD, PhD (Clínica de Diagnóstico por Imagem - CDPI/DASA)
11:40 AM
BREAK
SESSION 3:
1:50 AM– 1:00 PM
1
8
Interesting Cases
Moderator: Nuno Bettencourt (Porto, Portugal) At the conclusion of this session, participants will be better able to: • Identify essential CMR protocol components in imaging the adult with congenital heart disease
• Construct CMR-based strategies to address common clinical questions in cardiovascular care
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
PR E- CO N FER EN C E S ES S IO N S
12:10 PM “Why is my patient short of breath?”
Viviana Maestrini, MD (The Heart Hospital)
12:30 PM “Why does my patient have chest pain?”
Afshin Farzaneh-Far, MD, PhD (University of Illinois, Chicago)
12:50 PM
Q&A Session
CONGENITAL PRE-CONFERENCE COURSE
Location: Pacific Palisades
PRE-CONFERENCE
11:50 AM “What should I do with this adult with congenital heart disease?”
Marcus Carlsson, MD (Lund University)
Co-Chairs: Rajesh Krishnamurthy, MD (Texas Children’s Hospital), Emanuela Valsangiacomo, MD (University Children’s Hospital),
and Adam Dorfman, MD (University of Michigan)
SESSION 1:
:00 AM –10:00 AM CMR in Congenital Heart Disease: Adding Clinical Value
8
Moderators: Adam Dorfman, MD (University of Michigan C.S. Mott Children’s Hospital)
Willem Helbing, MD, PhD (Erasmus Medical Center, Rotterdam)
At the conclusion of this session, participants will be better able to:
• Understand the clinical value of CMR imaging in congenital heart disease
• Learn how to adopt protocols to address the clinically relevant issues for various congenital heart lesions
• Recognize common themes in the CMR approach to imaging various forms of congenital heart disease
8:00 AM Tetralogy of Fallot
Shiraz Maskatia, MD (Texas Children’s Hospital)
8:15 AM D-Looped Transposition of the Great Arteries
Andrew Crean, MD (Toronto General Hospital)
8:30 AM Single Ventricle Prior to Stage II and Stage III Palliation
Matthew Harris, MD (Children’s Hospital of Philadelphia)
8:45 AM
Fontan
Adam Dorfman, MD (University of Michigan)
9:00 AM Shunt Lesions
Beth Printz, MD, PhD (Rady Children’s Hospital)
9:15 AM Neonates with Congenital Heart Disease
Emanuela Valsangiacomo-Buechel, MD (University Children’s Hospital Zurich)
9:30 AM Aortic Coarctation
Ashwin Prakash, MD (Children’s Hospital Boston)
9:45 AM Vascular Rings and Slings
Jimmy Lu, MD (University of Michigan)
10:00 AM
BREAK
SESSION 2:
0:20 AM–11:35 AM CMR in Acquired Pediatric Disease: A Beginner’s Guide
1
Moderators: Tal Geva, MD (Children’s Hospital)
Shi-Joon Yoo, MD (The Hospital for Sick Children)
At the conclusion of this session, participants will be better able to:
• Understand the use of CMR for imaging acquired heart disease in children
• Recognize key elements that are specific to imaging children with these diseases
• Learn to adopt strategies to maintain the safety of pediatric patients during CMR scans
10:20 AM Keeping Children Safe in the MR Environment
Ramkumar Krishnamurthy, PhD (Texas Children’s Hospital)
10:35 AM Evaluating the Valves
Jonathan Soslow, MD (Vanderbilt University)
www.scmr.org
9
From Innovation to Impact in Cardiovascular Care
PR E- CO N FER EN C E S ES S IO N S
10:50 AM Myocarditis in Children
Sohrab Fratz, MD, PhD (Deutsches Herzzentrum Munchen)
11:05 AM Pediatric Heart Transplant
Michael Taylor, MD, PhD (Cincinnati Children’s Hospital)
11:20 AM Pulmonary Hypertension
Vivek Muthurangu, MD (University College London)
11:35 AM
BREAK
SESSION 3:
1:45 AM– 1:00 PM Advanced Clinical Techniques: How do I start these programs?
1
Moderators: Emanuela Valsangiacomo Buechel, MD (University Children’s Hospital, Zurich)
Kevin Whitehead, MD, PhD (Children’s Hospital of Philadelphia)
At the conclusion of this session, participants will be better able to:
• Learn key elements to implementing advanced imaging techniques in a pediatric CMR practice
• Understand how the use of these imaging techniques may differ in a pediatric population compared to adults
• Recognize the challenges of imaging infants and young children and learn strategies for successful
imaging in this population
11:45 AM Blood Pool Contrast Imaging
Joshua Robinson, MD (Lurie Children’s Hospital)
12:00 PM Myocardial Mechanics
Kan Hor, MD (Nationwide Children’s Hospital)
12:15 PM Tissue Characterization
Lars Grosse-Wortmann, MD (University of Toronto)
12:30 PM 4D Flow
Shreyas Vasanawala, MD, PhD (Stanford University)
12:45 PM Imaging Young Patients
Emanuela Valsangiacomo-Buechel, MD (University Children’s Hospital- Zurich)
CLINICAL TRIALS WORKSHOP
Location: Olympic
Co-Chairs: Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London) and John Greenwood, MBChB, PhD, FRCP (University of Leeds)
8:00 AMWelcome – Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London)
and John Greenwood, MBChB,PhD, FRCP (University of Leeds)
SESSION 1:
:05 AM – 9:45 AM Trial Design & Analysis Part 1
8
Moderators: Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London)
John Greenwood, MBChB, PhD, FRCP (University of Leeds)
At the conclusion of this session, participants will be better able to:
• Formulate clinical research questions that take advantage of CMR-afforded opportunities
• Differentiate various approaches to clinical research and their respective strengths/weaknesses
• Identify strategies for successful design and execution of single-center randomized trials
8:05 AM Patient-Centered Outcomes Research: Expectations for Cardiovascular Imaging
Diane Bild, MD, PhD (Patient-Centered Outcomes Research Institute)
8:25 AM Portfolio of CMR Opportunities in Clinical Research
Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London)
8:45 AM Pros and Cons of Observational Studies and Registries
Christopher Kramer, MD (University of Virginia Health System)
9:05 AM Pros and Cons of RCT’S and Systematic Reviews
Mohammed Khanji, MB BCh (Queen Mary University of London )
10
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
9:25 AM
New and Emerging Trial Designs
John Greenwood, MD, PhD (University of Leeds)
9:45 AM
BREAK
SESSION 2:
0:00 AM–11:20 AM
1
Trial Design & Analysis Part 2
Moderator: Valentina Puntmann, MD, PhD, MRCP (University Hospital Frankfurt)
At the conclusion of this session, participants will be better able to:
• Use and interpret p values appropriately in clinical trials
• Construct adequately-powered study samples and prescribe suitable univariate and multivariate analyses
• Recognize the factors involved in survival curve and net reclassification analyses
10:00 AM
What Do We Mean By p<0.05
Hyun Kim, PhD (UCLA)
10:20 AM
How to do a Sample Size Calculation
Steffen Petersen, MD, DPhil, MPH (Queen Mary, University of London)
10:40 AM
Univariate and Multivariate Analysis
Hyun Kim, PhD (UCLA)
11:00 AM
Kaplan Meier Curves and Net Reclassification
Hyun Kim, PhD (UCLA)
11:20 AM
BREAK
PRE-CONFERENCE
PR E- CO N FER EN C E S ES S IO N S
SESSION 3:
1:30 AM– 1:10 PM Clinical Applications
1
Moderators: Eike Nagel, MD, PhD, FACC, FESC (Goethe University Frankfurt)
Colin Berry, MD (University of Glasgow)
At the conclusion of this session, participants will be better able to:
• Coordinate use or implementation of core lab services for clinical trial image analysis
• Investigate the distinct needs of vascular vs. cardiac-focused clinical trials that use CMR
• Assess opportunities and mechanisms to incorporate comparative effectiveness measures in clinical trials
11:30 AM Vascular MRI in Atherosclerosis Clinical Trials
Denise Yates, PhD (Novartis Institutes for Biomedical Research)
11:50 AM CMR Core Labs: Pros and Cons for Multi-centre Clinical Trials
Joao Lima, MD (Johns Hopkins)
12:10 PM CMR in Clinical ACS Trials: Challenges and Opportunities
Gerry McCann, MD, BSc, MB, ChB, MRCP (University Hospitals Leicester)
12:30 PM Comparative Effectiveness Research
Rory Hachamovitch, MD, MSc (Cleveland Clinic)
12:50 PM Clinical Trials Committee Update and Closing remarks
John Greenwood, MD, PhD (University of Leeds)
I NTERVENTIONAL CMR
Location: Westwood
o-Chairs: Robert Lederman, MD (National Heart, Blood, and Lung Institute) and Kanishka Ratnayaka, MD (Children’s National Health System)
C
This activity will not be CME accredited.
8:00 AM Welcome
Robert Lederman, MD (National Heart, Blood, and Lung Institute) and Kanishka Ratnayaka, MD (Children’s
National Health System)
SESSION 1: TUTORIAL AND VENDOR SESSIONS
8:04 AM How to Start an Electrophysiology iCMR program
Philipp Sommer, MD (Heart Center)
www.scmr.org
11
From Innovation to Impact in Cardiovascular Care
PR E- CO N FER EN C E S ES S IO N S
8:19 AM
How to Begin MRI Cath in Patients Including Commercial Catheters
Kanishka Ratnayaka, MD (Children’s National Medical Center)
8:40 AM Vendor Panel 1: Large Vendors & Conversations
8:40 AM Martin Ostermeier (Siemens Healthcare)
8:45 AM Jouke Smink (Philips Healthcare)
8:50 AM Anja Brau (GE Healthcare)
8:55 AM Dahan Meir (Imris by Deerfield Imaging, Inc.)
9:00 AM Juan Santos (HeartVista, Inc.)
9:05 AM Vendor Panel 2: Infrastructure
9:05 AM Jeff Griebel (Mallinckrodt Pharmaceuticals)
9:10 AM Yuvi Kahana (Optoacoustics)
9:15 AM Vendor Panel 3: Hemodynamics & EP
9:15 AM Vladimir Shusterman (PinMed, Inc)
9:20 AM John Kakareka (National Institutes of Health)
9:25 AM Jay Ward, MS (E-TROLZ)
9:30 AM Steve Wedan (Imricor EP Systems)
9:35 AM
BREAK & MODERATED CONVERSATION
SESSION 2: CATH AND CONGENITAL SESSIONS
10:00 AM VISION by Outsider: What I Need to Do
Howaida El-Said (University of California San Diego)
10:10 AM XFM to Guide Transitional iCMR Procedures
Amish Raval, MD (University of Wisconsin- Madison)
10:20 AM Guidewires Update for MRI Catheterization
Ozgur Kocaturk, PhD (Boğaziçi University)
10:30 AM Real-Time, Image-Based Motion Compensation
Graham Wright, PhD (Sunnybrook University of Toronto)
10:40 AM Technology: New Designs & Sequences for Device Tracking
Ehud Schmidt, PhD (Brigham and Women’s Hospital)
10:50 AM Application: Extraanatomic Bypass for Congenital
Kanishka Ratnayaka (Children’s National Medical Center)
11:00 AM Application: MRI Myocardial Biopsy
Toby Rogers, BMBCh (NIH)
11:10 AM Human: MRI Cath for Pulmonary Hypertension
Vivek Muthurangu (Great Ormond Street London)
11:20 AM Human: MRI Cath for Aortic Coarctation Update 2016
Sohrab Fratz (DHZ Munich)
11:30 AM Newcomers & Open Mic 1 MD Anderson
Juan Lopez-Mattei, MD (University of Texas Anderson Cancer Center)
11:35 AM Newcomers & Open Mic 2 Update Houston Methodist
C Huie Lin, MD, PhD (Methodist DeBakey Heart & Vascular Center)
11:40 AM
BREAK & MODERATED CONVERSATION
SESSION 3: EP SESSIONS
12:00 AM VISION by Outsider: What I Need to Do
Kalyanam Shivkumar, MD, PhD (University of California Los Angeles)
12:10 PM Chemoablation for iCMR EP: A Completely New Approach
Toby Rogers, BMBCh (NIH)
12:20 PM RFA for iCMR EP: Preclinical and Imaging
Elena Grant (Children’s National Medical Center)
12
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
PR E- CO N FER EN C E S ES S IO N S
Human iCMR EP Update 1
Henry Halperin, MD, MA (Johns Hopkins University)
PRE-CONFERENCE
12:30 PM
12:40 PM Human iCMR EP Update 2 Marco Götte, MD, PhD (Haga Teaching Hospital)
12:50 PM Human iCMR EP Update 3: Active Catheter Afib Ablation
Philipp Sommer, MD (Heart Center)
1:00 PM
Human iCMR EP Update 4: How to Begin MRI EP Mapping and Ablation in Patients
Reza Razavi (King’s College London)
1:10 PM
BREAK & MODERATED CONVERSATION
1:00 PM –7:00 PM
EXHIBIT HALL OPEN
Location: California Showroom
TRAINING AND CERTIFICATION IN CMR JOINTLY WITH EACVI
oderators: Manish Motwani, MB ChB (Cedars Sinai Hospital) and Gina LaRocca, MD (Mount Sinai Hospital)
M
This activity will not be CME accredited.
1:00 PM
Location: Encino
Training and Research with CMR within United States
Gina LaRocca, MD (Mount Sinai Hospital)
1:20 PM The European Experience
Manish Motwani, MB ChB (Cedars Sinai Hospital)
1:40 PM The Importance of Certification for CMR: How to Achieve Standards of Excellence?
Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute)
SC I ENTI FIC S ES S IO N S
THURSDAY, JANUARY 28, 2016
2:00 PM – 3:45 PM OPENING PLENARY SESSION Location: Los Angeles Ballroom
Delivering on the Promise of CMR
Moderators: Victor A. Ferrari, MD (University of Pennsylvania Medical Center)
Subha V. Raman, MD (The Ohio State University)
At the conclusion of this session, participants will be better able to:
• Recognize opportunities to leverage innovations in CMR to advance cardiovascular science and clinical care
• Learn about key elements contributing to successful partnerships in CMR
• Identify strategies to deliver on the promise of CMR through education and collaboration
2:00 PM Welcome from the President of the Society for Cardiovascular Magnetic Resonance and Program Chair
Victor A. Ferrari, MD (University of Pennsylvania Medical Center)
Subha V. Raman, MD, MSEE (The Ohio State University)
2:10 PM Cardiovascular Practice Needs and CMR Solutions: The Practitioner’s Perspective
Patrick O’Gara,MD (Brigham and Women’s Hospital)
2:29 PM Advancing Cardiovascular Care through Innovation, Teaching, and Community Engagement
Christopher Kramer, MD (University of Virginia)
2:48 PM The Translational Science Perspective on Myocardial Edema
José Palomares, MD on behalf of David Garcia-Dorado, MD-PhD (Universitat Autònoma de Barcelona)
3:07 PM Collaboration to Deliver Impact: The LGE Story
Robert Judd, PhD (Duke University) and Raymond Kim, MD (Duke University)
3:26 PM Team CMR Advances the Care of Patients with Congenital Heart Disease
Andrew Powell, MD (Boston Children’s Hospital)
Mehdi Hedjazi Moghari, PhD (Boston Children’s Hospital)
www.scmr.org
13
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
4:00 PM – 5:20 PM INVITED LECTURE SESSION 1: Location: Los Angeles Ballroom
Big Data and Computational Models
Moderators: Steffen Petersen, MD, DPhil, MPH (Queen Mary University London)
Declan O’Regan, PhD (Imperial College London)
At the conclusion of this session, participants will be better able to:
• Recognize the motivation of applying computational approaches to heart disease
• Identify methods for acquisition and analysis of large datasets that include CMR
• Integrate the application of big data and computational methods to mechanistic and interventional studies
4:00 PM How Can Computational Models Lead to Better Cardiovascular Care?
Declan O’Regan, PhD (Imperial College London)
4:12 PM UK Biobank- First Experiences
Steffen Petersen, MD, DPhil, MPH (Queen Mary University London)
4:24 PM The Cardiac Atlas Project
Alistair Young, PhD (University of Auckland)
4:36 PM Cardiovascular Image Understanding via Big Data
Tanveer Mahmood, PhD (Almaden Research Center)
4:48 PM Big Data in MESA: Challenges and Successes for CMR
David Bluemke, MD, PhD (National Institute of Health)
5:00 PM Computational Biofluid Dynamics Based on Four-Dimensional Flow
Michael Markl, PhD (Northwestern University)
5:12 PM
Panel Discussion: Is CMR Ready for Big Data?
4:00 PM – 5:20 PM ORAL ABSTRACT SESSION 1: Coronary Artery Disease and Acute Coronary Syndrome
Moderators: Mark Westwood, MD (The London Chest Hospital)
Sebastian Kelle, MD (German Heart Institute Berlin)
Location: Constellation
4:00 PM O 001 Prevalence of Dysfunctional but Viable Myocardium in Patients with Ischemic Cardiomyopathy – Results from
Clinical Scans Performed in 2010-2014 at Four U.S. Hospitals
Aditya Mandawat, MD (Duke University Hospital)
4:10 PM O 002 The Clinical Value of Stress Cardiac Magnetic Resonance Imaging in Symptomatic Patients with Low to
Intermediate Acute Coronary Syndrome Risk
Wei Dong (Beijing Anzhen Hospital)
4:20 PM O 003 Subclinical Systolic and Diastolic Dysfunction in Women with Signs and Symptoms of Ischemia But No
Obstructive Coronary Disease: Novel Insights Using Myocardial Feature Tracking in the NHLBI WISE Study
Michael Nelson, PhD (Barbra Streisand Women’s Heart Center, Cedars-Sinai Medical Center)
4:30 PM O 004 3D-Dixon Cardiac Magnetic Resonance Detects an Increased Epicardial Fat Volume in Hypertensive Men with
Myocardial Infarction
Rami Homsi (University Hospital Bonn)
4:40 PM O 005 Assessment of Coronary Wall Thickening in Autosomal Dominant Hyper- immunoglobin E Syndrome (AD-HIES)
Using TRAPD-MRI
Khaled Abd-Elmoniem, PhD (NIH)
4:50 PM O 006
Markers of Abnormal Tissue Deformation and Fibrosis in Remote Myocardium Following Acute Myocardial
Infarction: A Comparison of Diabetics Versus Non-diabetics Performed Using Spatially Matched 4D Strain and
Native T1 Mapping
Alessandro Satriano, PhD (Stephenson Cardiac Imaging Centre, University of Calgary)
5:00 PM O 007 Non-contrast Myocardial Perfusion Assessment in Porcine Acute Myocardial Infarction using Arterial Spin Labeled CMR
Hung Do, PhD (University of Southern California)
5:10 PM O 008 Nonlinear Myocardial Perfusion Imaging with Motion Corrected Reconstruction: Validation via Quantitative
Flow Mapping
Hui Xue, PhD (National Institutes of Health)
14
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
4:00 PM – 5:20 PM CASE REVIEW 1: Physiology or Pathology? Questions in Sports
Moderators: Gerry McCann, MD (Leicester, UK)
Clerio Avezedo, MD (Rio de Janeiro, Brazil)
Location: Pacific Palisades
4:10 PM CR 02 Relative Apical Hypertrophy – Disease or Incidental Finding?
Paul Scully, MBBS MRes (Ashford and St Peter’s Hospitals NHS Foundation Trust)
4:20 PM CR 03 Time to Play? A Subtype of Apical Hypertrophic Cardiomyopathy Presenting as Chest Pain in a Professional Athlete
Tendoh Timoh, MD (Medstar Georgetown University Hospital and Washington Hospital Center)
THURSDAY PROGRAM
4:00 PM CR 01 Trabeculations of The Left Ventricle; Novel Cardiomyopathy or Physiological Adaptation to Exercise
Sabiha Gati, MRCP (St. Georges’ University)
4:30 PM CR 04 Myocarditis or Physiologic T2 Increase in a Swimmer
Emily A Ruden, MD (The Ohio State Univeristy)
4:40 PM CR 05 PVCs in a Soccer Player
Clerio Azevedo, MD, PhD (Clínica de Diagnóstico por Imagem - CDPI/DASA) 4:50 PM CR 06 Focal Fibrosis and Lipomatous Metaplasia Seen in a 77 Year Old Former Marthon Runner and
Athlete with Palpitations
Daniel W Groves, MD (Cardiovascular Pulmonary Branch, NIH/NHLBI)
5:00 PM CR 07 Asymptomatic Athlete with Family History of DCM
Christopher Miller, MBChB (University Hospital of South Manchester)
5:10 PM CR 08 Time to Quit? Apical Hypertrophic Cardiomyopathy in a Marathon Runner
Justin H. Beckett. MD (Medstar Georgetown UniversityHospital)
4:00 PM – 5:20 PM ORAL ABSTRACT SESSION 2: Translational CMR
Moderators: Allison Hays, MD (Johns Hopkins)
Wolfgang Rehwald, PhD (Siemens Medical Solutions)
Location: Olympic
4:00 PM O 009 Differential Responses of Post-Exercise Recovery Leg Blood Flow and Oxygen Uptake Kinetics
in HFPEF versus HFREF
Richard Thompson, PhD (University of Alberta)
4:10 PM O 010 An Interactive Videogame Designed to Optimize Respiratory Navigator Efficiency in Children
Undergoing Cardiac Magnetic Resonance
Sean Hamlet, MS (University of Kentucky, University of Kentucky)
4:20 PM O 011 Quantitative Myocardial Perfusion Imaging Using a Step Arterial-Input Function
Richard Thompson, PhD (University of Alberta)
4:30 PM O 012 Reliable Detection of Subendocardial Ischemia by High-Resolution End-Systolic First-Pass
Perfusion Imaging in the Absence of Obstructive Coronary Disease
Behzad Sharif, PhD (Cedars-Sinai Medical Center)
4:40 PM O 013 Regional Coronary Endothelial Dysfunction is Related to Local Epicardial Fat in HIV+ Patients
Allison Hays, MD (Johns Hopkins)
4:50 PM O 014 Standardised Postprocessing of Native T2 in Detection and Discrimination of Myocarditis Comparison with Native T1 Mapping
Valentina Puntmann, MD, PhD, FRCP (University Hospital Frankfurt)
5:00 PM O 015 The Incretin Axis offers a Novel Therapeutic Target to Preserve Myocardial Energy Metabolism
in Cardiorenal Syndrome
Marie Schroeder, DPhil (Sunnybrook Health Sciences Centre)
5:10 PM O 016 Molecular MRI of Myocardial Peroxidase Activity in Ischemic Injury Reveals a Chemical Milieu
Incompatible with Stem Cell Survival
Howard Chen, PhD (Massachusetts General Hospital, Harvard Medical School)
5:30 PM – 6:00 PM
CMR TECHNOLOGY UPDATE
6:00 PM – 7:00 PM Welcome Reception, Poster Group P 1 & Exhibits
www.scmr.org
Location: Westwood
Location: California Showroom
15
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
FRIDAY, JANUARY 29, 2016
7:30 AM – 8:30 AM Physics for Physicians: What Your Technologist Wish You Knew
Location: Los Angeles
Moderators: Stephen Darty, BS, RT(N)(MR) (Duke University Medical Center)
Elizabeth Jenista, PhD (Duke University Medical Center)
At the conclusion of this session, participants will be better able to:
• Identify key scan types and parameters influencing MR image weightings
• Consider alternate scanning approaches to deliver a useful CMR exam when triggering and breath-holding are limited
• Address MR safety questions that arise before and during scanning
7:30 AM T1, T2, and Other Weightings in Typical CMR Acquisitions
Elizabeth Jenista, PhD (Duke University Medical Center)
7:50 AM When Good Triggering and Breathholding Go Bad: What are your Options?
Stephen Darty, BS, RT(N) (MR) (Duke University Medical Center)
8:10 AM Is It Safe To Put This Patient (Back) in The Scanner? Questions That Arise During Screening and Scanning
Anna Lisa Crowley, MD (Duke University Medical Center)
7:30 AM – 8:30 AM Cardiology for Non-Clinicians: Location: Constellation
What the Sick Patient in the Scanner Needs You to Know
Moderators: Daniel Lee, MD (Northwestern University)
Daniel Messroghli, MD (German Heart Institute Berlin)
At the conclusion of this session, participants will be better able to:
• Recognize CMR’s value in the sick patient with cardiovascular disease
• Prescribe practical CMR approaches when scanning sick patients
• Develop strategies for inpatient care coordination guided by CMR
7:30 AM High Risk, High Reward: CMR in The Hospitalized Patient with Cardiovascular Disease
Sharon Roble, MD (The Ohio State University)
7:45 AM Get What You Need, Then Get Out of Dodge: Fast Scanning Techniques
Deborah Kwon, MD (Cleveland Clinic)
8:00 AM To Stress or Not To Stress, That Is The Question
Pairoj Rerkpattanapipat, MD (Piedmont Cardiology Associates)
8:15 AM
Panel Discussion: My Biggest Disasters: What I Learned
7:30 AM – 8:30 AM CASE REVIEW 2:
Location: Olympic
The Patient Referred for Evaluation of Ischemic Heart Disease
Moderators: Christopher Dyke, MD (Alaska Heart Institute)
Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute)
7:30 AM CR 09
Ventricular Intramyocardial Dissection, Ventricular Aneurysm and Ventricular Septal Rupture
Presenting as a Delayed Complication of Inferoseptal Myocardial Infarction: The Value of
Cardiac MR in Multimodality Imaging Correlation for Diagnosis and Management
Joao Inacio, MD (The Ottawa Hospital, Ottawa Hospital Research Institute)
7:40 AM CR 10 Stress CMR in a Device Patient; A Viable option?
Ashley Nickerson, DO (University of Kentucky)
7:50 AM CR 11 Unlikely Events are Very Likely as Soon as They Have Occurred
Britt-Marie Ahlander, RN (Divisions of Medical Diagnostics, Linkoping University)
8:00 AM CR 12 Global Myocardial Hibernation
Gabriella Di Giovine, MD (A.O.U. Maggiore della Carità in Novara, Italy)
8:10 AM CR 13 Expansion of Left Ventricular Inferior Wall Pseudoaneurysm Following Myocardial Infarction
Amita Singh, MD (University of Chicago Hospitals)
8:20 AM CR 14 MTHFR and G20210A Prothrombin Gene Mutations as a cause of Early Coronary Artery Disease
and Ventricular Thrombi: CMRI Assessment of Viability and Thrombus Characterization
Menhel Kinno, MD (Rutgers University - New Jersey Medical School)
16
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
7:30 AM – 8:30 AM Careers in CMR: Aligning Your Path Across Opportunities Location: Westside
Moderators: Timothy Albert, MD (Tanner Health System)
Yiu-Cho Chung, PhD (Lauterbur Research Center Shenzhen)
At the conclusion of this session, participants will be better able to:
• Construct CMR-related career development strategies
• Recognize common and distinct expectations across career pathways
• Establish inter-disciplinary partnerships that foster career development
7:30 AM Academics
Eike Nagel, MD, PhD (Goethe University)
8:00 AM Community Practice
Michael Elliott, MD (Sanger Heart and Vascular Institute)
8:15 AM
Resonant Frequencies and Overlapping Bandwidths: Matching Interests to Job Opportunities
8:40 AM – 10:00 AM ORAL ABSTRACT SESSION 3: Basic Science (Early Career Awards)
Moderators: Michael Jerosch-Herold, PhD (Brigham and Women’s Hospital)
Albert de Roos (Leiden University)
Location: Constellation
8:40 AM O 017 Quantifying Passive Myocardial Stiffness and Wall Stress in Heart Failure Patients Using
Personalized Ventricular Mechanics
Zhinuo Jenny Wang, PhD (University of Auckland)
FRIDAY PROGRAM
7:45 AM Industry
Denise Yates, PhD (Novartis Institutes for Biomedical Research)
8:50 AM O 018 In Vivo Cardiac DTI on a Widely Available 3T Clinical Scanner: an Optimized M2 Approach
Christopher Nguyen, PhD (Cedars-Sinai Medical Center)
9:00 AM O 019
Towards Reliable Myocardial Blood-Oxygen-Level-Dependent (BOLD) CMR Using Late
Effects of Regadenoson with Simultaneous 13N-ammonia PET Validation in a Whole-body
Hybrid PET/MR System
Hsin-Jung Yang, MS (Cedars Sinai Medical Center)
9:10 AM O 020 Combining Acquisition and Image Processing Methods to Improve Evaluation of Arial
Wall Scar Patterns after Pulmonary Vein Isolation
Adrian Lam (Georgia Institute of Technology)
9:20 AM O 021 Comparison of Oscillatory Wall Shear Stress in the Abdominal Aorta of Men and Women:
Relationship to Abdominal Aortic Aneurysm (AAA) Development
Elizabeth Iffrig (Emory University, Georgia Institute of Technology)
9:30 AM O 022 Coronary Atherosclerosis T1-weighed Characterization with integrated anatomical
reference (CATCH)
Yibin Xie (Cedars-Sinai Medical Center)
9:40 AM O 023 The Shape of the Healthy Heart Is Optimized for Vortex Ring Formation
Per Arvidsson, MD (Lund University)
9:50 AM O 024 Assessment of Metformin Induced Changes in Cardiac Redox State Using
Hyperpolarized[1-13C]pyruvate
Andrew Lewis (University of Oxford)
8 :40 AM – 10:00 AM INVITED LECTURE SESSION 2: Game Changers in CMR
Location: Los Angeles
Moderators: Stefan Neubauer, MD (Oxford University)
Michael Salerno MD, PhD (University of Virginia)
At the conclusion of this session, participants will be better able to:
• Investigate novel approaches that offer significant advances in CMR
• Summarize new techniques for myocardial tissue characterization and their basis
• Recognize novel methods to shorten scan time and overcome gating and breathholding limitations
8:40 AM New Frontiers in Advanced Image Reconstruction
Leon Axel, PhD, MD (New York University School of Medicine)
www.scmr.org
17
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
8:56 AM Novel Non-Contrast CMR Approaches
Andreas Kumar, MD (Laval University)
9:12 AM Advanced Applications and Techniques for First Pass Perfusion CMR
Behzad Sharif, PhD (Cedars-Sinai Medical Center)
9:28 AM ECV: What Are We Really Measuring?
Håkan Arheden, MD, PhD (Lund University)
9:44 AM The Future of Non-ECG and Non-Breath-hold Techniques
Debiao Li, PhD (Cedars-Sinai)
8 :40 AM – 10:00 AM CASE REVIEW 3:
Location: Olympic
The Patient Referred for a Cardiac Mass with Pathologic Correlation
Moderators: M. Barbara Srichai-Parsia, MD (Georgetown University)
Jennifer Dickerson, MD (The Ohio State University)
8:40 AM CR 15 Papillary Fibroelastoma: A Known Cause of TIA in an Uncommon Location
Rajesh Janardhanan, MD, MRCP, FACC, FASE (Sarver Heart Center, University of Arizona)
8:50 AM CR 16 An Unusual Case of Biventricular Hypertrophy
Anna Baritussio (Bristol Heart Institute)
9:00 AM CR 17 The Case of the Pulsating Pimple
Nayla Chaptini, MD (Advocate Heart Institute, Advocate Lutheran General Hospital)
9:10 AM CR 18 Intrapericardial Paraganglioma
Lorenzo Monti, MD (Humanitas Research Hospital)
9:20 AM CR 19 Unusual Cause of Angina in a Young Male
Elizabeth Joseph (Christian Medical College)
9:30 AM CR 20 A Rare Case of Left Atrial Sarcoma: Role of CMR in the Diagnosis and Management
Naveen Rajpurohit, MD (Piedmont Heart Institute)
9:40 AM CR 21 An Unusual Case of a Usual Suspect
Jorge Gonzalez, MD (University of Virginia)
9:50 AM CR 22 Multimodality Imaging of an Unusual Presentation of LV Lipoma
Roy Sasil (Philippine Heart Center)
8:40 AM – 1
0:00 AM ORAL ABSTRACT SESSION 4: Congenital Heart Disease I
Moderators: Brian Soriano, MD (Seattle Children’s Hospital)
David Parra, MD (Vanderbilt Children’s Hospital)
Location: Westside
8:40 AM O 025 The Right Ventricle in Congenital Heart Disease - Cardiac T1 Mapping for Measurements of
Diffuse Myocardial Fibrosis
Nadya Al-Wakeel (Deutsches Herzzentrum Berlin)
8:50 AM O 026
Quantifying Right Ventricular Diffuse Fibrosis in Tetralogy of Fallot - A Novel Customised
Approach for The Challenges of the Right Ventricle
Ee Ling Heng, MBBS BSc MRCP (Royal Brompton & Harefield NHS Foundation Trust and
Imperial College London)
9:00 AM O 027 Diffuse Myocardial Fibrosis Using Native T1 Mapping in Children with Repaired
Tetralogy of Fallot: Correlation with Surgical Factors and Exercise Capacity
Deane Yim, MBchB (Hospital for Sick Children)
9:10 AM O 028 Diffuse Myocardial Fibrosis in Patients After Fontan Operation: A T1 Relaxometry
Magnetic Resonance Pilot Study
Atsuko Kato, MD (The Hospital for Sick Children)
9:20 AM O 029 The Relative Importance and Interactions of CMR-Derived Parameters of Ventricular Mechanics
in the Prediction of Death and Transplant Late after the Fontan Operation
Rahul Rathod, MD (Boston Children’s Hospital, Harvard Medical School)
9:30 AM O 030 The Impact of Ventricular Morphology on Wall Stress and Ventricular Strain in Fontan Patients
Sunil Ghelani, MD (Boston Children’s Hospital)
18
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
9:40 AM O 031 Feature Tracking (Ft) and Extracelluar Volume (Ecv) by Cardiac Magnetic Resonance
Segmentally Analyze Change of Lv in Ebstein: A Novel Perspective in Myocardial Remodeling
Dan Yang (West China Hospita Sichuan University)
9:50 AM O 032 Association of Ventricular Dyssynchrony and Strain with Cardiac Function in Patients with
Repaired Tetralogy of Fallot
Linyuan Jing, PhD (Geisinger Health System University of Kentucky)
Location: Plaza Foyer
8:40 AM Q 01 Realtime Cardiac Function Using Compressed Sensing: Initial Clinical Evaluation
Volker Rasche (University Hospital of Ulm)
8:48 AM Q 02 CMR-Based 3D Statistical Shape Modelling Reveals Left Ventricular Morphological Differences
Between Healthy Controls and Arterial Switch Operation Survivors
Jan Bruse, MSc (UCL Institute of Cardiovascular Science)
8:56 AM Q 03 Aging and Gender Effects in Native T1 and Extracellular Volume Fraction Assessment Using Sasha
Joseph Pagano, MD (University of Alberta)
9:04 AM Q 04 Epicardial Adipose Tissue, Aortic Stiffness and Myocardial Fibrosis in Healthy Individuals:
A Quantitative Cardiac Magnetic Resonance Study
Rami Homsi (University Hospital)
FRIDAY PROGRAM
8:40 AM – 10:00 AM WALKING POSTER SESSION 1: Methods to Analyze Tissue and Function
Moderators: Victor A. Ferrari, MD (University of Pennsylvania Medical Center)
Orlando P. Simonetti, PhD (The Ohio State University)
9:12 AM Q 05 T1 and T2 Mapping Reveal Contribution of Hemorrhage in Myocardial Remodeling Following
Acute Myocardial Infarction
Nilesh Ghugre, PhD (Sunnybrook Research Institute, University of Toronto)
9:20 AM Q 06 Validation of a Novel Dark-Blood Delayed Enhancement Technique for the Detection of
Papillary Muscle Scar
Dave Wendell, PhD (Duke University)
9:28 AM
Q 07 Withdrawn
9:36 AM Q 08 Accuracy of Ecv Imaging for the Detection of Subendocardial Infarction – Comparison with
Black Blood Delayed Enhancement and Pathology
Elizabeth Jenista, PhD (Duke University)
9:44 AM Q 09 Comparison of T1-Mapping and T2-Weighted Imaging for Diagnostic Oedema Assessment in
St-Segment Elevation Myocardial Infarction
Sheraz Nazir, BSc, MB BChir, MRCP (University of Leicester)
9:52 AM Q 10 Comparison of T2-Preparation and Magnetization-Transfer Preparation for Black Blood
Delayed Enhancement
Elizabeth Jenista, PhD (Duke University)
10:00 AM–10:30 AM
REFRESHMENT BREAK/EXHIBITS
10:40 AM–12:00 PM INVITED LECTURE SESSION 3: CMR Practice Models Around the World
Location: Los Angeles
Moderators: Lilia M Sierra-Galan, MD (ABC Medical Center)
Carmen Chan, MBBS (University of Hong Kong)
At the conclusion of this session, participants will be better able to:
• Recognize distinct health care system factors that impact the delivery of CMR to appropriate patients around the world
• Examine regional differences in employment opportunities and staffing needs to deliver CMR services
• Summarize current training opportunities and mechanisms to address training gaps
10:40 AM Latin America: Challenges and Opportunities
Lilia Sierra-Galan, MD, FACC, FSCCT (American British Cowdray Medical Center)
10:52 AM India: Challenges and Opportunities
Elizabeth Joseph, MBBS, DMRD, DNB (Christian Medical College)
www.scmr.org
19
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
11:04 AM Australia and New Zealand: Challenges and Opportunities
Sylvia Chen, MBBS (The Northern and The Epworth Hospitals)
11:16 AM Japan: Challenges and Opportunities
Hajime Sakuma, MD, PhD (Mie University Hospital)
11:28 AM China: Challenges and Opportunities
Yucheng Chen, MD (West China Hospital, Sichuan University)
11:40 AM CMR in Medical Tourism
Vimal Raj, MBBS (Narayana Hrudayalaya Hospitals)
11:52 AM
Rapid-Fire Roundtable: Appropriate, Inappropriate, Uncertain
10:40 AM–12:00 PM ORAL ABSTRACT SESSION 5: Clinical CMR (Early Career Awards)
Moderators: W. Gregory Hundley, MD (Wake Forest University)
Joao Lima, MD (Johns Hopkins)
Location: Constellation
10:40 AM O 033 Right Atrial Volume Indexed by Cardiovascular Magnetic Resonance as a Predictor of Mortality in Patients with Heart Failure with Reduced Ejection Fraction
Alexander Ivanov, MD (New York Methodist Hospital)
10:50 AM O 034 Prognostic Value of MRI T2 Quantification in Heart Transplant Patients:
A 5-year Outcome Study
Varun Chowdhary, MD (Northwestern University, Staten Island University Hospital)
11:00 AM O 035
Successful Ablation of Atrial Fibrillation does not Normalise Left Ventricular Function,
Reverse Impaired Myocardial Energetics or Increase Perfusion Reserve: Novel Mechanistic
Insights with Clinical Implications
Rohan Wijesurendra, MB BChir MA (Cantab) MRCP (University of Oxford)
11:10 AM O 036
Myocardial Perfusion Reserve but not fibrosis Predicts Outcomes in Initially Asymptomatic Patients with Moderate
to Severe Aortic Stenosis: The PRognostic Importance of MIcrovascular Dysfunction in AS study- PRIMID AS
Anvesha Singh, MBChB (University of Leicester and the NIHR Leicester Cardiovascular Biomedical
Research Unit)
11:20 AM O 037 Diffuse Myocardial Fibrosis – A Therapeutic Target? Proof of Regression At 1-Year Following
Aortic Valve Replacement: The RELIEF-AS Study
Thomas Treibel, MBBS (Barts Heart Centre, Institute for Cardiovascular Sciences, University College London)
11:30 AM O 038 CMR Findings in High Endurance Veteran Athletes – a 247 subject study
Viviana Maestrini, MD (La Sapienza)
11:40 AM O 039
Ultrafast CMR to Deliver High Volume Screening of an at Risk Thalassemia Population in the
Developing World: Preliminary Results from the TIC-TOC Study (Thailand and UK International
Collaboration in Thalassaemia Using an Optimised Ultrafast CMR Protocol)
Amna Abdel-Gadir, MBBS, MRCP (University College London, Barts Heart Centre)
11:50 AM O 040 Occult Senile Cardiac Amyloid in Severe Calcific Aortic Stenosis is Not Rare and has a Poor
Prognosis: A 146 Patient CMR Biopsy Study
Thomas Treibel, MBBS (Barts Heart Centre, Institute of Cardiovascular Sciences, University College London)
10:40 AM–12:00 PM CASE REVIEW 4: The Patient Referred for Vascular Imaging
Moderators: John Heitner, MD (New York Methodist Hospital)
Robert Edelman, MD (Evanston Hospital)
Location: Olympic
10:40 AM CR 23 Aortitis Masquerading as Chest Pain
Clint Walters, MD (Georgia Regents University)
10:50 AM CR 24 A Man with Broad-complex Tachycardia and Dilated Cardiomyopathy
Anna Baritussio (Bristol Heart Institute)
11:00 AM CR 25 Is This a Vascular Ring?
Tiffanie Johnson, MD (Riley Hospital for Children/Indiana University)
11:10 AM CR 26 Evaluation of Severe Pulmonary Arterial Hypertension Using Cardiovascular Magnetic Resonance
El-Sayed Ibrahim (University of Michigan)
20
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
11:20 AM CR 27 3D Printing from Cardiac Magnetic Resonance Imaging for Surgical Planning in a Patient with Superior-Inferior
Ventricles, Criss-Cross Atrio-Ventricular Inflows, Atrial and Ventricular Septal Defects and Left Lung Collapse
Shafkat Anwar, MD (St. Louis Children’s Hospital, Washington University School of Medicine)
11:30 AM CR 28 Venous Confluence in an Adult
Alexander Ivanov, MD (New York Methodist Hospital)
11:40 AM CR 29 Usefulness of Cardiac MRI in Assessment of Aortic Stenosis
Amitabh Parashar, MD (VAMC Salem, Virginia Tech Carilion SOM)
10:40 AM–12:00 PM INVITED LECTURE SESSION 4: Location: Westside
Congenital Scanning: Beyond Structure and Function
Moderators: Lars Grosse-Wortman, MD (University of Toronto)
Gerald Greil, MD, PhD, UT (Southwestern, Dallas, TX)
At the conclusion of this session, participants will be better able to:
• Differentiate submaximal from maximal stress, and when each can be used in pediatric and congenital heart disease
• Determine the predictive utility of late gadolinium enhancement for poor outcomes in pediatric and congenital
heart disease
• Evaluate the role for assessment of vascular function by CMR in the pediatric and congenital heart patient population
10:40 AM
FRIDAY PROGRAM
11:50 AM CR 30 Pulmonary Artery Dissection in Patients with Eisenmenger’s Syndrome and Conservative Medical Treatment
Kyung-Hee Kim, MD, PhD (Sejong General Hospital)
Congenital and Pediatric Stress CMR: What Should I Do, When, and When Not?
Cory Noel, MD (Texas Children’s Hospital)
10:55 AM Stress Testing for Functional Capacity, Not Ischemia, in Congenital Heart Disease
Heiko Stern, PhD (German Heart Center)
11:10 AM Myocardial Viability in Pediatric and Congenital Heart Disease, Can We Risk Stratify?
Rahul Rathod, MD (Boston Children’s Hospital)
11:25 AM Vascular Function and Vessel Wall Imaging: Fad or Future for Pediatric and Congenital Heart Disease?
Tarique Hussain, MD, PhD (King’s College London)
11:40 AM Catheterization and CMR for Congenital Heart Disease
Kanishka Ratnayaka, MD (National Institutes of Health)
Location: Plaza Foyer
10:40 AM–12:00 PM WALKING POSTER SESSION 2: CMR in Coronary Artery Disease
Moderators: Jeanette Schulz-Menger, MD (Charite Universitatsmedizin and HELIOS Clinics)
Peter Kellman, PhD (National Institute of Health)
10:40 AM Q 11
Diagnostic Accuracy of Dixon Water Fat Suppression Coronary Artery Magnetic Resonance
Angiography at 3.0 Tesla
David Ripley, MBChB (University of Leeds)
10:48 AM Q 12 The Feasibility of Combining Low-Level Exercise with Vasodilator Stress in Patients Referred
for Stress Perfusion Cardiac MRI
Jason Craft, MD (Advocate Christ Medical Center)
10:56 AM Q 13 Diagnosis of Chronic Allograft Vasculopathy Using Semiquantitative Stress Perfusion CMR
in Heart Transplant Patients
Madeline Schwid (Northwestern University)
11:04 AM Q 14 Correcting T2* Effects in the Myocardial Perfusion Arterial Input Function Avoids
Overestimation of Myocardial Blood Flow
Hui Xue, PhD (National Institutes of Health)
11:12 AM Q 15 Combined High-resolution Assessment of Quantitative Perfusion and Late Enhancement.
Towards Accurate Estimation of the Ischaemic Burden in Patients with Coronary Artery Disease.
Adriana Villa, MD (King’s College London)
11:20 AM Q 16 Comparison of Derived Strain Values of Myocardial Regions, Levels, and Segments by Field
Strength and Temporal Resolution via Cine bSSFP MR Imaging
Eric Keller, MA (Northwestern University)
www.scmr.org
21
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
11:28 AM Q 17 Correlations and Validations of Dual-Bolus and Dual-Sequence Quantification of First-Pass Myocardial Perfusion CMR in Humans and Canines
Li-Yueh Hsu, D.Sc (National Heart Lung and Blood Institute, National Institutes of Health)
11:36 AM Q 18 T1 Measurements in a Rat Model of Acute Myocardial Ischemia/reperfusion
Darach O h-Ici, MB (German Heart Institute)
11:44 AM Q 19 Association of Smoking with Myocardial Injury and Clinical Outcome in Patients Undergoing
Mechanical Reperfusion for ST-Elevation Myocardial Infarction
Ingo Eitel, MD (University Heart Center Lübeck)
11:52 AM Q 20 Overall Impact of Outpatient Stress Cardiac Magnetic Resonance (CMR) Imaging on Clinical
Care is Independent of Appropriate Use Criteria
Sloane McGraw, DO (University of Illinois- Chicago)
SCMR BUSINESS MEETING
2:00 PM–12:30 PM
1
Moderator: Victor Ferrari, MD, SCMR President (University of Pennsylvania)
SCMR Leadership will present important society updates including the progress of the Global CMR Registry
and the activities of the U.S. Working Group. All members are encouraged to attend.
12:30 PM– 1:30 PM
LUNCH/EXHIBITS/POSTER GROUP P 2
1:30 PM – 2:50 PM INVITED LECTURE SESSION 5: Location: Los Angeles
Multimodality Imaging to Guide Surgical and Transcatheter Valve Repair
Moderators: Yuchi Han, MD (University of Pennsylvania)
Ingo Eitel, MD (University of Leipzig - Heart Center)
At the conclusion of this session, participants will be better able to:
• Recognize various modalities’ roles in evaluating valvular heart disease
• Identify key questions for cardiovascular imaging in planning transcatheter valve interventions
• Develop integrated approaches to imaging the patient with aortic stenosis
1:30 PM CMR Advances in Valvular Regurgitation
Seth Uretsky, MD (Atlantic Health System)
1:44 PM Echocardiography in Low Gradient Aortic Stenosis
Jiwon Kim, MD (Weill-Cornell University)
1:58 PM CTA in Transcatheter Interventional Planning
Jonathon Leipsic, MD (University of British Columbia)
2:12 PM Nuclear Imaging of the Right Heart in Valvular Disease
Daniel Berman, MD (Cedars-Sinai Medical Center)
2:26 PM Valvular Heart Disease: When I Must Have Invasive Data
Florian Boenner, MD (University of Duesseldorf)
2:40 PM
Panel Discussion: an 85 Year-Old Woman Presents with Severe AS: What Is Your Workflow?
1:30 PM – 2:50 PM ORAL ABSTRACT SESSION 6: Tissue Characterization Moderators: Christopher Miller, MBChB (University Hospital of South Manchester)
Marianna Fontana (The Heart Hospital)
1:30 PM O 041
Location: Constellation
Apparent Diffusion Coefficient (ADC), T1 and T2 Quantitative Indexes of the Myocardium in Athletes Before,
Duringand After Extreme Mountain Ultra-marathon: Correlation with Myocardial Damages and
Inflammation Biomarkers
Magalie Viallon, PhD (CREATIS/ CHU de Saint Etienne)
1:40 PM O 042 Native Myocardial T1 and ECV with Age and Gender Developing Normal Reference Ranges –
A 94 Healthy Volunteer Study
Stefania Rosmini, MD (Cardiac Imaging)
1:50 PM O 043 Tissue Characterization with Native T1 Mapping in Suspected Coronary Microvascular Dysfunction and No
Obstructive Coronary Artery Disease: Results from the NHLBI-sponsored WISE Study
Jaime Shaw, PhD (Cedars-Sinai Medical Center, UCLA)
22
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
2:00 PM O 044 Relationship Between the Transmural Extent of High Resolution Parametric (T1- and T2)
Mapping and the Ischemic Area at Risk Defined by Pathology
Dave Wendell, PhD (Duke University)
2:10 PM O 045 Does T1-mapping in Border-Zone and/or Remote Regions can Help to Predict Functional
Recovery After Revascularization in Chronic Coronary Total Occlusion (CTO) patients?
Pierre Croisille, MD PhD (CHU Saint-Etienne)
2:30 PM O 047 Cardiac Magnetic Resonance in Heart Transplant Patients: Diagnostic Value of Quantitative
Tissue Markers (T2 Mapping and ECV) for Acute Cardiac Rejection Diagnosis
Emmanuelle Vermes, MD (CHU TROUSSEAU)
2:40 PM O 048 Incremental Benefit in Correlation with Histology of Native T1 Mapping, Partition Coefficient and Extracellular Volume Fraction in Patients with Aortic Stenosis
Vassilis Vassiliou, MA, MBBS, MRCP (Royal Brompton Hospital, Imperial College London)
1:30 PM – 2:50 PM CASE REVIEW 5: The Adult Patient Referred for Evaluation of Congenital Heart Disease
Moderators: Ali Zaidi, MD (Montefiore Medical Center)
Sharon Roble, MD (The Ohio State University)
Location: Olympic
FRIDAY PROGRAM
2:20 PM O 046 Quantitative Assessment of Diffuse Myocardial Fibrosis in II-Type Diabetes Mellitus Patients
Using T1 Mapping Technique: Preliminary Data
Iacopo Carbone, MD (Sapienza - University of Rome)
1:30 PM CR 31 Unusual Findings in a Patient with Chronic Pulmonary Hypertension: Diagnostic Value of Cardiac MRI/MRA
Mohit Pahuja, MD (St. Josephs Hospital and Medical Center)
1:40 PM CR 32 A Young Man with Dilated Right Ventricle
Anna Baritussio (Bristol Heart Institute)
1:50 PM CR 33 Sub-Aortic Membrane: Role of Multi-Modality Imaging
Ruchit Shah, MD (Georgia Regents University)
2:00 PM CR 34 Aortopulmonary Window: A Rare Etiology of Dyspnea in an Adult
Lindsey McPhillips, DO (Northshore Long Island Jewish- Cohen Children’s Medical Center)
2:10 PM CR 35 An Extremely Rare Congenital Cardiomyopathy Presenting in an Adult (<15 reported cases):
“Apical Hypotrophy”
Arash Seratnahaei, MD (UKMC)
2:20 PM CR 36 Double Chambered Right Ventricle: Initial Presentation in Adulthood
Olga Toro-Salazar, MD (Connecticut Children’s Medical Center, University of Connecticut)
2:30 PM CR 37 An Unusual Case of ‘Dextrocardia’
Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR (NIHR Cardiovascular Biomedical
Research Unit, Bristol Heart Institute)
2:40 PM CR 38 Evaluation of Left Main Coronary Artery and Left Ventricular Scar in a Patient who
Underwent Takeuchi Procedure
Ruchit Shah, MD (Georgia Regents University)
1:30 PM – 2:50 PM ORAL ABSTRACT SESSION 7: New Techniques
Moderators: Anthony Aletras, PhD (Aristotle University)
Krishna Nayak, PhD (University of Southern California)
Location: Westside
1:30 PM O 049 Quantification of Pulmonary Edema in Heart Failure using MRI: Invasive Validation and
Evaluation in HFpEF and HFrEF Patients
Richard Thompson, PhD (University of Alberta)
1:40 PM O 050 Accelerating Cine DENSE Using a Zonal Excitation
Andrew Scott (The Royal Brompton Hospital, Imperial College London)
1:50 PM O 051 Cardiac and Respiratory Self-Gated 4D Multi-phase Steady-state Imaging with Ferumoxytol
Contrast (MUSIC)
Fei Han, MS (University of California, Los Angeles)
www.scmr.org
23
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
2:00 PM O 052 Accelerated Free-Breathing Diffusion Tensor MRI of the Entire Human Heart Using
Spatiotemporal Registration and Retrospective Image Selection
Choukri Mekkaoui, PhD (Harvard Medical School - Massachussets General Hospital)
2:10 PM O 053 Coronary Artery Distensibility is Impaired in HIV Patients without Significant
Coronary Atherosclerosis
Lia Petrose (Johns Hopkins)
2:20 PM O 054 Phase-Sensitive Chemical Selection (PiSCES) Method for Fat Signal Removal in LGE
Martin Janich, PhD (GE Global Research)
2:30 PM O 055 Flow-Independent Dark-blood DeLayed Enhancement (FIDDLE): Validation of a Novel Black
Blood Technique for the Diagnosis of Myocardial Infarction
Han Kim, MD (Duke University Medical Center/Duke Cardiovascular Magnetic Resonance Center)
2:40 PM O 056 High-Resolution Late Gadolinium Enhancement Imaging with Compressed Sensing:
A Single-Center Clinical Study
Mehmet Akcakaya, PhD (University of Minnesota, University of Minnesota)
1:30 PM – 2:50 PM WALKING POSTER SESSION 3: Clinical Outcome and Prognosis
Moderators: Dudley J Pennell, MD (Royal Brompton Hospital)
Michael Jerosch-Herold (Brigham and Women’s Hospital)
Location: Plaza Foyer
1:30 PM Q 21 Left Atrial Volume and Function Are Predictive of Cardiac Death or Appropriate Device
Therapy in Patients with Non-Ischemic Dilated Cardiomyopathy
Punitha Arasaratnam, MRCP (Stephenson Cardiac Imaging Centre, Libin Cardiovascular Institute of Alberta)
1:38 PM Q 22 Cardiac Magnetic Resonance Imaging in Healthy Volunteers in Normoxic and Hypoxic Exercise
Shareen Jaijee, MBBS, FRACP (Medical Research Council)
1:46 PM Q 23 Pulmonary Blood Volume Variation Indexed to Stroke Volume and Perfusion Gradients:
Novel Diagnostic Tools in Heart Failure
Mariam Al-Mashat, MSc (Skane University Hospital, Lund University)
1:54 PM Q 24 Acute Cellular Rejection in Pediatric Heart Transplant Recipients is Associated with Abnormal
Left Ventricular Mechanics by CMR
Heynric Grotenhuis, MD, PhD (The Hospital for Sick Children, The Wilhelmina Children’s Hospital)
2:02 PM Q 25 Higher Extracellular Volume is Associated with Longer Bypass Times at Corrective Surgery and Reduced Exercise Tolerance in Children Late After Repair of Tetralogy of Fallot
Eugenie Riesenkampff, MD (Hospital for Sick Children)
2:10 PM Q 26
Electrocardiographic Detection of Left Atrial Enlargement in Arterial Hypertension:
Re-Calibration Against Cardiac Magnetic Resonance
Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR (NIHR Cardiovascular Biomedical
Research Unit, Bristol Heart Institute)
2:18 PM Q 27 Initial Cardiac Diagnostic Imaging Choicesfor Obese Patients: Cost and Outcomes
with Cardiac MRI
John Lisko, MD, MPH (Northeast Ohio Medical University (NEOMED))
2:26 PM Q 28 Reproducibility of Late Gadolidium Enhancement of Atrial Ablation Scar
Henry Chubb, MBBS (King’s College London)
2:34 PM Q 29
Cardiovascular Magnetic Resonance Characterisation of Pericardial and Myocardial
Involvement in Patients with Tuberculous Pericardial Constriction with and without
HIV Co-Infection
Ntobeko Ntusi, FCP(SA) DPhil (University of Cape Town & Groote Schuur Hospital)
2:42 PM Q 30 High Spatiotemporal Resolution Hyperpolarized 13C Angiography
Galen Reed (HeartVista)
2:50 PM – 3:40 PM
24
REFRESHMENT BREAK/EXHIBITS
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
3:40 PM – 5:00 PM INVITED LECTURE SESSION 6: Location: Los Angeles
Reducing Cost, Increasing Value, and Allocating One’s Time, Co-provided by ESCR
Moderators: Patricia Bandettini, MD (National Institutes of Health)
Nadine Kawel-Boehm, MD (University Hospital Basel)
At the conclusion of this session, participants will be better able to:
• Identify methods to improve efficiency and increase value of CMR for patients, providers and payors
• Adapt the delivery of CMR services to changing compensation models
• Recognize areas where CMR delivers unique value for cardiovascular care
3:52 PM Efficiency and Throughput on the MR Scanner in Brazil
Paulo Schvartzman, MD, PhD (Federal University of Rio Grande do Sul)
4:04 PM Delivering CMR to my Practice as a Cardiologist
Timothy Albert, MD (Tanner Health System)
4:16 PM Delivering CMR to my Practice as a Radiologist
Jens Bremerich, MD (University Hospital Basel)
4:28 PM Cost-Effectiveness for Patients, Payers and Providers
Karine Moschetti, PhD (IEMS, Unil and UET, CHUV)
FRIDAY PROGRAM
3:40 PM Efficiency and Throughput on the MR Scanner in the US
Edward Martin, MD (Oklahoma Heart Institute)
4:40 PM Values-Driven Reimbursement: Precertification of CMR
Gerald Pohost, MD (University of Southern California)
4:52 PM
Roundtable Discussion: More vs. Less CMR to Lower Healthcare Costs and Improve Outcomes
3:40 PM – 5:00 PM ORAL ABSTRACT SESSION 8: CMR and Outcome
Moderators: Daniel Lee, MD (Northwestern University)
Niels Vejlstrup, PhD (Rigshospitalet)
Location: Constellation
3:40 PM O 057 MRI Relaxation Parameters Predict Functional Outcome After Experimental
Myocardial Infarction
Sebastian Haberkorn, MD (University Hospital Duesseldorf)
3:50 PM O 058 Risk Prediction in Stable Coronary Artery Disease Using Quantified Myocardial Ischemia and
Necrosis By Cardiac Magnetic Resonance Imaging – A Prospective Long-Term Follow-Up Trial
Dominik Buckert (Uniklinik Ulm)
4:00 PM O 059 Does Revascularisation for Residual Ischaemia in Patients with ACS Influence Prognosis?
Kenneth Fung, MBBS, BSc (Barts Heart Centre, Barts Health NHS Trust)
4:10 PM O 060 Prognostic Value of CMR and Spect in Suspected Coronary Heart Disease:
Long Term Follow-Up of The CE-Marc Study
John Greenwood, MD, PhD (Leeds University, Leeds General Infirmary)
4:20 PM O 061 Prevalence and Prognosis of Non-Ischemic Patterns of Late Gadolinium Enhancement
in Older Adults by Cardiovascular MR in the Iceland-Mi Study
Sujata Shanbhag, MD, MPH (NIH/NHLBI)
4:30 PM O 062 Out of Hospital Cardiac Arrest Survivors with Inconclusive Coronary Angiogram: Impact of
Cardiovascular Magnetic Resonance on Clinical Management and Decision-Making
Anna Baritussio (Bristol Heart Institute, University of Padua)
4:40 PM O 063 Prognostic Impact of Late Gadolinium Enhancement Cardiac Magnetic Resonance in the Risk
Stratification of Heart Transplant Patients
Patrizia Pedrotti, MD (Ospedale Niguarda)
4:50 PM O 064 Prognostic Value of Dual T1 Mapping to Predict Adverse Events in Tavr-Patients:
Extra Cellular Volume as a Possible Predictor for Peri- and Post-Tavr Adverse Events
Jonathan Nadjiri (Klinikum rechts der Isar, Technische Universität München)
www.scmr.org
25
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
3:40 PM – 5:00 PM CASE REVIEW 6: The Patient Referred for Evaluation of Cardiomyopathy
Moderators: Andrew Crean, MD (Toronto General Hospital)
Karen Ordovas, MD (University of California San Francisco)
Location: Olympic
3:40 PM CR 39 Native T1 in Deciphering the Reversible Myocardial Inflammation in Cardiac Sarcoidosis
with Anti-inflammatory Treatment
Alexander Isted (King’s College London)
3:50 PM CR 40 20 Year Old Female with Pulmonary Hypertension: A Presentation of Mitral Valve Disease
or a Rare Form of Cardiomyopathy?
Jason Johnson, MD MHS (University of Tennessee, LeBonheur Children’s Hospital)
4:00 PM CR 41 Out of The Frying Pan, Into The Fire: From Untreated Thalassemia to Severe Iron Overload.
A Reflection on Modern Healthcare
Amna Abdel-Gadir, MBBS, MRCP (Institue of Cardiovascular Science, UCL, Barts Heart Centre)
4:10 PM CR 42 Serial T1 Mapping in Cardiac Amyloidosis: Can It Provide Evidence of Clinical Response to
Treatment and Reversal of Amyloid Deposition in the Myocardium?
David Hur, MD (Yale School of Medicine)
4:20 PM CR 43 A Case of Combined Arrhythmogenic Left Ventricular Cardiomyopathy with Noncompaction
of the Myocardium
Harshal Patil, MD (University of Missouri Kansas City/Saint Luke’s Mid America Heart Institute Kansas City)
4:30 PM CR 44 Acute Florid HIV-related Myocarditis with Rapid Response of Clinical and CMR Parameters
to Anti-retroviral Therapy
Sabrina Nordin (Barts Heart Centre)
4:40 PM CR 45 Dobutamine Stress Cardiac MRI for the Evaluation of Outflow Obstruction and Mitral
Regurgitation in Hypertrophic Cardiomyopathy
Edward Hulten, MD MPH (Walter Reed National Military Medical Center)
4:50 PM
CR 46 Withdrawn
3:40 PM – 5:00 PM INVITED LECTURE SESSION 7: Diffusion Cardiac Magnetic Resonance
Location: Westside
Moderators: Robert R. Edelman, MD (NorthShore University Health System Research Institute)
Dudley Pennell, MD (Imperial College London)
At the conclusion of this session, participants will be better able to:
• Summarize the scientific and clinical value of diffusion-mediated effects in the heart
• Identify the inherent technical challenges associated with diffusion CMR
• Recognize the advances (pulse sequences, processing methods and validation standards) that form basis
for the current state of the art
3:40 PM Myocardial Microstructure: What Is There To See?
Jurgen Schneider, PhD (Oxford University)
3:54 PM Diffusion Weighted Cardiac Sequences: Will It Work?
Christopher Nguyen, PhD (Cedars-Sinai Medical Center)
4:08 PM Post Processing Pipelines: What Does It Take to See Anything?
Elizabeth Tunnicliffe, PhD (Oxford University)
4:22 PM Pre clinical Results: What Can Be Visualized?
Sebastian Kozerke, PhD (Institute for Biomedical Engineering University and ETH Zurich)
4:36 PM Clinical Findings: Do You See What I See?
Sonia Nielles-Vallespin, PhD (National Institute of Health)
4:52 PM
Panel Discussion – What Resources Are Available to Shorten the Development Cycle in Diffusion CMR?
26
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
3:40 PM–5:00 PMWALKING POSTER SESSION 4: Mechanisms in Cardiovascular Disease
Moderators: Warren J. Manning, MD (Beth Israel Deaconess Medical Center)
Carlos Rochitte, MD (Heart Institute - InCor)
Location: Plaza Foyer
3:40 PM Q 31 Free-Breathing Myocardial T2* Mapping Using Gre-Epi and Moco for Myocardial and Hepatic
Iron Overload Assessment: A Multi-Center Study
Ning Jin, PhD (Siemens Healthcare)
3:48 PM Q 32 Altering Substrate Availability Profoundly Affects Left Ventricular Function in the Normal Heart
Andrew Lewis (University of Oxford)
4:04 PM Q 34 Transgenic Mice with Mutations in Nkx2.5 Gene: Animal Model Proposal to
Study Non Compaction
Julien Frandon, MD (Grenoble University Hospital, France)
4:12 PM Q 35 Using CMR To Improve the Diagnostic Accuracy of the ECG for the Detection of Left
Ventricular Hypertrophy; Production of a Simple Adjustment for Body Mass Index
Oliver Rider, BMBCH, MRCP, DPhil (University of Oxford)
4:20 PM Q 36 La Structural Remodeling is Predicted by Arterial Stiffening Independently of
Conventional Risk Factors
Miguel Vieira, MD (King’s College London British Heart Foundation Centre)
4:28 PM Q 37
FRIDAY PROGRAM
3:56 PM Q 33 Prevalence of Regional and Whole-Heart Viability in Patients with Myocardial Akinesis
Consecutively Enrolled from 4 U.S. Hospitals
Dina Labib (Duke University)
It’s Not Just The Mitral Valve - Abnormal Motion of the Whole Aorto-Mitral Apparatus Occurs
in Both Overt and Subclinical Hypertrophic Cardiomyopathy
Chinwe Obianyo (University College London, Bart’s Heart Centre and Centre for Biostatistics
and Epidemiology)
4:36 PM Q 38 Differential Effects of Body Composition on Left Ventricular Geometric Remodelling and
Aortic Elastic Dysfunction in Obesity
Jennifer Rayner (University of Oxford)
4:44 PM Q 39 A Pathway Linking Liver Fat and Arterial Stiffness – Direct as Well as Indirect Effects
Jennifer Rayner (University of Oxford)
4:52 PM Q 40
Utility of The Signal Intensity Ratio of The Spleen and Myocardium (SMR) On T2-Weighted
Short Tau Inversion Recovery Black-Blood (T2-Stir Bb) Images Compared to Semi-Quantitative
Analysis in Patients with Images with Diffuse High T2 Signal Intensity, Such as that with
Takotsubo Cardiomyopathy, Cardiac Amyloidosis, Hypereosinophilic Myocarditis, and Apical
Hypertrophic Cardiomyopathy.
Ryosuke Aoki (Saitama Cardiovasucular and Respiratory Center)
5:10 PM – 6:30 PM INVITED LECTURE SESSION 8: From Molecular Pathways to Clinical Protocols Location: Los Angeles
Moderators: David E. Sosnovik, MD (Massachusetts General Hospital, Harvard Medical School)
Brent French, PhD (University of Virginia)
At the conclusion of this session, participants will be better able to:
• Summarize key concepts in the molecular and genetic understanding of common diseases in cardiovascular medicine
• Review emerging techniques in CMR and the potential they have to provide novel molecular, cellular and genetic
information in these disease states
• Connect basic science, translational and clinical participants to foster bench-to-bedside cross-talk and communication
5:10 PM The Biology of Myocardial Regeneration
Eduardo Marbán, MD, PhD (Cedars-Sinai, UCLA)
5:22 PM Emerging Techniques to Image Myocardial Regeneration
Dara Kraitchman, VMD, PhD (Johns Hopkins University)
5:34 PM
Molecular Pathways and Substrate for Atrial Fibrillation
Akoum Nazem, MD (University of Washington School of Medicine)
www.scmr.org
27
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
5:46 PM Imaging the Left Atrium
Nassir Marrouche, MD (University of Utah)
5:58 PM The Biology of Atherosclerotic Plaque and Valvular Heart Disease
Marcella Press (UCLA)
6:10 PM
MRI of Coronary Plaque and Valves: Are We There Yet?
Rene Botnar, PhD (Kings College)
5:10 PM – 6:30 PM ORAL ABSTRACT SESSION 9: Translational CMR (Early Career Awards)
Moderators: Andrew Arai, MD (NHLBI - National Institutes of Health)
Rohan Dharmakumar, PhD (Cedars-Sinai Medical Center)
Location: Constellation
5:10 PM O 065 The Association of Left Atrial Volume with Age, Ethnicity and Cardiovascular Risk Factors in Men
and Women: The Multi-Ethnic Study of Atherosclerosis (Mesa)
Filip Zemrak, MD, MRCP (Queen Mary University of London, Barts Heart Centre)
5:20 PM O 066
Adenosine Stress and Rest T1-Mapping Differentiates Ischemic, Infarcted, Remote and Normal
Myocardium – A Novel Gadolinium-Free Method for Ischemia Detection with Immediate
Applications in Coronary Artery Disease
Alexander Liu, MBBS, BSc, MRCP (University of Oxford)
5:30 PM O 067 Multiparametric Mapping in The Diagnosis and Management of Cardiac Transplant Rejection:
A Prospective, Histologically-Validated Study
Muhammad Imran, MBBS, FRACP (St. Vincent`s Hospital, Victor Chang Cardiac Research Institute)
5:40 PM O 068
The Kinetic Energies of Left Ventricular 4D Flow Components Correlate with Established
Markers of Prognosis and Represent Novel Imaging Biomarkers in Both Ischaemic and
Dilated Cardiomyopathy
Victoria Stoll (OCMR, University of Oxford)
5:50 PM O 069 MR-Augmented Cardiopulmonary Exercise Testing- A Proof of Concept in Sickle Cell Disease (SCD)
Emmanuel Ako, MBBS (University College London, Institute of Cardiovascular Science)
6:00 PM O 070 Optimized Cardiac Cest MRI for Assessment of Metabolic Activity in the Heart
Zhengwei Zhou, MS (Cedars-Sinai Medical Center, University of California, Los Angeles)
6:10 PM O 071 Combined Ventricular Output and Oxygen Delivery Are Reduced While Oxygen Extraction
Fraction is Increased in Fetuses with Ebstein’S Anomaly by MRI
Meng Yuan Zhu (University of Toronto, The Hospital for Sick Children)
6:20 PM O 072 Improvement of Computational Fluid Dynamics Simulations of Flow in Patients with Total Cavo
Pulmonary Connection and Predicting Interventional Outcomes
Petter Frieberg, MSc (Lund University)
5:10 PM – 6:30 PM ORAL ABSTRACT SESSION 10: Systolic and Diastolic Function
Moderators: Daniel Ennis, PhD (University of California- Los Angeles, CA)
Sotirios Tsaftaris (The University of Edinburgh)
Location: Olympic
5:10 PM O 073 Pharmacologic Immunomodulation via Adenosine 2a Receptor Stimulation Improves LV
Remodeling and Systolic Strain in Regions Adjacent to the Infarct as Assessed by Cardiac MRI
Brent French, PhD (University of Virginia)
5:20 PM O 074 A Comparison of Real-time Radial GRAPPA and Standard Cine Imaging for the Evaluation of
Cardiac Function in Children and Young Adults
Jooho Kim (Northwestern University Feinberg School of Medicine)
5:30 PM O 075 Derivation of Consolidated Normal Reference Values for Right and Left Ventricular
Quantification by Cardiac Magnetic Resonance using a Novel Meta-Analytic Approach
Jonathan Afilalo, MD, MSc (Jewish General Hospital, McGill University)
5:40 PM O 076 Differences in Left Ventricular Strain Measurements between Cine DENSE Cardiac Magnetic
Resonance and SSFP Feature Tracking
Christopher Haggerty, PhD (Geisinger Clinic)
28
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
5:50 PM O 077 Relationship of Regional Myocardial Deformation and Myocardial Fibrosis to Myocardial
Trabeculation: The Multi-Ethnic Study of Atherosclerosis
Nadine Kawel-Boehm, MD (National Institutes of Health, Kantonsspital Graubuenden)
6:00 PM O 078
Relative Influence of Peak Strain Delay and Peak Strain Amplitude of Non-Scarred
Myocardium in Response to Cardiac Resynchronization Therapy: Insights from Segmental
4D Strain Analysis
Alessandro Satriano, PhD (Stephenson Cardiac Imaging Centre, University of Calgary)
6:20 PM O 080 Left Atrial Dynamics During in-scanner Exercise: A CMR Myocardial Feature Tracking Study
Vera-Christine Stahnke, MD (Institute of Diagnostic and Interventional Radiology)
5:10 PM – 6:30 PM ORAL ABSTRACT SESSION 11: Post-processing and Modeling
Moderators: Rob van der Geest, PhD (Leiden University Medical Center)
Alistair Young, PhD (Univeristy of Auckland)
Location: Westside
5:10 PM O 081 Longitudinal Automated Assessments of Myocardial Strain from Cine MR in Cancer Patients
Receiving Cardiotoxic Chemotherapy
Marie-Pierre Jolly, PhD (Siemens Healthcare)
FRIDAY PROGRAM
6:10 PM O 079 MRI Feature Tracking Strain Profiles Distinguish Patients with Left Ventricular Systolic and
Diastolic Dysfunction with and without Clinical Heart Failure
Naila Choudhary (University of Florida College of Medicine)
5:20 PM O 082 CMR Myocardial Texture Analysis Tracks Different Etiologies of Left Ventricular Hypertrophy
Rebecca Schofield (Barts Heart Centre)
5:30 PM O 083 Right Ventricular Strain, Torsion and Synchrony in Healthy Subjects Using 3D Spiral Cine Dense
Jonathan Suever, PhD (Geisinger Health System)
5:40 PM O 084 Fully Automated Segmentation of Left Atrium and Pulmonary Veins in Late Gadolinium
Enhanced MRI
Qian Tao (Leiden University Medical Center)
5:50 PM O 085 Ultrafast Computation of Left Ventricular Ejection Fraction Using Temporal Intensity Variation in
Cine Steady-State Free Precession Cardiac MR Images with or without Contrast
Amol Pednekar, PhD (Philips Healthcare)
6:00 PM O 086 Hematocrit, Iron and Hdl-Cholesterol Explain 90% of Variation in Native Blood T1
Stefania Rosmini, MD ( Barts Heart Centre )
6:10 PM O 087 Fully Automated Pixel-Wise Myocardial Blood Flow Quantification with First-Pass Perfusion CMR
Li-Yueh Hsu (National Heart Lung and Blood Institute, National Institutes of Health)
6:20 PM O 088 In-Vivo Validation of Interpolation-Based Phase offset Correction in MR Flow Quantification:
A Multi-Vendor, Multi-Center Study
Mark Hofman, PhD (VU University Medical Center)
5:10 PM – 6:30 PM WALKING POSTER SESSION 5: CMR in Myocardial Disease
Moderators: Stefan Neubauer, MD (University of Oxford)
Andrew Flett, MBBS, MD (University Hospital Southampton)
Location: Plaza Foyer
5:10 PM Q 41 Native Left Ventricular Myocardial T1 Spatial Heterogeneity in Non-Ischemic
Dilated Cardiomyopathy
Abyaad Kashem (Beth Israel Deaconess Medical Center)
5:18 PM Q 42 Cardiovascular Magnetic Resonance Can Detect Occult Anthracycline Cardiotoxicity in
Adolescents and Young Adults Cancer Survivors with Normal Ejection Fraction
Miguel Vieira, MD (King’s College London British Heart Foundation Centre)
5:26 PM Q 43 Native T1 Mapping Versus CMR Feature Tracking (Ft) Derived Strain Analysis for the Assessment of Cardiac Disease Manifestation in anderson Fabry
Anna Reid, MBChB (University Hospital of South Manchester)
5:34 PM Q 44 Native T1 Mapping in Children and Young Adults with Hypertrophic Cardiomyopathy
Keyur Parekh, MD (Northwestern University)
www.scmr.org
29
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
5:42 PM Q 45 Abnormal Myocardial T1 Mapping of Hypertrophic Cardiomyopathy in Areas without Delayed
Enhancement, as Compared to NICM and Controls at Both 1.5 and 3T
Orhan Sancaktar, MD (Medical College of Wisconsin)
5:50 PM Q 46 Evaluation of Myocardial Strain in Patients with Myocardial Amyloidosis Using
Feature-Tracking Technique
Mohan Mallikarjuna Rao Edupuganti, MD, FRACP (University of Arkansas for Medical Sciences)
5:58 PM Q 47 There is No Association Between Autosomal Dominant Polycystic Kidney Disease and Left
Ventricular Non-Compaction Cardiomyopathy: A Cardiac Magnetic Resonance Imaging Study
Shadi Akhtari, MD (Beth Israel Deaconess Medical Center)
6:06 PM Q 48 ECG, LVH and T1 Changes in Fabry Disease – Implications for Screening and Understanding
of the Disease Model
Sabrina Nordin (Barts Heart Centre)
6:14 PM Q 49 3D T1-Weighted Self-Gated Cardiac MRI for Assessing Myocardial Infarction in Mouse Models
Xin Liu, MD, PhD (Shenzhen Institutes of Advanced Technology)
6:22 PM Q 50 Free-Breathing Real-Time Cardiac Cine MR for Evaluation of Left-Ventricular Function:
Comparison to Standard Multi-Breath-Hold Cardiac Cine Mr in 50 Patients
Masashi Nakamura (Saiseikai Matsuyama Hospital)
6:30 PM – 8:30 PM CMR OUTREACH DINNER PROGRAM (Special Registration)
Moderators: Puja Mehta, MD (Cedars-Sinai Women’s Heart Center)
Lauren Baldassarre, MD (Yale CMR)
At the conclusion of this session, participants will be better able to:
• Identify solutions for cardiovascular imaging in women
• Integrate key advances in CMR to evaluate cardiovascular disease in women
• Describe steps for practice implementation of CMR
Location: Santa Monica
6:30 PM Cardiovascular Imaging in Women: Who, When, How
Leslee Shaw, PhD (Emory)
7:10 PM Q&A: What Evidence is Missing to Demonstrate Value?
Leslee Shaw, PhD (Emory)
7:20 PM CMR in 2016: Key Advances for Women
Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute)
8:00 PM Q&A: How Do You Implement CMR in a Women’s Cardiovascular Care Practice?
Chiara Bucciarelli-Ducci, MD, PhD (Bristol Heart Institute)
8:10 PM
Roundtable Discussion and Audience Q&A
SATURDAY, JANUARY 30, 2016
7:30 AM – 8:50 AM LIVE CASE Location: Santa Monica
Moderators: J. Paul Finn, MD (UCLA)
Ibrahim Saeed, MD (Saint Luke’s Mid America Heart Institute Cardiovascular Consultants)
At the conclusion of this session, participants will be better able to:
• Plan appropriate localization scans to identify standard short axis and long axis cardiac planes
• Generate reliable steady-state free precession cine images suitable for measuring left ventricular volumes and
ejection fraction
• Formulate a strategy to do phase contrast imaging through the aortic root and main pulmonary artery
• Explore additional right heart imaging planes and acquisition techniques
7:30 AM – 8:50 AM INVITED LECTURE SESSION 9: CMR in Multisystem Disorders
Moderators: Sabha Bhatti, MD (University of Arkansas)
Ali Ylimaz, MD (University Hospital Münster)
30
Location: Los Angeles
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
At the conclusion of this session, participants will be better able to:
• Recognize CMR’s role in the management of multisystem disorders
• Integrate CMR in a comprehensive approach to understanding human health and disease
• Use CMR to identify novel mechanisms of disease and treatment targets
7:30 AM Cardio-Oncology
W.Gregory Hundley, MD (Wake Forest University)
7:44 AM Comprehensive Metabolic Imaging
Robert Weiss, MD (Johns Hopkins University)
7:58 AM CMR in Infiltrative Diseases
James Moon (University College London)
8:26 AM
Heart-Brain Interactions
Albert de Roos, PhD (Leiden University)
8:40 AM
Roundtable Discussion: Approaches to Multisystem Understanding with Magnetic Resonance
7:30 AM – 8:50 AM PEDIATRIC AND CONGENITAL CMR: ASK THE EXPERTS
Location: Constellation
Moderators: Emanuela Valsangiacomo, MD (Children’s Hospital Zurich)
Ruchira Garg, MD (Cedars-Sinai Medical Center)
At the conclusion of this session, participants will be better able to:
• Identify methods to improve assessment of cardiac flow in congenital heart disease
• Prescribe optimized CMR coronary angiography sequences for the pediatric population
• Appraise the utility of different contrast agents for various indications in congenital and pediatric CMR
7:30 AM
How Do I Do Flow?
Mark Fogel, MD, FACC, FAHA, FAAP (Children’s Hospital of Philadelphia)
7:50 AM
How Do I Do Coronary Angiography?
Taylor Chung, MD (Children’s Hospital of Oakland)
8:10 AM
How Do I Do Structural/Cine Imaging?
Andrew Powell, MD (Boston Children’s Hospital)
8:30 AM
How Do I Do Contrast Angiography and What Do I Know About Contrast Agents?
Cynthia Rigsby, MD (Northwestern University)
8:40 AM
How I Use Contrast: Panelists Responses and Audience Q&A
7:30 AM – 8:50 AM ORAL ABSTRACT SESSION 12: Flow and Hemodynamics
Moderators: Florian von Knobelsdorff-Brenkenhoff, MD (Charité Medical University Berlin)
Michael Markl, PhD (Northwestern University)
SATURDAY PROGRAM
8:12 AM Muscle is Muscle: CMR in the Dystrophies
Ali Yilmaz, MD (University Hospital Münster)
Location: Olympic
7:30 AM O 089 4D flow CMR detects progressive improvement in ventricular function following cardioversion of atrial fibrillation
Hanna Erixon (Linköping University)
7:40 AM O 090 Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation
Michael Markl (Northwestern University)
7:50 AM O 091
Left Ventricular Kinetic Energy as a Marker of Mechanical Dyssynchrony in Failing Hearts with
LBBB: A 4D Flow CMR Study
Jakub Zajac (Division of Cardiovascular Medicine, Department of Medical and Health Sciences,
Linköping University)
8:00 AM O 092 Redistribution of Organ Specific Blood Flow in Response to Food Ingestion Measured by
R-R-Interval Averaged Golden-Angle Spiral Phase Contrast MRI
Jakob Hauser, MB (University College London)
8:10 AM O 093 Effect of Respiratory Suspension on the Computation of Volume-based Early Peak Filling Rate to
Late Peak Filling Rate Ratio
Amol Pednekar, PhD (Philips Healthcare)
www.scmr.org
31
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
8:20 AM O 094 Background Phase Correction in Congenital Heart Disease: Does Reliability Vary Based on
Underlying Disease Type?
Sassan Hashemi, MD (Children’s Healthcare of Atlanta)
8:30 AM O 095
Influence of Right Ventricular Remodeling on Ventricular Function, Flow and Energetics in
Pulmonary Regurgitation Vs. Stenosis: A 4-Dimensional Phase Contrast MRI and Admittance
Catheterization Study
Filip Konecny (Transonic Scisense, Inc. , University of Nebraska Medical Center, Chiildren’s Hospital and
Medical Center)
8:40 AM O 096 Improved Assessment of Aortic Hemodynamics by k-t Accelerated Dual-Venc 4D flow MRI
in Pediatric Patients
Susanne Schnell, PhD (Northwestern University, Feinberg Medical School)
7:30 AM – 8:50 AM CASE REVIEW 7: Patient Referred for Evaluation of Acute Chest Pain
Moderators: Nadine Kawel-Boehm, MD (University Basel Hospital)
Timothy Wong, MD (University of Pitttsburgh)
Location: Westside
7:30 AM CR 47 Cardiomyopathy from Methamphetamine Abuse: Rare Presentation with Multiple
Bi-Ventricular Thrombi
Rajesh Janardhanan, MD, MRCP, FACC, FASE (Sarver Heart Center, University of Arizona)
7:40 AM CR 48 Pheochromocytoma Presenting as Acute Myocarditis
Pranav Bhagirath, MD (HAGA Teaching Hospital)
7:50 AM CR 49 Is Always Echocardiography the Best Choice in the Assessment of Pericardial Effusion?
Tamas Erdei, PhD (Bristol Heart Institute)
8:00 AM CR 50 An Unusual Case of Acute Heart Failure and Left Ventricular Hypertrophy
Anna Baritussio (Bristol Heart Institute)
8:10 AM CR 51 CMR Findings in Giant Cell Myocarditis
Sowmya Pinnamaneni, MD (Geisinger Clinic and Health System )
8:20 AM CR 52 Depot Medroxyprogesterone Acetate Induced Myocardial Infarction Detected by Cardiac
Magnetic Resonance Imaging
Osama Niazi, DO (Rutgers New Jersey Medical School)
8:30 AM CR 53 Importance of Full Thoracic Overview in Cardiac MRI
Christina Unterberg-Buchwald (University Clinic Goettingen, Institute of Diagnostic and
Interventional Radiology)
8:40 AM CR 54 Atypical Chest Pain, Atypical Perfusion CMR Scan
Heerajnarain Bulluck, MBBS (University College London, Barts Heart Centre)
7:30 AM – 8:50 AM WALKING POSTER SESSION 6: Advances in CMR Methods
Moderators: Matthias G. Friedrich, MD (Montreal Heart Institute)
Reza Nezafat, PhD (Harvard Medical School)
7:30 AM Q 51
Location: Plaza Foyer
Would Adding Two Left Atrial Piloted Images to a Cardiac Magnetic Resonance Protocol Enable
Rapid, Accurate Calculation of Left Atrial Volume? Use of 320 Slice Cardiac CT as Proof
of Concept
Stuart Moir, MBBS, FRACP, PhD (Monash Health)
7:38 AM Q 52 Systolic T1 Mapping for Estimation of Myocardial Diffuse Fibrosis
Vassilis Vassiliou, MA, MBBS, MRCP (Royal Brompton Hospital, Imperial College London)
7:46 AM Q 53 Use of T2 Maps for Rapid Prediction of Stress Effectiveness Before the Injection of Contrast
in Myocardial Perfusion Studies at 3.0T
Juliano Fernandes, MD, PhD, MBA (Jose Michel Kalaf Research Institute)
7:54 AM Q 54 Left Ventricular Myocardial Deformation Measurements by Magnetic Resonance Tissue
Tracking Agrees with Tagging (HARP) in Healthy Volunteers
Kanae Mukai, MD (University of California, San Francisco)
32
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
8:02 AM Q 55 Late Gadolinium Enhancement is not Related to the Severity of Aortic Regurgitation:
A Single Center Study
Henrique Trad, MD (HCFMRP)
8:10 AM Q 56 Histological Validation of a New CMR T1-Mapping-Based Protocol to Improve Accuracy for
Fibrosis Assessment in Patients with Aortic Stenosis
Vassilis Vassiliou, MA, MBBS, MRCP (Royal Brompton Hospital, Imperial College London)
8:18 AM Q 57 Aortic Flow and Wall Shear Stress in Aortic Stenosis is Associated with Left
Ventricular Remodeling
Florian von Knobelsdorff-Brenkenhoff, MD (Working group Cardiovascular MRI)
8:26 AM Q 58 Diagnosis of Deep Vein Thrombosis using 3D Black-Blood Thrombus Imaging (BTI):
Preliminary Clinical Experience
Qi Yang, MD, PhD (Xuanwu Hospital, Cedars-Sinai Medical Center)
8:42 AM Q 60 An Extended 3D Whole-Heart Myocardial First-Pass Perfusion Sequence: Alternate-Cycle
Views with Isotropic and High-Resolution Imaging
Merlin Fair (Imperial College London, Royal Brompton Hospital)
Location: Los Angeles Ballroom
8 :50 AM –10:00 AM CMR OUTREACH PLENARY SESSION: Cardiovascular Disease in Women - CMR’s Essential Role
Moderators: Puja Mehta, MD (Cedars-Sinai Medical Center)
Lauren Baldassarre, MD (Yale School of Medicine)
At the conclusion of this session, participants will be better able to:
• Recognize opportunities for CMR to address unmet needs in women’s cardiovascular disease management
• Design CMR protocols to address major conditions affecting women’s heart health
8:50 AM
Cardiovascular Disease in Women: Where We Are Going and What We Need from CMR
C Noel Bairey Merz, MD (Cedars-Sinai)
Chest Pain and Troponin Elevation: What Does CMR Have to offer?
Jeanette Schulz-Menger, MD (Charite Universitatsmedizin and HELIOS Clinics)
9:14 AM
9:26 AM
CMR in Infiltrative Diseases
Karen Ordovas, MD (University of California San Francisco)
9:38 AM
CMR in Connective Tissue Diseases
Sophie Mavrogeni, MD (Onassis Cardiac Surgery Center)
10:00 AM–10:40 AM
REFRESHMENT BREAK/EXHIBITS/POSTER VIEWING
SATURDAY PROGRAM
8:34 AM Q 59 Ferumoxytol MRA and Non-Contrast CT Fusion in TAVR Candidates with Renal Failure
Takegawa Yoshida, MD (David Geffen School of Medicine at UCLA)
10:40 AM–12:00 PM INVITED LECTURE SESSION 10: Location: Los Angeles
Translating Advances in CMR to the Community
Moderators: Christopher Dyke, MD (Alaska Heart Institute) Stephen Cheung, MBBS (Radiology Queen Mary Hospital)
At the conclusion of this session, participants will be better able to:
• Identify the essential protocols for a new clinical CMR service
• Develop strategies to overcome barriers to translating CMR advances to community practices
• Leverage relationships among physicists, technology providers and physicians to deliver CMR with impact
10:40 AM
You Have to Be Able to Do This and Do It Well
Timothy Wong, MD, MS (University of Pittsburgh Medical Center)
10:52 AM
Tissue Mapping vs. Traditional Weighted Imaging in Practice
Erik Schelbert, MD, MS (University of Pittsburgh)
11:04 AM
Expanding Your Referral Base and Educating Practitioners on Appropriate Use
Ashish Aneja, MD (MetroHealth heart and Vascular Center)
11:16 AM
Quantitative Reporting: Guidelines vs. Real-World Practice
Ibrahim Saeed, MD (University of Missouri - Kansas City)
www.scmr.org
33
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
11:28 AM
Making the Case for CMR Amidst Advances in Other Modalities
Sharmila Dorbala, MD, MPH (Brigham and Women’s Hospital)
11:40 AM
Relationships That Matter: What I Need from My Physicist and Technology Partners
Jason Craft, MD (Advocate Healthcare)
11:52 AM
Roundtable Discussion: Team-Based Care – Where Does CMR Fit in?
10:40 AM–12:00 PM ORAL ABSTRACT SESSION 13: Inflammatory Cardiomyopathy
Moderators: Vanessa Ferreira, MD, DPhil (University of Oxford)
Kai Muellerleile, MD (University Heart Center Hamburg)
Location: Constellation
10:40 AM O 097 Viral Myocarditis vs Lupus Myocarditis, Distinctive Features in Cardiovascular Magnetic Resonance.
Maria Espinoza Barillas (Instituto Nacional De Ciencias Medicas Y Nutricion Salvador Zubiran)
10:50 AM O 098
Performance of Comprehensive Cardiac Magnetic Resonance Imaging including T1 and T2 mapping on
1.5 vs. 3.0 Tesla as Compared to Biventricular Endomyocardial Biopsy in Patients with Suspected Myocarditis
- The MyoRacer Trial
Philipp Lurz, MD, PhD (Heart Center of the University Leipzig)
11:00 AM O 099 T1 and T2 Mapping Cardiovascular Magnetic Resonance to Monitor the Course of Myocarditis
Kai Muellerleile, MD (University Heart Center Hamburg)
11:10 AM O 100 Myocarditis and Colchicine: A New Perspective From Cardiac MRI
Daniel Morgenstern (Sharon Regional Health System)
11:20 AM O 101 Sarcoidosis: Comprehensive CMR Evaluation and Major Adverse Cardiac Events
Thomas Hauser, MD, MPH, MMSc (BIDMC)
11:30 AM O 102 Assessment of Left Ventricular Systolic and Diastolic Function in Patients with Sarcoidosis with and without
Cardiac Involvement by Magnetic Resonance Feature Tracking at 1.5T: A Follow Up Study
Darius Dabir, MD (University of Bonn)
11:40 AM O 103 Extracellular Volume By CMR is Associated with Serum Biomarkers of Extracellular Matrix Turnover and
Inflammation in Hypertensive Heart Disease
Peter Shaw, MD (University of Virginia)
11:50 AM O 104 HIV-1-Related Cardiovascular Disease is Associated with Chronic Inflammation, Frequent Pericardial Effusions and Increased Myocardial Oedema
Ntobeko Ntusi, MB.ChB FCP(SA) MD (University of Oxford)
0:40 AM–12:00 PM CASE REVIEW 8: Potpourri Case Session + Best Web Case of the Week
1
Moderators: Vikas Rathi, MD (Bon Secours Richmond Health System)
Juliano Lara Fernandes, MD, PhD (Jose Michel Kalaf Research Institute)
Location: Olympic
10:40 AM CR 55 Coxsackie Myocarditis Presenting with Sustained Ventricular Tachycardia and Slow Coronary Flow: Role of
Cardiac Magnetic Resonance Imaging in Diagnosis
Menhel Kinno, MD (Rutgers - New Jersey Medical School)
10:50 AM CR 56 Tissue Characterization of a Giant Isolated Aneurysm of the Right Coronary Artery by CMR
Lilia Sierra-Galan, MD, FACC, FSCCT (American British Cowdray Medical Center)
11:00 AM CR 57 Rosai-Dorfman Disease: A Rare Case of Histiocytosis with Infiltrative Polyserositis Leading to Reversible
Constrictive Pericarditis
Girish Dwivedi (UOHI)
11:10 AM CR 58 COTW 15-13: Budd-Chiari: an unexpected imaging journey that ends with congenital CMR
Daniel Devos, MD (UZ Gent)
11:20 AM CR 59 COTW 15-04: Metastatic Renal Cell Carcinoma Presenting as ST-Segment Elevation Myocardial Infarction
Michael Mikolaj, MD (Gill Heart Institute, University of Kentucky)
11:30 AM CR 60 COTW 15-17: CMR for Suspected Pulmonary Embolism
Lilia Sierra-Galan, MD, FACC, FSCCT (American British Cowdray Medical Center)
11:40 AM CR 61 COTW 15-09: Are Myocardial Crypts a genetic phenomenon related to Hypertrophic Cardiomyopathy?
Heiko Kindler (Cork University Hospital)
34
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
11:50 AM CR 62 COTW 15-15: Contained Cardiac Rupture Presenting with Syncope
Mariano Estefan (Hospital de Sant Pau, Universitat Autònoma de Barcelona)
10:40 AM–12:00 PM INVITED LECTURE SESSION 11: Location: Westside
What is this Congenital Patient Doing on My Schedule?
Moderators: Andrew Crean, MD (Toronto General Hospital)
Anne Marie Valente, MD (Boston Children’s Hospital)
At the conclusion of this session, participants will be better able to:
• Integrate the most recent recommendations for CMR in the evaluation and management of adult congenital
heart disease
• Identify critical elements of the adult congenital CMR scan and adopt protocols to address the clinically relevant issues
• Recognize technical challenges in scanning adults with congenital heart disease to adopt strategies to scan these
patients optimally
10:40 AM
Get with the Guidelines: How CMR is Incorporated into Various ACHD Guidelines
Craig Broberg, MD, MCR (Oregon Health & Sciences University)
11:12 AM Tetralogy of Fallot
Sara Partington, MD (Children’s Hospital of Philadelphia)
11:28 AM
Congenital Aortic Problems: Imaging Left Ventricular Outflow Tract Obstructive Lesions and Beyond
Ali Zaidi, MD (Montefiore Medical Center)
11:44 AM
Pearls and Pitfalls in Imaging Adults with Congenital Heart Disease
Andrew Taylor, MD (Cardiovascular Imaging at University College London)
10:40 AM–12:00 PM WALKING POSTER SESSION 7: Novel CMR Strategies
Moderators: Andrew E. Arai, MD (National Institutes of Health)
Matthias Stuber, PhD (CIBM/CHUV/UNIL)
Location: Plaza Foyer
SATURDAY PROGRAM
10:56 AM The CMR approach to Determining Congenital Etiologies of Right Heart Dilation
Sonya Babu-Narayan, MD (Royal Brompton Hospital)
10:40 AM Q 61 Intracardiac Hemodynamic Forces Using 4D Flow: A New Reproducible Method Applied To Healthy Controls,
Elite Athletes and Heart Failure Patients
Johannes Töger, PhD (Lund University and Lund University Hospital)
10:48 AM Q 62 Characterization of Myocardial Fiber Orientation to Assess Therapeutic Exosomes from Cardiosphere-derived
Cells (CDCs) in Myocardial Infarcted Porcine with in Vivo Diffusion-Tensor CMR on a Clinical Scanner
Christopher Nguyen, PhD (Cedars-Sinai Medical Center)
10:56 AM Q 63 Genome Wide Association Analysis of the Heart Using High-resolution 3D Cardiac MRI Identifies New
Genetic loci Underlying Cardiac Structure and Function
Antonio de Marvao, MB ChB (Imperial College London)
11:04 AM Q 64 Equivalence of Conventional and Fast Late Gadolinium Enhancement (LGE) Techniques for Quantitative
Evaluation of Fibrosis in Ischemic and Non-ischemic Cardiac Disease – Save the Time!
Fabian Muehlberg, MD (Charité University Medicine and HELIOS Clinics)
11:12 AM Q 65 Accuracy of a Prototype Dark Blood Late Gadolinium Enhancement Technique for the Detection and
Quantification of Myocardial Infarction
Akos Varga-Szemes, MD, PhD (Medical University of South Carolina)
11:20 AM Q 66 Extracellular Volume Fraction Correlates with Myocardial Stiffness and Allows for Differentiation Between
Impaired Active Relaxation and Passive Stiffness in Heart Failure with Preserved Ejection Fraction
Karl-Philipp Rommel, MD (Heartcentre Leipzig)
11:28 AM Q 67 Left Ventricular Remodeling After Reperfused Acute Myocardial Infarction: Insights from Automated ECV Mapping
Heerajnarain Bulluck, MBBS ( University College London, Barts Heart Centre)
11:36 AM Q 68 Transcatheter Real-time MRI Guided Myocardial Chemoablation Using Acetic Acid
Toby Rogers, MA, BM BCh, MRCP (National Institutes of Health)
11:44 AM Q 69 Real-time Magnetic Resonance Imaging Guidance Improves the Yield of Endomyocardial Biopsy
Toby Rogers, MA, BM BCh, MRCP (National Institutes of Health)
www.scmr.org
35
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
11:52 AM Q 70 A Semi-automatic Method for Quantification of Respiratory Variation in Early Mitral Inflow Velocity Using
Real Time Phase Contrast Cardiac Magnetic Resonance – Normal Values and Clinical Feasibility
Simon Thalén (Karolinska Institute)
12:00 PM– 1:00 PM
LUNCH/EXHIBITS/POSTER GROUP P 3
1:10 PM – 2:30 PM
INVITED LECTURE SESSION 12: 1:10 PM
CMR Tissue Characterization in Hypertrophic Cardiomyopathy to Calibrate Sudden Death Risk
Martin Maron, MD (Tufts Medical Center)
Location: Los Angeles
CMR Guided Management of Sudden Cardiac Death in Nonischemic Disease
Moderators: Christopher Kramer, MD (University of Virginia)
Jon Kalman, MBBS, PhD, FACC (Royal Melbourne Hospital)
At the conclusion of this session, participants will be better able to:
• Recognize how CMR may inform treatment planning for patients with hypertrophic cardiomyopathy
• Address management questions in nonischemic cardiomyopathy with appropriate CMR acquisitions and reporting
• Coordinate CMR in patients at risk for sudden cardiac death as well as SCD survivors
1:24 PM Ventricular Morphology in HCM by CMR guides surgical therapy
Milind Desai, MD (Cleveland Clinic)
1:38 PM
Sudden Death Risk in Patients with Nonischemic Cardiomyopathy and Midwall Fibrosis
Dudley Pennell, MD (Royal Brompton Hospital)
1:52 PM
Myocarditis: Acute vs. Long-Term CMR-Guided Management
Matthias Friedrich, MD (McGill University Health Centre)
2:06 PM
Before and After the Defibrillator Goes in – What CMR Adds and How
Sharath Subramanian, MD (St Cloud Hospital)
2:20 PM
Roundtable Discussion: When Does (and Does Not) CMR Alter Management?
1:10 PM – 2:30 PM ORAL ABSTRACT SESSION 14: Rapid Efficient Imaging
Location: Constellation
Moderators: Sebastian Kozerke, PhD (Institute for Biomedical Engineering University and ETH Zurich)
Kelvin Chow, PhD (University of Virginia)
1:10 PM O 105 Free-Breathing 3D Whole-Heart Coronary MRA Using Respiratory Motion-Resolved Sparse Reconstruction
Davide Piccini (Siemens Healthcare, University Hospital (CHUV) and University of Lausanne (UNIL))
1:20 PM O 106 Whole Heart Free Breathing Phase Sensitive Inversion Recovery MRI Integrated with Iterative
Self Navigation for 100% Scan Efficiency; a First Patient Study
Giulia Ginami, MSC (Department of Radiology, University Hospital (CHUV) and University of Lausanne (UNIL))
1:30 PM O 107 High Efficiency Coronary MRA with Non-rigid Cardiac Motion Correction: Beyond the Quiescent Period
Jianing Pang, PhD (Cedars-Sinai Medical Center)
1:40 PM O 108 Improved Scan Efficiency for Golden-Angle Radial CMR with Anisotropic Field-of-View
Ziyue Wu (University of Southern California)
1:50 PM O 109 Simultaneous Multi-Slice Excitation for Single Breath Hold Estimates of Left Ventricular Rotational Mechanics
Zhe Wang, PhD (University of California Los Angeles)
2:00 PM O 110 Motion Compensated Reconstruction From Free Breathing 2D Radial Cardiac MRI Data
André Fischer (GE Global Research, GE Healthcare)
2:10 PM O 111 Radial Simultaneous Multi Slice imaging for Rapid Cardiac Imaging
Ganesh Adluru, PhD (University of Utah)
2:20 PM O 112 Improved Dynamic Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) Using Iterative
Data Reconstruction
Luigia D’Errico, MD (University of Toronto)
1:10 PM – 2:30 PM ORAL ABSTRACT SESSION 15: Congenital Heart Disease 2
Moderators: Shelby Kutty, MD (University of Nebraska)
Piers Barker, MD (Duke University)
36
Location: Olympic
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
1:10 PM O 113 4D Multiphase Steady State Imaging with Contrast (MUSIC) Enhancement Using Ferumoxytol: A New
Paradigm in Pediatric Congenital Heart Disease
Kim-Lien Nguyen, MD (David Geffen School of Medicine at UCLA)
1:20 PM O 114 Multicontrast 3D Automated Segmentation of Cardiovascular Images
Matthew Bramlet, MD (Children’s Hospital of Illinois, University of Illinois College of Medicine at Peoria)
1:30 PM O 115 Imaging Insights from the Bifurcated Y-Graft Fontan Procedure
Tim Slesnick, MD (Emory University)
1:40 PM O 116 Impaired Cardiac Growth and Function in Children and Adolescents After Heart Transplantation Assessed by
Cardiac Magnetic Resonance
Heiner Latus (Pediatric Heart Centre)
2:00 PM O 118 New Insights in Ventriculo-Arterial Coupling and Ventricular Shape in Repaired Tetralogy of Fallot:
A Retrospective Cohort Study
Giovanni Biglino, PhD (University College London, Great Ormond Street Hospital for Children)
2:10 PM O 119 Atrio-Ventricular Mechanics and Heart Failure in Ebstein’S Anomaly – A Cardiac Magnetic Resonance Study
Marike Broder (University Medical Center of he Georg-August-Uiversity)
2:20 PM O 120 Cardiac Magnetic Resonance Imaging Can Be Performed without the Use of Anesthesia in Patients 7-10
Years of Age with Child Life Support and MRI Video Goggles
Jon Detterich, MD (Children’s Hospital Los Angeles)
Location: Westside
1:10 PM – 2:30 PM INVITED LECTURE SESSION 13: CMR’s Role in Coronary Artery Disease
Moderators: Sven Plein, MD, PhD (University of Leeds)
Ronald Blankstein, MD (Brigham & Women’s Hospital)
At the conclusion of this session, participants will be better able to:
• Review current understanding of coronary artery disease
• Evaluate the utility of available CMR methods in different stages of CAD
• Relate CMR approaches to different aspects of CAD
1:10 PM
SATURDAY PROGRAM
1:50 PM O 117 MRI of the Fetal Heart: Comparison of the Obstetric Sonography and Fetal Magnetic Resonance
Imaging Findings
Flavia Junqueira, PhD (DASA-SP)
Coronary Artery and Myocardium: Current Concepts in CAD Pathophysiology and Guidelines
John Greenwood, MD, PhD (University of Leeds)
1:22 PM
CMR Techniques for the Assessment of Coronary Plaques and Stenosis
Rene Botnar, PhD (King’s College London )
1:34 PM
CMR Techniques for the Assessment of Ischemia
Rolf Gebker, MD, PhD (National Institutes of Health Laboratory of Cardiac Energetics)
1:46 PM
CMR techniques for the assessment of myocardial state
Peter Kellman, PhD (National Institute of Health)
1:58 PM
Clinical application of CMR in acute chest pain
John Heitner, MD (New York Methodist Hospital)
Clinical Application of CMR in Chronic Chest Pain
Ronald Blankstein, MD (Brigham & Women’s Hospital)
2:10 PM
2:22 PM
Roundtable Discussion: What Could We Do Better for CAD Patients?
BEST OF WALKING POSTER SESSION The top-rated posters from the previous Walking Poster Sessions will be presented and
1:10 PM – 2:30 PM
compete for the Best Poster Award of the Walking Poster Sessions
2:30 PM – 2:40 PM
BREAK
Location: Santa Monica
2:40 PM – 4:00 PM INVITED LECTURE SESSION 14: Parametric Mapping
Location: Santa Monica
Moderators: James Moon, MD (Heart Hospital London)
Peter Kellman, PhD (National Institutes of Health Laboratory of Cardiac Energetics)
www.scmr.org
37
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
At the conclusion of this session, participants will be better able to:
• Recognize common principles behind various parametric imaging approaches
• Assign specific patterns of T1, T2, and T2star to different myocardial diseases
• Select appropriate mapping strategies for clinical CMR protocols
2:40 PM
Parametric Mapping: Basic Concepts
Steven White, BSc MBChB MRCP (The Heart Hospital London)
2:52 PM
T1 Mapping: Overview on Acquisition Strategies
Sebastian Weingärtner, MSc (Israel Deaconess Medical Center, Harvard)
3:04 PM
Workflow and Analysis Strategies
Marianna Fontana, MD (Heart Hospital London)
What’s Normal in Parametric Mapping?
Michael Salerno, MD, PhD (University of Virginia)
3:16 PM
3:28 PM
Clinical Role of T1 Mapping and ECV
Vanessa Ferreira, MD DPhil (University of Oxford)
3:40 PM
Clinical Role of T2 and T2star Mapping
Karolina Zareba, MD (The Ohio State University)
3:52 PM
Roundtable Discussion: What Do You Report, and What Do You Limit to Research?
2:40 PM – 4:00 PM ORAL ABSTRACT SESSION 16: CMR in Arrhythmia and Devices
Moderators: Edward DiBella, PhD (University of Utah)
Matthias Gutberlet, MD (University of Leipzig – Heart Center)
Location: Constellation
2:40 PM O 121 RF Induced Heating of Pacemaker/ICD Lead-Tips During MRI Scans at 1.5T and 3T: Evaluation in Cadavers
Volkan Acikel, PhD (University of California Los Angeles)
2:50 PM O 122 An MRI-compatible Defibrillator: Initial Testing in Volunteers and Swine
Ehud Schmidt, PhD (Brigham and Womens Hospital)
3:00 PM O 123 Safety of CMR in Patients with Cardiac Implanted Electronic Devices
El-Sayed Ibrahim (University of Michigan)
3:10 PM O 124 Clinical Utility of Cardiovascular Magnetic Resonance in Patients with Cardiac Rhythm Management Devices
Nikhil Jariwala, MD (Loyola University)
3:20 PM O 125 Current Provision for MRI Scanning of Patients with Cardiac Implantable Electronic Devices - A National Survey
of Hospitals in England
James Oldman (University College London)
3:30 PM O 126 Comparison of CMR DENSE Strain Imaging and 2D Speckle Tracking Echocardiography for Cardiac
Resynchronization Therapy (CRT) Response
Jorge Gonzalez, MD (University of Virginia)
3:40 PM O 127 Incremental Diagnostic Role of Cardiac MRI in Young-middle aged Patients with High-grade Atrio-ventricular Block
Anna Baritussio (Bristol Heart Institute)
3:50 PM O 128 T2*-weighted MRI Technique for Visualization of RF Ablation Lesions
Eugene Kholmovski, PhD (University of Utah, CARMA Center)
2:40 PM – 4:00 PM INVITED LECTURE SESSION 15: Location: Los Angeles
Myocardial Mechanics: No Strain No Gain
Moderators: Nathaniel Reichek, MD (St. Francis Hospital)
Kan Hor, MD (Nationwide Children’s Hospital)
At the conclusion of this session, participants will be better able to:
• Summarize different methods for assessing myocardial strain
• Recognize strengths and weaknesses of routine cine-derived strain estimation
• Identify opportunities to incorporate strain assessment in clinical practice
2:40 PM
38
Current Methods and Applications of Tagging-Based Techniques
El-Sayed Ibrahim, PhD (Department of Radiology, University of Florida)
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
2:54 PM
Current Methods and Applications of Tissue Phase Mapping
Daniela Föll, PD Dr. (Freiburg)
3:08 PM
Current Methods and Clinical Applications of Echocardiography – Based Strain Assessment
Kan Hor, MD (Nationwide Children’s Hospital)
3:22 PM
Current Methods and Clinical Applications of Cine-Based Strain Techniques
Andreas Schuster, MD PhD (Georg-August-University Göttingen)
3:36 PM
Assessing Myocardial Mechanics for Diastolic Function
Pierre Croisille, MD, PhD (CHU Saint-Etienne)
3:50 PM
Panel Discussion: How to Overcome the Strain of Clinical Translation?
2:40 PM – 4:00 PM ORAL ABSTRACT SESSION 17: Clinical Trials
Moderators: Joseph Selvanayagam (Flinders Medical Centre)
Juerg Schwitter, MD (University Hospital Lausanne – CHUV)
Location: Westside
2:50 PM O 130 ST2 is Reduced By High-Dose Omega-3 Fatty Acid Treatment Following Acute MI and is Correlated with
Reduction of the Extracellular Volume Fraction of Non-Infarcted Myocardium
Bobby Heydari (Brigham and Women’s Hospital, University of Calgary)
3:00 PM O 131 Prevalence of Unrecognized Myocardial Scarring in Patients with Normal Contractile Function Across
Four U.S. Hospitals
Han Kim, MD (Duke University Medical Center/Duke Cardiovascular Magnetic Resonance Center)
3:10 PM O 132 Diagnostic Performance of Treadmill Exercise Cardiac Magnetic Resonance: The Prospective,
Multicenter EXACT Trial
Subha V. Raman, MD (Ohio State University)
SATURDAY PROGRAM
2:40 PM O 129 Absence of DNA Double Strand Breaks in Human Peripheral Blood Mononuclear Cells After Magnetic
Resonance Imaging Assessed by H2AX Flow Cytometry: A Prospective Blinded Trial
Martin Fasshauer (University Medical Center Göttingen)
3:20 PM O 133 Association of Myocardial Fibrosis and Prior Cardiovascular Disease: The Multi-Ethnic Study of
Atherosclerosis (Mesa)
Bharath Ambale Venkatesh, MD, PhD (Johns Hopkins University)
3:30 PM O 134 Cost Savings Associated with an MRI Based Strategy in Suspected Severe Mitral Regurgitation
Cindy Comeau, R.T. (N)(MR) (Carnegie Hill Radiology)
3:40 PM O 135 Disproportionate Abdominal Visceral Fat Mass Reduction and Complete Reversal of Cardiovascular Remodelling
Accompany Roux-En-Y Gastric Bypass but not Gastric Banding - Benefits Beyond Simply Weight Loss
Jennifer Rayner (University of Oxford)
3:50 PM O 136 Does Late Gadolinium Enhancement Still Have Value for the Rv? Rv Internal Mechanical Work,
Ea/Emax (Vvc) and Lge as Prognostic Markers in Pulmonary Hypertension; A CMR Study
Robert Biederman, MD (Temple School of Medicine)
2:40 PM – 4:00 PM CASE REVIEW 9: The Pediatric Patient Referred for Congenital Heart Disease
Moderators: Tiffanie Johnson, MD (Riley Hospital for Children/Indiana University)
Nancy Halnon, MD (University of California- Los Angeles)
Location: Olympic
2:40 PM CR 63 An Unusual Case of Congenital Partial Absence of Pericardium, Partial Anomalous Pulmonary Venous Return,
Sinus Venosus Defect and Systemic Venous Anomalies in a Teenager with Marfanoid Habitus
Supriya Jain, MD (Maria Fareri Children’s Hospital at WMC, New York Medical College)
2:50 PM CR 64 Dual Contrast Cardiac Magnetic Resonance: Utility in Long-Term Survivors of the Fontan Operation
Amitabh Parashar, MD (VAMC Salem, Virginia Tech Carilion SOM)
3:00 PM CR 65 Combined Cardiac MRI and Cardiac Catheterization Plays A Key Role in the Differentiation Between
Pulmonary and Cardiac Causes of Pulmonary Hypertension in Patients with Complex, Multifactorial Disease
Bram Ruijsink (King’s College London )
3:10 PM CR 66 Infected Ventricular Pseudoaneurysm in a Single Ventricle Patient Detected Just in Time Using Cardiac MR
Divya Shakti, MBBS, MPH (Batson Children’s Hospital, University of Mississippi)
www.scmr.org
39
From Innovation to Impact in Cardiovascular Care
SC I ENTI FIC S ES S IO N S
3:20 PM CR 67 3D Printing from Cardiac Magnetic Resonance Imaging or Surgical Planning in a Patient with Situs Inversus,
Dextrocardia and Double Outlet Right Ventricle
Shafkat Anwar, MD (St. Louis Children’s Hospital, Washington University School of Medicine)
3:30 PM CR 68 CMR-Based 3D Printed Heart Model of Complex Single Ventricle Anatomy Assists with Pre-Procedural
Planning of Combined Atrial Maze and Extracardiac Fontan Conduit Procedure
Ryan Moore, MD (Cincinnati Children’s Medical Center)
3:40 PM CR 69 Two Cases of a Prenatally Diagnosed Double Aortic Arch with a Postnatal Obliteration of the Left Aortic Arch
Tam Doan, MD, MS (Connecticut Children’s Medical Center)
3:50 PM CR 70 Extensive Evaluation of a Benign Murmur
Shiraz Maskatia, MD (Baylor College of Medicine)
4:15 PM – 6:00 PM CMR WORLD CUP: A Joint SCMR/EuroCMR Event Location: Los Angeles
& CLOSING PLENARY SESSION
Moderators: Mark Westwood, MD (The London Chest Hospital) Patricia Bandettini, MD (National Heart, Lung, and Blood Institute)
At the conclusion of this session, participants will be better able to:
• Interpret challenging CMR cases in a time-sensitive setting
• Evaluate CMR’s performance in clinical trials
• Summarize future trends and advances in CMR
4:15 PM
Late-Breaking Clinical Trials: Current State and Future Directions
Colin Berry, BSc PhD (University of Glasgow)
4:23 PM World Cup Case Competition: Soccer vs. Football
Soccer:
Matthew Martinez, MD (Lehigh Valley Health Center)
Scott Flamm, MD (Cleveland Clinic)
Craig Broberg, MD (Oregon Health Sciences)
Football:
Christopher Miller, MBChB (University Hospital of South Manchester)
Robin Nijveldt, MD, PhD (VU University Medical Center)
Oliver Tann, FRCR (Great Ormond Street Hospital)
5:03 PM
Point/Counterpoint: The Future of CMR is High Field/Low Field
Moderator: Roderic Pettigrew (National Institute of Biomedical Imaging and Bioengineering)
Thoralf Niendorf (Max-Delbrück Center for Molecular Medicine)
Orlando P. Simonetti, PhD (The Ohio State University)
Carrying SCMR ’16 Forward: Practical Takeaways
Juliano Fernandes, MD, PhD (Jose Michel Kalaf Research Institute)
Daniel Ennis, PhD (UCLA)
5:15 PM
5:25 PM
Closing Remarks from the Incoming President
Jeanette Schulz-Menger, MD (Berlin)
5:30 PM
Awards Ceremony
6:00 PM – 7:00 PM
AWARDS RECEPTION
TEC H N OLOG I ST TR AC K
FRIDAY, JANUARY 29, 2016
8:40 AM –10:00 AM SESSION 1: The Basics
Moderator: Beth Goddu (Beth Israel Deaconess Medical Center)
Location: Westwood 8:40 AM Welcome
Alison Fletcher, DCRR, PG Dip (Papworth Hospital)
8:45 AM CMR Physics
Elizabeth Jenista, PhD (Duke University Medical Center)
40
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
TEC H N O LOG I ST TR AC K
At the conclusion of this session, participants will be better able to:
• Identify and describe common CMR pulse sequences
• Describe image contrast differences among common CMR pulse sequences
• Describe differences in acquisition strategies for CMR vs. MRI of other body parts
9:10 AM Anatomy and Slice Positioning
Ralph Gentry (William Beaumont Hospital)
At the conclusion of this session, participants will be better able to:
• Recognize how to acquire a CMRI basic exam for LV function
• Recognize the normal cardiac anatomy and some abnormal cardiac anatomy
• Recognize the normal EKG pattern and how it relates to acquiring a CMRI exam and how each segment
relates to the function of the heart
9:35 AM
Why do we want CMR? The Cardiologists Point of View
Oliver Rider, MRCP DHIL (University of Oxford)
At the conclusion of this session, participants will be better able to:
• Understand the role of CMR to help differentiate the hypertrophied heart
• Understand the role of CMR to help differentiate the dilated heart
• Understand the role of CMR to help differentiate a segment of hypokinesia
10:30 AM
Tips and Tricks
Alison Fletcher, DCRR, PG Dip (Papworth Hospital)
At the conclusion of this session, participants will be better able to:
• Optimise pulse sequences prior to scanning
• Manipulate pulse sequences in line with physiological findings
• Obtain diagnostic images in the non compliant patient
11:00 AM
Optimizing 3T Imaging
Patricia Feuchter, MSc (St. Bartholomew’s Hospital)
At the conclusion of this session, participants will be better able to:
• Identify common technical issues with CMR on 3T
• Learn most common fixes for 3T scanning
• Learn how to identify and implement the correct delta frequency for your cine images for 3T scanning
11:30 AM
Optimization for the Pediatric Patient
George Englehardt (Children’s Hospital of Philadelphia)
At the conclusion of this session, participants will be better able to:
• Be able to describe the different sedation/anesthesia techniques and how they affect the image quality
• Know the different ways to communicate to the pediatric patient to successfully allow them to undergo an MRI
• Understand the factors that go into image quality in children and how to optimize them in pediatrics
TECHNOLOGIST TRACK
10:30 AM –12:00 PM SESSION 2: Optimizing Your Imaging Moderator: Ron Williams (Allegheny General Hospital)
1:00 PM – 2:20 PM SESSION 3: Running a CMR Service
Moderator: Ron Williams (Allegheny General Hospital)
1:00 PM
Clinical CMR Unit
Anne Garcia (Ohio State University)
At the conclusion of this session, participants will be better able to:
• Establish tools for more efficient workflow- pre procedural and intra procedural techniques
• Understand benefits of a dedicated team
1:25 PM
Research CMR Unit
Chris Lawton (Bristol Heart Institute)
At the conclusion of this session, participants will be better able to:
• Cardiovascular Disease - Why perform Research?
• What are the many types of Research?
• Research design and implantation - the Technologists role
www.scmr.org
41
From Innovation to Impact in Cardiovascular Care
TEC H N OLOG I ST TR AC K
1:50 PM
Post Processing and the Extended Role
Christine Mancini (Suburban Hospital)
At the conclusion of this session, participants will be better able to:
• Recognize which applications should have a qualitative vs quantified assessment
• Understand the appropriateness of the study requested
• Identify and understand the guidelines set by the SCMR for standardizing the post processing and interpretation of CMR
3:10 PM – 4:30 PM 3:10 PM
SESSION 4: Cardiomyopathy
Moderator: Robert Biederman, MD, FACC, FAHA (Allegheny General Hospital)
Non Ischemia Heart Failure
Andrew Flett, MBBS (University Hospital Southampton)
At the conclusion of this session, participants will be better able to:
• Understand the basic pathophysiology of non ischemic heart failure
• Understand the role of CMR in the diagnosis of various aetiologies of heart failure
• Understand the prognostic significance of CMR in non ischemic heart failure
• Understand the ability of CMR to guide management
3:35 PM The Hypertrophied Heart
Amardeep Dastidar, MBBS,MRCP (University of Bristol)
At the conclusion of this session, participants will be better able to:
• Define and quantify left ventricular hypertrophy (LVH) by CMR
• Describe the diagnostic approach when investigating a patient with LVH.
• Discuss and illustrate the usefulness of CMR in identifying the cause and prognosis of LVH
4:00 PM Oral Abstracts
4:00 PM T 1 Acute Detection of VENtricular Thrombus by Technologists (ADVENTT study) and the impact of
an image interpretation teaching intervention
Chris Lawton (Bristol Heart Institute)
4:10 PM T 2 Exercise CMR: real-time assessment of cardiac performance with phase contrast imaging
Marina Quinlan (Imperial College London)
At the conclusion of this session, participants will be better able to:
• Learn the principles and applications of exercise CMR
• Understand the techniques for assessing cardiac function during exercise
• Appreciate the future role of exercise CMR
4:20 PM T 3 Translating CMR Innovations to Impact Cardiovascular Care with a Dedicated Team
Elliot Hembree (Ohio State University)
At the conclusion of this session, participants will be better able to:
• Establish an understanding of a dedicated CMR team
• Recognize measurable impact on staff satisfaction, throughput, and volume
42
4:40 PM – 6:00 PM 4:40 PM
SESSION 5: Ischemia and Viability 5:05 PM
Adenosine Stress CMR
Bobak Heydari, MD, MPH (University of Calgary)
At the conclusion of this session, participants will be better able to:
• Importance of ischemia and imaging of ischemia in clinical decision making
• Learn standard views and techniques for assess ischemia with stress CMR
• Clinical application for acute and stable chest pain syndromes / suspected ischemic heart disease
Moderator: Stephen Darty (Duke University Medical Center)
Late Gadolinium Enhancement
Gerry McCann, MD (University Hospitals Leicester)
At the conclusion of this session, participants will be better able to:
• Understand the importance of viability imaging in patients with coronary artery disease
• Understand the different techniques for assessing myocardial viability with MRI
• Understand the principles of late gadolinium enhanced (LGE) sequences for scar detection
• Understand how to optimize image quality of LGE sequences
• Understand how LGE sequences are analysed and reported for myocardial viability
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
TEC H N O LOG I ST TR AC K
5:30 PM Dobutamine Stress CMR
Dan Augustine, MD (Royal United Hospital Bath NHS)
At the conclusion of this session, participants will be better able to:
• Understand the indications, advantages and disadvantages of using dobutamine for pharmacological stress
• Gain knowledge in how to prepare patients for dobutamine stress (what to avoid pre-hand, what to expect,
risks, common side effects)
• Describe a commonly used dobutamine stress protocol including the use of adjunct medications
• Understand dobutamine stress image interpretation and analysis
SATURDAY, JANUARY 30, 2016
10:40 AM –12:00 PM SESSION 6: Congenital Imaging - What You Need To Image and Why Moderator: Alison Fletcher, DCRR, PG Dip (Papworth Hospital)
The Unexpected Congenital Patient
Vivek Muthurangu, MD (University College London)
At the conclusion of this session, participants will be better able to:
• How to be alert to possible congenital defects
• Mains causes of right and left ventricular dilation
• Mains causes of right and left ventricular hypertrophy
• Simple shunt calculations
TGA- Atrial and Arterial Switch
Michael J. Campbell, MD (Duke University Hospital)
At the conclusion of this session, participants will be better able to:
• Understand the basics of cardiac anatomy and cardiac interrelationships
• Have knowledge of common abnormalities of cardiac anatomy
• Comprehend the basics of congenital heart disease and common congenital cardiac defects
The Univentricular Heart
Charles Peebles, MBBS, MRCP, FRCR (Southampton University Hospital)
At the conclusion of this session, participants will be better able to:
• Understand the spectrum of anatomy of the single ventricular circulation
• Appreciate the imaging requirements for follow-up of the Fontan patient
• Develop a practical CMR imaging strategy for the Fontan circuit
1:10 PM – 2:30 PM 1:10 PM
1:35 PM
2:00 PM
SESSION 7: Imaging The Right Heart
TECHNOLOGIST TRACK
10:40 AM
11:05 AM
11:30 AM
Moderator: Ralph Gentry (William Beaumont Hospital)
Right Heart Cardiomyopathy
Erica Dall’Armellina, MD, DPhil (University of Oxford)
At the conclusion of this session, participants will be better able to:
• Assessment of RV abnormalities by CMR: when the RV looks abnormal
• Potential differential diagnosis and focused CMR scanning
Right Heart Cardiomyopathy
Michael Gallagher, MD (William Beaumont Hospital)
At the conclusion of this session, participants will be better able to:
• Appreciate the spectrum of right heart cardiomyopathies.
• Discuss CMR techniques used to evaluate right heart cardiomyopathies.
• Recognise CMR findings in respect to right heart cardiomyopathies
CMR in Pulmonary Hypertension
Uyen Truong, MD (Children’s Hospital Colorado)
At the conclusion of this session, participants will be better able to:
• Understanding myocardial analysis in pediatric pulmonary hypertension
• Understanding vascular analysis in pediatric pulmonary hypertension
• Understanding comparison of MRI to cardiac catheterization in pediatric pulmonary hypertension
www.scmr.org
43
From Innovation to Impact in Cardiovascular Care
TEC H N OLOG I ST TR AC K
2:40 PM – 4:00 PM SESSION 8: Emerging Technologies
Moderator: Chris Lawton (Bristol Heart Institute)
2:40 PM
T1 and T2 Mapping
Michael Gallagher, MD (William Beaumont Hospital)
At the conclusion of this session, participants will be better able to:
• Understand indications for T1 and T2 myocardial mapping
• Understand technique of myocardial mapping
• Understand interpretation of myocardial mapping
3:05 PM 4D Flow
Michael Markl, PhD (Northwestern University
At the conclusion of this session, participants will be better able to:
• Explain basics and fundamental principles of 4D flow MRI data acquisition
• Understand the use 4D flow data analysis tools for 3D blood flow visualization and quantification of
cardiovascular hemodynamics
• Identify emerging applications of 4D flow MRI for the comprehensive evaluation of cardiovascular disease
3:30 PM
3D Printing
Laura Olivieri, MD (National Institutes of Health)
At the conclusion of this session, participants will be better able to:
• Introduce the basics of 3D printing
• Understand the uses of 3D printing in cardiovascular applications.
• Recognize the potential future for 3D printing and CMR.
3:55 PM Close
Alison Fletcher, DCRR, PG Dip (Papworth Hospital)
TECHNOLOGIST POSTERS
T 4
An Unusual Cause of Right Heart Dilatation
Yi-Hui Hung
T 5
Asymptomatic Contained Left Ventricular Rupture
Ceri Twigg (University Hospital Southampton)
T 6
Increasing PACE of PACEMAKER Imaging!
June Yamrozik, BS (Allegheny General Hospital)
T 7
Gadolinium Contrast Agents: Over Exposure?
Ronald Williams, BA,RT(R)(MR) (Allegheny General Hospital)
T8
TWIST-MR-Angiography to aid central venous access in challenging patients. A single centre experience.
Chris Lawton (Bristol Heart Institute)
T 9
Myocardial T1 and ECV mapping: how we optimise technical aspects of acquisition
Ricardo Wage (Royal Brompton Hospital)
Location: California Showroom
T 10 Essentials of Cardiac MRI in Clinical Practice
Albert Piersson, MSc (Tamale Teaching Hospital)
T 11 Streamlining Trigger Delay Estimation for T1 Mapping
George Mathew, BA (Royal Brompton Hospital)
T 12 A Model Argument for Accurate EF
Geetha Rayarao, MS (Allegheny General Hospital)
T 13 Virtual Reality Visualization of Patient Specific Heart Model
Matthew Bramlet, MD (Children’s Hospital of Illinois, University of Illinois )
This activity will not be CME accredited.You are invited to meet the poster authors during the Welcome Reception on Thursday, January 28, 2016
from 6:00 PM – 7:00 PM.
44
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
POSTER S
POSTER VIEWING SESSIONS
This activity will not be CME accredited. You are invited to meet the poster authors during the following times:
Thursday, January 28, 2016:6:00 PM – 7:00 PM
Poster Session 1 (P001-P113)
Categories being presented in Poster Session 1 are:
• Basic Translational - Post Processing and Workflow
• CAD/Ischemic Heart Disease
• CAD-Other
Friday, January 29, 2016: 12:30 PM – 1:30 PM
Poster Session 2 (P114-P248)
Categories being presented in Poster Session 2 are:
• Clinical Outcome and Prognosis
• Congenital Heart Disease
• Cost-Effectiveness and Comparison to Other Modalities
• EP and Interventional Applications
• Early Career Award
Saturday, January 30, 2016:12:00 PM – 1:00 PM
Poster Session 3 (P249-P366)
Categories being presented in Poster Session 3 are:
• Inflammatory Heart Disease
• Molecular Imaging; Contrast Agents
• Multi-Center Trials
• Non-Inflammatory Primary or Secondary CMP
• Rapid, Efficient Imaging
• Valvular Heart Disease
• Vascular MRI
P 001 Michael Markl
P 002 Anish Bhuva, MRCP MA MBBS
P 003 Liang Zhong, PhD
P 004 Melanie Dufva, MS
P 005 Kai Lin, MD
P 006 Volker Rasche
P 007 Yu Gao, BS
P 008 Bashir Alaour, MD
P 009 Kenneth Mangion
P 010 Shuo Li
P 011 Sofia Kvernby P 012 Mehdi Hedjazi Moghari, PhD
P 013 Choukri Mekkaoui, PhD
P 014 Jiun-Jie Wang, PhD
P 015 Fei Han, MS
P 016 Qi Yang, MD, PhD
P 017 Eileen Hu-Wang
P 018 Mitsue Miyazaki, PhD
P 019 Maryam Nezafat
P 020 Gilles Soulat, MD
P 021 Takami Yoshida
P 022 Vanessa Ferreira, MD, DPhil
P 023 Yanchun Zhu, PhD
LA Velocities and Stasis Assessed by 4D Flow MRI are Closely Associated with LAA Peak Velocities by Doppler TEE in
Patients with Atrial Fibrillation
Reproducibility of native T1 mapping using ShMOLLI and MOLLI – implications for sample size calculation.
Lower-than-normal myocardial stress and excess hypertrophy from CMR are associated with worsening ventricular
contractile performance in hypertrophic cardiomyopathy
Left Ventricular Torsion Rates by CMR correlate with invasively-derived hemodynamic data in Pediatric
Pulmonary Hypertension
Displacement- versus velocity-encoding: Tracking regional myocardial motion using MR imaging
High-quality reconstruction of arrhythmic cardiac cycles
Improved Respiratory Motion Self-gating in Cardiaovascular MRI
T1 Mapping Across the Ejection Fraction Spectrum
Pixel-tracking derived strain using the GlasgowHeart Method.
The accuracy and effectiveness of self-gating signals in free-breathing 3D cardiac cine MRI
Myocardial mapping of T1 and T2 with 3D-QALAS – precision of independent and dependent scans in healthy subjects
Prospective Heart Tracking for Respiratory Motion Compensation in Whole-heart Magnetic Resonance Angiography
Characterization of the Myocardium in the 4-Chamber View Using Accelerated Free-Breathing Diffusion Tensor MRI
Quantitative susceptibility map from the patients with chronic heart failure
Image-Based 3D Non-Rigid Respiratory Motion Correction for Free-breathing Thoracic MR Angiography
Early Detection and Quantification of Cerebral Venous Thrombosis by Magnetic Resonance Black Blood Thrombus
Imaging (MRBTI)
The Reproducibility of Heart Deformation Analysis for the Evaluation of Global Cardiac Function
Non-Contrast Myocardium Blood Flow: Consideration of Technical Differences between 4D Time-SLIP using Tagging Aortic Root and FAIR
Myocardial T1 mapping with spectrally-selective inversion pulse to reduce the influence of fat
Comparison of brachial and central blood pressures using an oscillometric device with 2 or 6 metre tubing lengths for
assessment of central pressure during mri exam.
Morphology-Matching-Based R-Wave Detection For Noise-Robust ECG Gating
Post-contrast T1-mapping Provides A Novel Approach To Optimal Myocardial Nulling For Late Gadolinium Enhancement
Imaging: A Quantitative Prescription for the Correct TI Without the Guesswork
Nonlinear Profile Order for 3D Hybrid Radial Acquisition Applied to Self-Gated Free-Breathing Cardiac CINE MRI
www.scmr.org
POSTERS
BASIC TRANSLATIONAL - NEW TECHNIQUES READY FOR CLINICAL APPLICATION (POSTER SESSION 1)
45
From Innovation to Impact in Cardiovascular Care
POSTER S
P 024 Mohammed S. M. ElBaz
P 026 Eric Aliotta, Bs.
P 027 Emeline Lugand, MSc
P 028 Kelvin Chow, PhD
P 029 Ria Mazumder, Master of Science
Apical inflow is associated with increased energy loss during left ventricular diastole in patients with a repaired
atrioventricular septal defect: A 4D flow MRI study
High-Resolution Spin-Echo Cardiac Diffusion-Weighted MRI with Motion Compensated Convex Optimized Diffusion
Encoding (CODE)
Breath-Held High-Resolution Cardiac T2 Mapping with SKRATCH
Robust free-breathing SASHA T1 mapping using high-contrast image-based registration
Quantification of Myocardial Stiffness in Heart Failure with Preserved Ejection Fraction Porcine Model Using Magnetic
Resonance Elastography
BASIC TRANSLATIONAL - POST-PROCESSING AND WORKFLOW
P 030 Christopher Roy, MSc
P 031 Mihir Sanghvi, MB BS, BSc
P 032 Shuo Zhang, PhD
P 033 Robert Jablonowski
P 034 Hong Liu
P 035 Elizabeth Tunnicliffe
P 036 Pankaj Garg, MD
P 037 Yuhua Chen
P 038 Kai Lin, MD
P 039 Vera-Christine Stahnke, MD
P 040 Johannes Kowallick P 041 Filip Zemrak, MD, MRCP
P 042 Georgios Kantasis P 043 Felicia Seemann, MSc in Engineering
P 044 Christopher Roy, MSc
P 045 Daniel Auger
P 046 Prahlad Menon, PhD
P 047 Haifa Almutairi, MSc
P 048 Tazim Merchant P 049 Edvin Johansson
P 050 Nivedita Naresh, PhD
P 051 Steven Bellm, MD
P 052 Kai Homer
P 053 David Gross, MS
P 054 Steven Bellm, MD
P 055 Walter Witschey, PhD
P 056 Davide Piccini P 057 Steven Bellm, MD
P 058 Dominik Buckert P 059 Dominik Buckert P 060 El-Sayed Ibrahim
P 061 Christian Stoeck, PhD
P 062 Maxine Tang, MS
Accelerated Phase Contrast Measurements of Fetal Blood Flow Using Compressed Sensing
Automatic left ventricular analysis with Inline VF performs well compared to manual analysis: Results from Barts
Cardiovascular Registry.
Extracellular volume fraction mapping at 3T with non-rigid image co-registration
MR photography of 3D-MR images
Distribution pattern of left ventricular myocardial strain by feature-tracking CMR in Chinese normal subjects
Intercentre reproducibility of second eigenvector orientation in cardiac diffusion tensor imaging
Reliability and reproducibility of trans-valvular flow measurement by 4D flow magnetic resonance imaging in acute
myocardial infarct patients: two centre study.
Fully Automated Left Ventricle Function Analysis with Self-Gated 4D MRI
Automated Assessment of Left Ventricular Function and Mass Using Heart Deformation Analysis: Initial Experience in
160 older adults
Left ventricular strain during exercise stress: a CMR myocardial feature tracking study
Quantitative Assessment of Left Ventricular Mechanical Dyssynchrony using Cine Cardiovascular Magnetic Resonance
Imaging: Inter-study Reproducibility
Can left ventricular endocardial surface roughness be measured by fractal dimension on fast gradient echo sequences?
Accelerated Cloud and GPU-based Simulations for Quantification of Relaxation Times: An Example with MOLLI.
Automated Time-Resolved Tracking Algorithm Of The Atrioventricular Plane Displacement In Cmr Images
High Resolution Multislice Imaging of the Fetal Heart Using iGRASP and MOG
Comparison of heart deformation analysis and cine DENSE in volunteers and heart failure patients
Virtual Surgical Myectomy as a Planning Tool for Obstructive Hypertrophic Cardiomyopathy
A comparison of cardiac motion analysis software packages: application to left ventricular deformation analysis in
healthy subjects
Physiologic Assessment of CMR Strain: Afterload and Contractility
Rat heart T2-mapping with full coverage of the left ventricle myocardium
High Temporal-Resolution Phase-Contrast MRI Demonstrates Impaired Left-ventricular Diastolic Relaxation in Mice Fed a
High-Fat High-Sucrose Diet
Reproducibility of Slice-Interleaved T1 (STONE) Mapping Sequence
Use of Left Ventricle Blood Pool Oxygenation-Sensitive Signal Intensity as a Measure of Arterial Hemoglobin Saturation
In Vivo and Post-Mortem Measurements of Radio Frequency Induced Heating during MRI of Pigs Implanted with
Vascular Stents
Reproducibility of Slice-Interleaved Myocardial T2 Mapping Sequences
Alterations in ectopic myocardial contraction assessed using real-time MRI
Respiratory Self Navigated Whole-Heart Angiography with Ultra-small Super-paramagnetic Iron Oxide Particles:
A Feasibility Study
Blood T1 Measurements using Slice-Interleaved T1 Mapping (STONE) Sequence
Reproducibility of Regional- and Global Left-Ventricular Strain Analyzes Using Tagging and Feature Tracking Techniques A Cardiac Magnetic Resonance Imaging Study in Healthy Volunteers
Physiological Changes in Regional and Global Left-Ventricular Strain During Exercise – A Cardiac Magnetic Resonance
Imaging Study Using Tagging and Feature Tracking in Healthy Volunteers
HARP Versus SinMod for Measuring Regional Heart Function from Tagged CMR Images
Second order motion compensated spin echo cardiac diffusion tensor imaging on clinical MR systems
Left Atrial Wall Imaging Using a Novel Black-Blood Late Gadolinium Enhancement Sequence
CAD/ISCHEMIC HEART DISEASE
P 063 Sotirios Tsaftaris
P 064 Tomas Lapinskas, MD
P 065 Wei Chen, PhD Student
46
Towards pixel-wise area-at-risk characterization with cardiac BOLD MRI at rest
Evaluation of left atrial myocardial deformation in patients with acute MR after STEMI using CMR feature tracking
Characterazation of Myocardial Edema in Rats with Acute Reperfused Myocardial Infarction at Multiple Time Points by 7 T MR
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
P 066 Alessandro Satriano, PhD
P 067 Elisabeth Paiman, MD, MSc
P 068 John Lisko, MD, MPH
P 069 Robert Edelman, MD
P 070 Yoshitaka Goto P 071 Tom Gyllenhammar
P 072 Manish Ramlall
P 073 Ian Paterson, MD
P 074 Tobias Rutz, MD
P 075 John Greenwood, MD, PhD
P 076 Sebastian Kelle, MD, PhD, FESC
P 077 Leah Iles, FRACP, PhD
P 078 Daniel Lee, MD
P 079 Peter Shaw, MD
P 080 Lorenzo Monti, MD
P 081 Michael Jesinger, MD
P 082 Ahmed AlBadri, MD
P 083 Anna Schmidt, MD-PhD Candidate
P 084 Ryo Ogawa
P 085 Kalyan Kancherla, MD
P 086 Joy Shome, MBBS MRCP
P 087 Akimasa Yamada
P 088 Joyce Wong, MRCP, PhD
P 089 Francesco Secchi, MD
P 090 Antonia Camporeale, MD
P 091 Joseph Soltys, PhD
P 092 Enver Tahir, MD
P 093 Nadine Abanador-Kamper
P 094 David Nordlund
P 095 Paras Parikh, MS
P 096 Nicola Galea, MD PhD
P 097 Gerald Pohost
P 098 Terrence Jao, BS
P 099 Vishal Mehra, MD, PhD
P 100 Terrence Jao, BS
P 101 Paras Parikh, MS
P 102 Steven Bellm, MD
Segmental Strain Analysis by Deformation of a Mesh Model: Comparison of Segmental Strain Metrics and Late
Gadolinium Enhancement Quantification in Myocardial Infarction.
MRI-derived cardiac mechanical dispersion for risk stratification in patients with ischemic cardiomyopathy:
a preliminary study
Assessment of Transient Ischemic Dilation With Cardiac MRI
Breath-Hold Imaging Of The Coronary Arteries Using Quiescent-Interval Slice-Selective (Qiss) Magnetic Resonance Angiography - Pilot Study At 1.5 Tesla And 3 Tesla
Native T1 mapping allows for the accurate detection of the segments with chronic myocardial infarction in patients with
known or suspected coronary artery disease.
Myocardial perfusion using cardiac magnetic resonance: Evidence of decreased global myocardial perfusion in patients
with systemic sclerosis with possible gender differences
High-sensitivity Troponin-T levels in reperfused STEMI patients: A comparison with CMR
Right Ventricular Remodeling and Dysfunction Among the Spectrum of Heart Failure Phenotypes
Border sharpness of scar tissue after myocardial infarction as determined by self-navigated free-breathing isotropic 3D
whole-heart inversion recovery magnetic resonance
Rationale and design of the Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease 2 trial (CEMARC 2): A prospective, multi-centre, randomized controlled trial of diagnostic strategies for suspected coronary
heart disease
Prognostic value of cardiovascular magnetic resonance stress perfusion imaging in patients with atrial fibrillation.
Biomarker validation of cardiac magnetic resonance analysis of regional myocardial fibrosis in ischaemic heart disease
Electrocardiographic Markers of Myocardial Infarction Size, Transmural Extent, and Extent of Nonviable Myocardium Comparison to CMR
Quantitative CMR perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease.
Role of adenosine Stress CMR before Chronic Total Occlusion reopening
LV wall motion assessment during regadenoson vasodilator stress CMR
Interscan Reproducibility of Cardiovascular Magnetic Resonance Myocardial Perfusion Reserve Index in Women with
Suspected Coronary Microvascular Dysfunction and No Obstructive Coronary Artery Disease
Intra-Thoracic Fat Volume is Associated with Impaired Myocardial Function and Adverse Left Ventricular Remodeling in
Patients with Known or Suspected Coronary Artery Disease
Quantitative Circumferential Strain Analysis Using 3-Tesla Feature-Tracking Cardiovascular Magnetic Resonance in
Patients with Old Myocardial Infarction.
Effect of Myocardial Scar detected by cardiac Magnetic Resonance on perfusion time and short term outcomes after
Coronary Artery Bypass Graft Surgery
Validation of perfusion dyssynchrony indices as a novel non-invasive diagnostic tool in the detection of hemodynamically
significant coronary artery disease in the setting of three dimensional (3D) myocardial perfusion CMR.
Fermi function constrained deconvolution underestimates myocardial blood flow and myocardial perfusion reserve
regardless of saturation correction of arterial input curve.
DE-CMR and MPS for assessment of myocardial viability: to what extent do the two techniques agree?
Epicardial Adipose Tissue Evaluated with Cardiac Magnetic Resonance in Normal Subject and in patients with Ischemic
and Dilated Cardiomyopathies
Lack of right ventricular remodelling after surgical ventricular restoration
Initial Description of Changes in Wall Motion Parameters in Normal Subjects Undergoing Rest/Regadenoson Stress
Using A Tagged MRI Sequence
Reproducibility of native and contrast-enhanced CMR techniques to measure lesion size following acute
myocardial infarction
Impact of coronary flow on the risk of microvascular obstruction in acute myocardial infarction
The Evolution of Myocardium at Risk by T2-STIR MR imaging the first Week after Acute Myocardial Ischemia
Extracellular Volume Fractions Are Not Consistent in Gray Zones Determined by Late Gadolinium Enhancement Imaging
of Myocardial Infarction.
Application of native T1 map in characterization of acute myocardial infarction: can T1 distinguish between infarct area
and area-at-risk?
Impact of Ranolazine on Myocardial Metabolic Ischemia Detected by Phosphorus-31 Magnetic Resonance Spectroscopy
Demonstration of Velocity Selective Myocardial Arterial Spin Labeling Perfusion CMR
The Relationship of Gray Zone and Infarct Core in the Iceland MI Study
Myocardial ASL-CMR Perfusion Imaging with Improved Sensitivity using GRAPPA
A Novel Calibration Technique to Obtain High Resolution 3D T1 Maps for Infarct Characterization
The Native T1 in Remote Myocardium of Patients with Prior Chronic Infarction is Not Normal
www.scmr.org
POSTERS
POSTER S
47
From Innovation to Impact in Cardiovascular Care
POSTER S
CAD – OTHER
P 103 Susann Beier, BSME, ME
P 104 Sung A Chang, MD, PhD
P 105 Felix Range, MD
P 106 Enver Tahir, MD
P 107 Akhil Narang, MD
P 108 Tendoh Timoh, MD
P 109 Ryo Ogawa
P 110 Sarah Nasser, Masters
P 111 Darius Dabir, MD
P 112 Mita Patel, MD
P 113 Abbas Nasiraei-Moghaddam, PhD
A new method to quantify coronary flow conditions using dynamically scaled in vitro phase contrast magnetic
resonance imaging
Safety of Adenosine Stress Perfusion Cardiac MRI in Patients undergoing Lung Transplantation Evaluation
Acute regadenoson stress prefusion testing using cardiac MRI is a valuable test of high predictive value for risk
stratification of COPD-patients with NSTEM
Effects on blood pressure, cardiac mass and function after renal denervation in patients with resistant hypertension.
Vasodilator stress cardiovascular magnetic resonance imaging in post-orthotopic heart transplant recipients: evaluation
of safety, hemodynamics, and myocardial perfusion
How well do individual first pass perfusion images correlate with fully quantitative myocardial blood flow pixel maps?
T1 Mapping Using a Saturation Recovery Single-Shot Acquisition at 3 Tesla MRI in Differentiation of Normal Myocardium
from Hypertrophic Cardiomyopathy
Quantitative tissue characterization of cardiac myxomas by CMR-Mapping techniques validated by histology.
Association between early diastolic dysfunction and increased peri-/epicardial fat: A CMR based study
Novel 3-Dimensional K-Space Segmented Acquisition Scheme (CENTRA-PLUS) for Enhanced Coronary Imaging
A software tool for segmentation of the myocardium in CMR exams using level-set algorithm
CLINICAL OUTCOME AND PROGNOSIS
P 114 Francesco Secchi, MD
P 115 Sameer Raina, MD
P 116 Amir Rahsepar, MD
P 117 Raymond Chan, MD
P 118 Amardeep Ghosh Dastidar, MBBS, MRCP
P 119 Moon Young Kim, Doctor
P 120 George Cater, MD
P 121 Eric Yang, MD
P 122 Simon Lee, MD
P 123 Andrew Cheng, MD
P 124 Eks Pollock, MD
P 125 Xuefei Duan
P 126 Michael Nelson, PhD
P 127 Julius Weinrich, MD
P 128 Lei Zhao
P 129 Kenneth Mangion
P 130 Michael Chuang, MD
P 131 Sabha Bhatti, MD
P 132 Yoshiaki Ohyama, MD
P 133 Ian Chang, MD
P 134 Mohammed Khanji, MB BCh
P 135 Satish Chacko, MD
P 136 Huma Samar, MD
P 137 Antonella Meloni, P 138 Robert Biederman, MD, FACC, FAHA
P 139 Ke Wan
48
Prognostic Value of Late Enhancement in Cardiac Magnetic Resonance in Patients with Dilated Cardiomyopathy:
A Meta-analysis
Prognostic utility of Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Cardiac Amyloidosis:
A Meta-analysis.
MR Tissue Phase Mapping Reveals Reduced Left Ventricular Velocities in Patients with Myocardial Scar.
Prognostic Value of Late Gadolinium Enhancement Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy:
A Meta-analysis
Impact of cardiovascular magnetic resonance on management and clinical decision-making in patients presenting with
chest pain, elevated troponin and unobstructed coronary artery
Myocardial T1 mapping in asymptomatic subjects: variations according to left ventricular segments and correlation with
cardiovascular risk factors
Pulmonary Artery Pressure is Associated with Extracellular Volume Fraction in Patients with Normal Left Ventricular Function
Prognostic implications of myocardial fibrosis and troponin levels measured by a highly sensitive assay in
non-ischemic cardiomyopathy
Simplifying the Diagnosis of Left Ventricular Hypertrophy: Is Left Ventricular Mass to Volume Ratio Constant in Children
Throughout Growth?
Comparison of MOLLI and ShMOLLI at 1.5 and 3 Tesla for Detection of Early Cardiac Iron Deposition in Patients with
Transfusional Siderosis
Withdrawn
Extracellualr volume(ECV) quantified by T1 mapping could reflect effect of long term blood pressure control status in
patients with essential hypertension
Changes in left ventricular function and coronary blood flow velocity during isocapnic hypoxia: A cardiac magnetic
resonance imaging study
Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year
risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
Myocardial T1 mapping at 3 T in healthy adults: reference values and influencing factors
The Cardiac Toxicity CMR Study in Patients with Lung Cancer Treated with Chemo-radiotherapy: The CART study- a semi
quantitative analysis of the myocardial perfusion index.
Impact of Sex and Advancing Age on Left Atrial Volume and Shape: The Framingham Heart Study
Clinical characteristics and predictors of mortality in patients with normal wall thickness cardiac amyloidosis
Age-Related Association of Aortic Arch Pulse Wave Velocity Assessed by MRI with Incident Cardiovascular Events: The
Multi-Ethnic Study of Atherosclerosis (MESA)
Impact of Cardiovascular Imaging on the Management of Patients with Cardiac Masses
The applicability of current global cardiovascular risk scores and cardiovascular surrogates in chronic obstructive
pulmonary disease
Longitudinal fiber dysfunction assessed during cine-cardiac magnetic resonance imaging is an independent predictor of
adverse cardiac events
Pacemakers and AICDs in the Magnet; have we turned the corner?
Significant improvement of survival by T2* CMR in thalassemia major
Physiologic Left Ventricular Ejection Efficiency Assessed at the Level of the Aorta
The Right Ventricular End-systolic Volume Index Predicts Mortality in Patients with Cardiac Amyloidosis
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
POSTER S
P 140 Katia Menacho Medina
P 141 Antonella Meloni
P 142 Vikram Brahmanandam, MD
P 143 Michael Chuang, MD
P 144 Thomas Hauser, MD, MPH, MMSc
P 145 Sahadev Reddy, MD
P 146 Angela Koh, MBBS, MPH
P 147 Geeshath Jayasekera
P 148 Ryan Avery, MD
P 149 Robert White
P 150 El-Sayed Ibrahim The Right ventricle and cardiac surgery -- more resilient than thought: multiparametric quantification shows altered
rather than reduced function
Withdrawn
Improved Prediction of Adverse Events in Hypertrophic Cardiomyopathy with Quantitative Late Gadolinium Enhancement
and Myocardial Strain
Aortic Arch Width by CMR Is Highly Reproducible Between Readers and Across Imaging Sequences
CMR Measures of Left and Right Ventricular Systolic Performance and Mortality: A Factor Analysis
Cardio-Hepatic Risk Assessment by CMR in Liver Transplant Candidates; Advancing Beyond a Proof of Concept.
Subclinical Cardiac Abnormalities and Physical Function in Asymptomatic Elderly
Right Ventricular free wall myocardial tissue characterisation by systolic Cardiac Magnetic Resonance T1 mapping in
pulmonary hypertension.
Multiparameter Use of Cardiac Magnetic Resonance as a Predictor of Pulmonary Artery Hypertension
Atrial Fibrosis Progression in Patients with Atrial Fibrillation
CMR for Evaluation of Cardiac Function in Type-1 Diabetes
P 151 Theo Kingdom
P 152 Michael Morcos, MD
P 153 Gilles Soulat, MD
P 154 Avan Suinesiaputra P 155 Jonathan Levine, MD Candidate
P 156 Prashob Porayette, MBBS, MSc
P 157 Mun Cheang
P 158 Kevin Gralewski, MSE
P 159 Dan Yang
P 160 Hari Narayan, MD
P 161 Bram Ruijsink P 162 Bernadette Elders P 163 Ramkumar Krishnamurthy, PhD
P 164 Sara Swanson, MD, PhD
P 165 Tamadhir Gazzaz, MBBS
P 166 Jimmy Lu, MD
P 167 Cory Noel, MD
P 168 Emmanuel Ogele, BS Biology
P 169 James Enos, MD
P 170 Michael Rose, BSc
P 171 Joyce Woo
P 172 Jason Christensen, MD
P 173 Laura Olivieri P 174 Sujatha Buddhe, MD
P 175 Puneet Bhatla
P 176 Margaret Samyn, MD
P 177 David Lloyd
P 178 Nathaniel Barber, MBBS
P 179 Mahesh Kappanayil, MD
P 180 David Lloyd
The absolute and relative sizes of the brains and bodies of fetuses with different forms of congenital heart disease and
intrauterine growth restriction.
Comparison of Systemic Right Ventricular Function in Transposition of the Great Arteries after Atrial Switch and
Congenitally Corrected Transposition of the Great Arteries
Accuracy and Inter observer variability of blood flow quantification on 4D flow MRI in adult with transposition of the
great arteries corrected by arterial switch
Application of Atlas-Based Global Shape and Local Contraction Analysis to Single-Ventricle Congenital Heart Disease
Segmental late gadolinium enhancement and Gadolinium extracellular volume in hypertrophic cardiomyopathy
Serial Prenatal And Post-Natal Brain Mri Demonstrates Impact Of Congenital Heart Disease And Cardiac Surgery On
Brain Growth And Maturity
Comprehensive Cardiovascular Assessment of Children with Chronic Kidney Disease using Exercise Cardiac Magnetic
Resonance Imaging
Continuity equation-derived valve area using CMR phase-contrast provides flow-independent assessment of valve stenosis
LV geometric and substrate remodeling in patient with Ebstein anomaly - A Deep insight from MRI T1 mapping
fibrosis imaging
Reliable Aortic Arch Measurements Using a Novel Cardiac Magnetic Resonance Sequence: Navigated 3D SPACE
Right ventricular function and adaption after hemi-Fontan completion in children with hypoplastic left heart syndrome.
Ascending aortic wall shear stress and distensibility are different in patients with corrected atrioventricular
septal defect compared to healthy controls: a comprehensive CMR and 4D flow MRI evaluation
Ventricular Coupling in Single Ventricle Patients: A MRI Study of Cardiac Biomechanics in
Left ventricular extracellular volume measurements in repaired tetralogy of Fallot patients
Validation of a Semi-automatic Threshold-based Approach for Right Ventricular Endocardial Border Detection for Volumetry
Predictors of Change in Functional Health Status in Adults with Repaired Tetralogy of Fallot
Myocardial T1 Mapping as a Diagnostic Tool in Pediatric Patients with a Concern for Cardiac Disease
The Use of Cardiac Magnetic Resonance Imaging in Diagnosing and Characterizing Hypertrophic Cardiomyopathy
A Comparison of Right Ventricular Volumes in Children and Adults with Repaired Tetralogy of Fallot - Including and
Excluding Right Ventricular Trabeculations
Evaluating the Disease Progression of Pediatric Bicuspid Aortic Valve Patients Using 4D Flow MRI Data
Can 2-Dimensional Echocardiography Accurately Classify Patients with Repaired Tetralogy of Fallot in Possible Need of
Pulmonic Valve Replacement?
Relation of increased BMI to left atrial volume in repaired tetralogy of Fallot patients
Coronary Flow Reserve in Adults with Systemic Right or Single Ventricles
Myocarditis Masquerading as Acute Coronary Syndrome: Diagnostic Role of Cardiac MRI
Utility of rapid prototyping in Complex DORV: Does it alter management decisions?
Utility of Speckle Tracking Echocardiography in Measuring Systemic Right Ventricular Systolic Function for Patients with d-Transposition of the Great Arteries Status post Atrial Switch Procedure: A Comparison with Cardiac Magnetic
Resonance Imaging
Early experience of multi-sequence fetal cardiac magnetic resonance imaging within a clinical fetal cardiology service
MR-Augmented Cardio Pulmonary Exercise Testing: an integrated approach to assessment of children with
Pulmonary Hypertension.
From establishing a CHD-CMR unit to 3D printing in a developing country pediatric cardiac unit.
Prenatal MRI visualisation of the aortic arch and fetal vasculature using motion-corrected slice-to-volume reconstruction
www.scmr.org
POSTERS
CONGENITAL HEART DISEASE
49
From Innovation to Impact in Cardiovascular Care
POSTER S
P 181 Nao Sasaki, MD
P 182 Amita Singh, MD
P 183 Erin Paul, MD
P 184 Pia Sjöberg, MD
P 185 Nicole Wake, MS
P 186 AK Ortiz, BA
P 187 Sihong Huang, MD
P 188 Arni Nutting, MD
P 189 Tim Slesnick, MD P 190 Nicholas Byrne
Calculation of differential pulmonary blood flow in patients with congenital heart disease using pulmonary artery flow
versus pulmonary vein flow.
Alterations in Regional Right Ventricular Shape in Patients Following Tetralogy of Fallot Repair Involving a
Transannular Patch
Nonlinear Self-Calibrated Phase Contrast Correction in Pediatric and Congenital Cardiovascular Magnetic
Resonance Imaging
Patients with Tetralogy of Fallot have lower systolic KE in the left ventricle and higher diastolic KE in the right ventricle.
Whole Heart Self-Navigated 3D Radial MRI for the Creation of Virtual 3D Models in Congenital Heart Disease
Left Ventricular Shape Variation in Patients with Aortic Coarctation Pre- and Post-Stent Implantation
Prevalence of myocardial scarring in congenital heart disease – comparison between left ventricular pressure and
volume overload using a novel black-blood delayed enhancement imaging technique
Single center experience with a prototype self-navigated 3D SSFP whole heart sequence in assessing coronary
artery origin
Quantification and Origin of Differential Pulmonary Blood Flow in Patients with a Fontan Circulation
Steps towards automated image segmentation as part of a 3D printing pipeline in congenital heart disease
COST-EFFECTIVENESS AND COMPARISON TO OTHER MODALITIES
P 191 Gayathri Kumarasinghe, MBBS FRACP
P 192 Mohan Mallikarjuna Rao Edupuganti, MD, FRACP
P 193 Mohan Mallikarjuna Rao Edupuganti,
MD, FRACP
P 194 Mariam Narous P 195 Daniel Morgenstern
Cardiovascular Magnetic Resonance Imaging Produces Highly Reproducible Rodent Cardiac Volumetric and Functional
Data Using a 1.5 Tesla Scanner
Exploring difference in atrioventricular valve opening times to predict elevated left atrial pressure – a novel
approach to left atrial pressure quantification on cardiovascular MRI.
Comparison of regional and global Cardiac MRI diastolic strain rates with echo grading of diastolic dysfunction.
Do Whole Body Impedance Cardiography Estimates of Left Ventricular Structure, Volumes and Function Correlate with
the Gold Standard of Cardiac Magnetic Resonance Imaging?
Cardiac MRI Stress Testing in the Reduction of Radiation Exposure for Patients Undergoing Ischemic Evaluation
EP AND INTERVENTIONAL APPLICATIONS
P 196 Eugene Kholmovski, PhD
P 197 Stephanie Clement-Guinaudeau
P 198 Hubert Cochet, MD PhD
P 199 Maurits van der Graaf, MD
P 200 Erik Bieging, MD
P 201 Hubert Cochet, MD PhD
P 202 Christian Mahnkopf, MD
P 203 Joseph Soltys, PhD
P 204 Amir Durrani, MD
P 205 Adrienne Campbell-Washburn, PhD
P 206 Philippa Krahn, BSc
P 207 Dana Peters
P 208 Ozgur Kocaturk, PhD
P 209 Dana Peters
P 210 Zhen Qian
P 211 Peter Kellman, PhD
P 212 Mikayel Dabaghyan, PhD
P 213 Michael Guttman, MS
P 214 Thomas Gregory, MS
P 215 Daniel Auger
P 216 Adrienne Campbell-Washburn, PhD
Visibility of RF Ablation Lesions in Native T1-weighted MRI Reduces with Time after Ablation
Characterization of ARVC substrate on MRI and electrophysiological mapping
Post-Infarction Ventricular Fibrillation Mechanisms: Insights From Combined Body Surface Potential Mapping And Late
Gadolinium-Enhanced Cmr
Use and Safety of Magnetic Resonance Imaging in Patients With an Implanted MRI-Conditional Pacing Device
Regional left atrial wall fibrosis and recurrence after atrial fibrillation ablation
Atrial Scar On Late Gadolinium-Enhanced Imaging To Predict Electrical Reconnection After Pulmonary Vein Isolation For
Atrial Fibrillation
Assessment of left atrial structural remodeling in patients with cryptogenic stroke - Lessons Learned from LGE-MRI
Post Ablation Timing to Best Visualize Left-Atrial Lesions: A Feasibility Study
The Cumulative Effects and Clinical Safety of Repeat Magnetic Resonance Imaging on an MRI-conditional Pacemaker
System at 1 .5 Tesla
Real-time inversion recovery for infarct visualization during MR-guided interventions
Intrinsic MRI visualizes RF lesions within minutes after MR-guided ablation
Lower Left Atrial Strain in the Presence of Regional Atrial Fibrosis: An MRI Study of Patients with Atrial Fibrillation
Lithography Based Resonant Marker Design For Mri Catheter Visualization
Atrial fibrosis segmentation thresholds: a theoretical and empirical study
Comparison of Noninvasive Three Dimensional Delayed Enhancement MRI of Left Atrial Scar with Invasive Voltage Map
by Using Robust 4D Point-to-Point Registration in Patients with Atrial Fibrillation
Dark Blood Late Gadolinium Enhancement Improves Conspicuity of Ablation Lesions
3T Cardiac Imaging With On-Line 12-Lead Ecg Monitoring
Towards MRI-guided cardiac ablation procedures with no contrast agent: safety and efficacy considerations
Intra-MRI Extraction of Diagnostic Electrocardiograms using Dynamic Feedback from Carotidal
Magnetohydrodynamic Voltages
Cine DENSE MRI of Mechanical Activation in Heart Failure Patients Referred for Cardiac Resynchronization Therapy
Spiral imaging with off-resonance reconstruction for MRI-guided cardiovascular catheterizations using commercial
off-the-shelf nitinol guidewires
EARLY CAREER AWARD
P 217 Joseph Cheng, PhD
P 218 Zixin Deng
50
Feasibility of Ultra-High-Dimensional Flow Imaging for Rapid Pediatric Cardiopulmonary MRI
Pressure Gradient Measurement in the Coronary Artery Using Phase Contrast (PC)-MRI: Initial Patient Results Towards
Noninvasive Quantification of Fractional Flow Reserve
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
POSTER S
Remote myocardium is also affected in acute myocardial infarction: evidence from advanced CMR relaxometry
Skeletal Muscle Assessment to Understand Cardiometabolic Interactions
New automatic algorithm for segmentation of myocardial scar in both inversion recovery and phase sensitive inversion
recovery late gadolinium enhancement: validation against TTC and in multi-center, multi-vendor patient data
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers
and SPECT
Inter-study repeatability of self-gated CMR perfusion: A comparison of Fermi and compartment models
Cardiac and hepatic phenotype of diabetes in the presence and the absence of obesity - mechanistic role of ectopic/
visceral adiposity
Accuracy of Non-contrast-enhanced Quiescent Interval Single-Shot (QISS) Lower Extremity MRA for the Diagnosis of
Peripheral Artery Disease: Comparison with CTA and Digital Subtraction Angiography
Myocardial Extracellular Matrix Volume has independent prognostic value in patients with non-ischemic cardiomyopathy.
In the presence of a patent foramen ovale paroxysmal embolism risk increases with non-vortical right atrial blood flow
Comprehensive intra/extracellular myocardial structural and functional characterization of hypertensive heart
disease phenotypes
Quantification of the myocardial partition coefficient for intravenous iron (ferric carboxymaltose) using T1 mapping
cardiovascular magnetic resonance
Chronic iron deposit and left ventricular remodeling in reperfused STEMI patients
Myocardial haemorrhage after acute reperfused ST-elevation myocardial infarction evolves progressively and
contributes to the early bimodal pattern in T2-relaxation time: advanced imaging and clinical significance.
Improved assessment of aortic 3D blood flow with combined k-t accelerated 3D CINE bSSFP & 4D flow MRI
4D Strain Analysis within Non-Infarcted Myocardium of Patients with Ischemic Cardiomyopathy: Potential Marker for
the Prediction of Adverse Cardiac Events.
Refining the Characterization of Residual Function in Hypertrophic Cardiomyopathy through Remote Segment 4D
Strain Analysis.
A simple clinical model to predict presence of myocardial fibrosis in patients with aortic stenosis.
Withdrawn
Measurement of the intracellular lifetime of water to estimate myocardial cell size is not feasible in humans using
clinical contrast agent doses at 1.5T
Diffuse Myocardial Fibrosis detected by Multi-slice T1 Mapping using Slice Interleaved T1 (STONE) Sequence in
Patients with Hypertrophic Cardiomyopathy
Role of 12 lead ECG Q-waves as a marker of myocardial infarction in the era of cardiac magnetic resonance
Patients with Cardiac syndrome X have decreased global myocardial perfusion compared to gender matched controls;
insights from CMR coronary sinus flow measurements
Non-contrast cardiac MRI for tissue characterization in patients with end stage renal disease
Free-breathing respiratory self-gated Golden angle RAdial Three-dimensional whole-heart isotropic cine imaging for
left ventricular volumetric Evaluation (GRATE) – comparison with conventional 2D breath-hold cine imaging
Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy
Papillary Muscle Native T1 Time is Associated with Severity of Functional Mitral Regurgitation in Patients with
Non-ischemic Dilated Cardiomyopathy
Best precision in measuring Qp/Qs is achieved with quadratic, not linear, stationary tissue background correction in
phase contrast velocity encoded CMR
In Patients with Acute Myocarditis, the Difference in Apparent Extracellular Volume Fraction between Affected and
Healthy Myocardium does not differ between Early and Late Post-Contrast Imaging
Debt-Free Cardiac Health
Extrapolating echocardiographic determinants of elevated Left Atrial Pressure (LAP) to Cardiac Magnetic Resonance
Imaging (CMR) to determine the best CMR correlate of elevated LAP.
POSTERS
P 219 Amardeep Ghosh Dastidar
MBBS, MRCP
P 220 Vidhya Kumar
P 221 Jane Tufvesson, MSC
P 222 Jane Tufvesson, MSC
P 223 Devavrat Likhite
P 224 Eylem Levelt
P 225 Akos Varga-Szemes, MD, PhD
P 226 Tomas Vita P 227 Victoria Stoll
P 228 Jonathan Rodrigues, BSc(Hons),
MBChB(Hons), MRCP, FRCR
P 229 Goran Abdula, MD
P 230 Heerajnarain Bulluck, MBBS
P 231 David Carrick, BScMedSci,
MBChB, MRCP
P 232 Kelly Jarvis, MS
P 233 Alessandro Satriano, PhD
P 234 Alessandro Satriano, PhD
P 235 Vassilis Vassiliou, MA, MBBS, MRCP
P 236 Johannes Kowallick
P 237 Magnus Lundin, MSc, MD
P 238 Shingo Kato
P 239 Amardeep Ghosh Dastidar,
MBBS, MRCP
P 240 Tom Gyllenhammar
P 241 Tori Stromp
P 242 Karen Holst
P 243 James Starc, MD
P 244 Shingo Kato P 245 Jannike Nickander P 246 Magnus Lundin, MSc. Engg
P 247 Victor Farah, MD
P 248 Mohan Mallikarjuna Rao Edupuganti, MD, FRACP
INFLAMMATORY HEART DISEASE
P 249 Yoko Mikami, MD, PhD
P 250 Patrizia Pedrotti, Medical Doctor
P 251 Ahmed Kharabish, Master
P 252 Theodore Murphy, MD
P 253 Reina Tonegawa Inter-center variability in the application of the Lake Louise Criteria to the diagnosis of myocarditis
Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac
magnetic resonance
CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric
heart failure
Incidence of Cardiac Sarcoidosis in those with Extra-cardiac Disease without known Cardiac Involvement –
a CMR Study
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and T2-weighted short tau inversion
recovery black-blood images of cardiac magnetic resonance in cardiac sarcoidosis
www.scmr.org
51
From Innovation to Impact in Cardiovascular Care
POSTER S
P 254 Alban Redheuil
P 255 Darius Dabir, MD
P 256 Johannes Schüler, Student
P 257 Julius Traber
Detection of Subclinical Cardiac Involvement in Inflammatory Myopathy by CMR T1 Relaxometry
Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of
sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T
Combined parametric mapping allows discrimination of disease activity in myocarditis
Assessment of acute radiation therapy-related cardiotoxicity by cardiovascular magnetic resonance
MOLECULAR IMAGING; CONTRAST AGENTS
P 258 Jessica Bastiaansen, PhD
Flow imaging in vivo using off resonance spin labeling induced by extraneous contrast agent
P 259 Kim-Lien Nguyen, MD
Ferumoxytol across the Age Spectrum: a Single Center Experience of Safety
P 260 Naveen Rajpurohit, MD
Global and Regional Extracellular Volume and Myocardial Circumferential Strain Correlate Significantly in a
Heterogeneous Patient Population
P 261 Lindsay Urbinelli, MD
T1 Mapping in Becker Muscular Dystrophy Patients Detects Diffuse Microfibrosis Prior to Evidence of Late Gadolinium
Enhancement or Cardiac Dysfunction
P 262 Dara Kraitchman, VMD, PhD
Cardiac CEST-MRI For Tracking Stem Cell Survival and Determining the Role of CXCL2
MULTI-CENTER TRIALS
P 263 Amol Pednekar, PhD
Two-Center Clinical Validation of Free Breathing Respiratory Triggered Retrospectively Cardiac Gated Steady-State Free
Precession (RT-SSFP) Cine Imaging in Adults
NON-INFLAMMATORY PRIMARY OR SECONDARY CMP
P 264 Jonathan Rodrigues, BSc(Hons), MBChB(Hons), MRCP, FRCR
P 265 Shawn Pun, MD
P 266 Maria Espinoza Barillas, Resident
P 268 Olga Toro-Salazar, MD
P 269 Amardeep Ghosh Dastidar, MBBS, MRCP
P 270 Antonella Meloni P 271 Chiara Valentina Lario P 272 Yong Luo
P 273 Sabha Bhatti, MD
P 274 Julien Frandon, MD
P 275 Karolina Zareba, MD
P 276 Rami Homsi
P 277 Minjie Lu, MD, PhD
P 278 Xiaohai Ma, MD, PhD
P 279 Jonathan Soslow, MD
P 280 Lilia Sierra-Galan, MD, FACC, FSCCT
P 281 Upasana Tayal
P 282 Minjie Lu, MD, PhD
P 283 Upasana Tayal
P 284 Anna Schmidt, MD-PhD Candidate
P 285 Flavia Junqueira, PhD
P 286 Leena RV, MD
P 287 Yoko Mikami, MD, PhD
52
Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric CMR predictors
beyond end-diastolic wall thickness ≥15mm
Tissue Characteristics and Anatomic Distribution of Cardiac Metastases among Patients with Advanced Systemic
Cancer Assessed by Cardiac Magnetic Resonance (CMR)
Cardiovascular Magnetic Resonance in Familial Amyloidosis.
Cardiac Magnetic Resonance Characteristics of Acute Anthracycline-Induced Cardiotoxicity
Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic
cardiomyopathy (HCM)
Changes of cardiac iron and function during pregnancy in trasfusion-dependent thalassemia patients
Early markers of heart damage in systemic sclerosis: role of cardiac magnetic resonance with late
gadolinium enhancement
Mitral valve leaflet length as an important factor to differentiate hypertrophic cardiomyopathy from other causes of left
ventricular hypertrophy
Determination of strain pattern in patients with cardiac amyloidosis secondary to Multiple Myeloma: A Feature
Tracking Study
Evaluation of trabeculated mass in patient with non compaction: do we need criteria reappraisal?
Wide QRS-T angle and low T wave amplitude are associated with the presence of myocardial expansion as measured by
extracellular volume fraction with cardiac MRI
Pulmonary arterial hypertension is associated with increased T1 relaxation times and decreased left ventricular
performance in spite of preserved left ventricular function
CMR Assessment of the Left Ventricle Apical Morphology in Subjects with Giant T-wave Inversions and Without Apical
Wall Thickness>15mm
Systolic MOLLI T1 mapping with heart rate depends pulse sequence sampling scheme is feasible in patients with
atrial fibrillation
Myocardial T1 and T2 Mapping in Duchenne Muscular Dystrophy: Characterization of Late Gadolinium Enhancement
Presence Of Late Gadolinium Enhancement In “Healthy Subjects”: Correlation With Chronic Exposure To
Moderately High Altitudes.
Evaluation of CMR predictors of Right Ventricular Remodelling in Dilated Cardiomyopathy
Myocardial Extracellular Volume Fraction Quantified by Cardiovascular Magnetic Resonance is Increased in Hypertension
and Associated with Left Ventricular Remodeling
Evaluating the Significance of Left Ventricular Midwall Fibrosis Detected by Late Gadolinium Enhancement Imaging on
Left Ventricular Functional Remodelling in Dilated Cardiomyopathy
Cardiovascular Magnetic Resonance Imaging of Cardiac Remodeling and Strain Analysis in Adolescent Obesity
Fat Content Effect in the Measurement of T2* for Iron Quantification in the Liver in Patients With Suspected Myocardial
Iron Overload
Retrospective analysis of MR imaging characteristics and demographic characteristics of Tropical Endomyocardial
fibrosis in a tertiary care centre in South India
Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
POSTER S
P 288 Hong-Mi Choi P 289 Noha Behairy
P 290 Vassilis Vassiliou, MA, MBBS, MRCP
P 291 Elena Pena, MD
P 292 Rebecca Thornhill, PhD
P 293 Minjie Lu, MD, PhD
P 294 Yu-pin Chang, MD
P 295 Antonella Meloni, PhD
P 296 Shadi Akhtari, MD
P 297 Sharif Sabe
P 298 Ganesh Kumar Gnanappa
M.B.B.S, MD
P 299 Min Liu, MD
P 300 Tom Gyllenhammar
Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy
Delayed myocardial enhancement in pediatric hypertrophic cardiomyopathy: correlation with LV functional and
demographic parameters
Left atrial dilation in patients with heart failure and preserved ejection fraction: Value of CMR Simpson method.
Relationship between expansion of the myocardial interstitial space and ventricular performance in patients with
pulmonary hypertension
Relationship between MRI First pass Perfusion Parameters and Biventricular Performance in Pulmonary Hypertension
The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
Assessment of Fabry variant (IVS4+919G>A) Cardiomyopathy in Taiwanese: Emphasis on T1 mapping
Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients
Left and Right Ventricular Volumes and Global Systolic Function in Isolated Left Bundle Branch Block: A Cardiac
Magnetic Resonance Imaging Study
Predictors of Right Ventricular Ejection Fraction in Patients with Nonischemic Cardiomyopathy
Pediatrics, Fellowship in Paediatric cardiology Presence of Left Ventricular Non Compaction in Hypertrophic
Pediatrics Is Associated With Arrhythmia
Longitudinal strain correlated with haemodynamics in patients with chronic thromboembolic pulmonary hypertension
Right atrial volume measured by cardiac magnetic resonance correlates with NT-ProBNP and invasive right atrial
pressure in pulmonary hypertension, with and without systemic sclerosis
P 267 Aurelien Bustin
P 301 Peter Speier
P 302 Claudio Santelli
P 303 LI ZHANG, MaSc.
P 304 Iain Pierce, PhD
P 305 Xin Liu, MD, PhD
P 306 Marcos Ferreira Botelho, MD
P 307 Raluca Saru, MD
P 308 Raluca Saru, MD
P 309 Sanket Shah, MD MHS
P 310 Konstantinos Bratis
P 311 Dipan Shah, MD
P 312 Britt-Marie Ahlander, MRI tech, MSc
P 313 Juliano Fernandes, MD, PhD, MBA
P 314 Daniel Kuetting P 315 Abbas Nasiraei-Moghaddam, PhD
P 316 Lu Lin P 317 Karima Addetia, MD
P 319 Xiaoying Cai, Bachelor
P 320 Ying Liu
P 321 Keigo Kawaji, PhD
P 322 Wolfgang Rehwald, PhD
P 323 Gastao Lima da Cruz
P 324 Gergely Szantho, MD
P 325 Yang Yang, MS
P 326 R Reeve Ingle, PhD
P 327 Abbas Nasiraei-Moghaddam, PhD
P 328 Thomas Gregory, MS
P 329 Francisco Contijoch
P 330 Bram Ruijsink
A fully automated binning method for improved SHARP reconstruction of free-breathing cardiac images
CAIPIRINHA-accelerated 2D bSSFP imaging with improved banding behavior using Gradient-Controlled Local Larmor
Frequency (GC-LOLA)
L1 k-t ESPIRiT: Accelerating Dynamic MRI Using Efficient Auto-Calibrated Parallel Imaging and Compressed
Sensing Reconstruction
High-Resolution MR Characterization of Myocardial Infarction using Compressed Sensing with Edge Preservation
Late Gadolinium Enhancemnet imaging of the Left Ventricle in a sinlge breath-hold using multi-slice spiral PSIR
imaging at 3T
Accelerated 3D self-gated cardiac cine imaging at 3T using a tiny golden angle and compressed sensing
Dark Blood Imaging of the Heart using Dual-Inversion, Balanced Steady-State Free-Precession
Remote CMR 4D Flow Quantification of Pulmonary Flow
Global left ventricular function quantification with CMR 4D Flow
Improving Patient Throughput in a Busy Pediatric Mri Imaging Program Through a Nursing Coordinator
Clinical Evaluation of 3D High Resolution Late Enhancement using Image-Based Navigation
CMR Clinical Practice Patterns Across Four U.S. Medical Centers from 2010-2014
Development and validation of a questionnaire evaluating patient anxiety during Magnetic Resonance Imaging: the
Magnetic Resonance Imaging-Anxiety Questionnaire (MRI-AQ).
A Comprehensive Free-Breathing Protocol for Cardiovascular Magnetic Resonance Imaging of Ischemia and
Cardiomyopathies: a Feasibility Study
Quantitative assessment of systolic and diastolic function in patients with systemic amyloidosis
Real time circular tagging is possible through radial acquisition.
3.0T Cardiac Magnetic Resonance Quantification of Myocardial Extracellular Volume using different delay time of postcontrast T1 mapping for the Diagnosis of Cardiac Amyloidosis
Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible
alternative for patients who cannot receive gadolinium-based contrast agents
Free-breathing 2D Cine DENSE with Localized Excitation, Self-navigation and Motion Correction
T1 mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
Operator-guided Navigator Gating for Real-Time Interactive Coronary Cardiovascular Magnetic Resonance
Fully Automatic Rapid inversion time (TI) Adjustment for Late Gadolinium Enhancement (LGE) Imaging Using a Pencil
Beam Excitation Pulse for Single-Line T1 (SLT1) Mapping of Myocardium
Motion Corrected 3D Whole-Heart Vessel Wall Imaging
Aortic flow changes during free breathing exercise, measured with real time MRI
Reduced field-of-view stack-of-spirals enables high spatiotemporal resolution 3D perfusion imaging
Rapid left ventricular function MRI with an accelerated real-time-based spiral acquisition
Circumferenial Compression Encoding (CIRCOME) using Polar K-space
ECG Electrode Placements for Magnetohydrodynamic Voltage Suppression and improving Cardiac Gating in high-field MRI
Impact of Respiration on LV Volume and Function Using rt-MRI
Routine 3D Ssfp Cine Imaging For Improved Analysis Of Myocardial Volumetry And Deformation.
www.scmr.org
POSTERS
RAPID, EFFICIENT IMAGING
53
From Innovation to Impact in Cardiovascular Care
POSTER S
P 331 Samuel Ting
P 332 Abbas Nasiraei-Moghaddam, PhD
P 333 Amol Pednekar, PhD
Patch-based, Iteratively-Reweighted Compressive Recovery for Reconstruction of Highly Accelerated Exercise Stress
Cardiac Cine
Rotational Motion of Left Ventricle by Harmonic Phase on Radial Tagging
Quantitative Assessment of Temporal Stability of the Myocardial Signal and Relative Blood to Myocardial Contrast in Free
Breathing Respiratory Triggered Retrospectively Cardiac Gated Cine Steady-State Free Precession (RT-SSFP) Imaging.
VALVULAR HEART DISEASE
P 334 Yang Lin
P 335 Juliana Serafim da Silveira, MD
P 336 Florian von Knobelsdorff-
Brenkenhoff, MD
P 337 John Greenwood, MD, PhD
P 338 J. Paul Finn, MD
P 339 Willis Lam, MD
P 340 Henrique Trad, MD
P 341 Malenka Bissell, MD
P 342 Hae Jin Kim, Doctor
P 343 Diego Medvedofsky, Fellow
P 344 Noha Behairy
P 345 Katherine McGee
P 346 Eric Keller, M.A.
P 347 Stephanie Marchesseau
Comparison of Two Methods for Correcting Baseline Offset Error in Phase-Contrast MR Imaging
Peak velocity estimation in aortic stenosis patients using a fast three-directional two-dimensional phase contrast
technique in a single breath-hold: comparison to unidirectional phase contrast MRI and transthoracic echocardiography.
Abnormal regional myocardial morphology in patients with left ventricular pressure overload and preserved
ejection fraction detected by multiparametric MR tissue mapping
Post-procedural myocardial infarction following surgical and trans-catheter aortic valve replacement – mechanistic
insights from cardiovascular magnetic resonance imaging
Ferumoxytol MR Angiography for Pre-TAVR Assessment
Severe Aortic Stenosis with High Valvulo-arterial Impedance (Zva) Has More Adverse Cardiac Changes on
Cardiovascular Magnetic Resonance.
Aortic Regurgitation Quantification using Cardiac Magnetic Resonance. Is there a best imaging plane for flow
quantification? A single center clinical trial.
Inherited aortopathy assessment in bicuspid aortic valve disease relative
Aortic valve planimetry by high-resolution 3-dimensional MR image acquisition with a breath-hold: comparison with conventional cine MR imaging and echocardiography to assess the severity of aortic valve stenosis
Quantification of the Severity of Tricuspid Regurgitation from Cardiac Magnetic Resonance Cine Images
Congenital biscuspid aortic valve in pediatric and early adulthood: Is there a relationship between the valvular leaflet
fusion pattern and other functional parameters
Impact of Beta-blocker, ACE Inhibitor, and ARB therapy on thoracic aorta wall shear stress in bicuspid aortic valve patients
Restoration of Physiologic Hemodynamics in the Ascending Aorta Following Aortic Valve Replacement: a 4D Flow MR Study
Ejection and Filling rates assessed from Cardiac Magnetic Resonance Imaging: possible indices of Degenerative Mitral
Valve Regurgitation
VASCULAR MRI
P 348 Xiangzhi Zhou, Ph.D
P 349 Stig F. Samnøy
P 350 Zhaoyang Fan, PhD
P 351 M. R. Avendi, PHD
P 352 Jorge Gonzalez, MD
P 353 Yoshiaki Ohyama, MD
P 354 Karunakaravel Karuppasamy
P 355 Wenchuan Wang
P 356 Jorge Gonzalez, MD
P 357 Emilie Bollache, PhD
P 358 Marcos Ferreira Botelho, MD
P 359 Tomoki Fujii, MS,RT
P 360 Ria Mazumder, Master of Science
P 361 Yi He
P 362 Leonard Bergau, MD
P 363 Ziwu Zhou P 364 Da Wang, MS
P 365 Rouzbeh Ahmadian, MD, MS
P 366 Robert Edelman, MD
54
Fresh Blood Imaging using Variable TR and Variable Refocusing Flip Angle for Non-Contrast Peripheral MR Angiography at
3T: A 7-Minute Iliac to Calf Station Run-Offs Scan
Visualization and Quantification of Regional Ventricular Wall and Blood Velocities by 3T 4D PC-MRI
Development of a clinically practical whole-brain intracranial vessel wall MRI technique at 3 Tesla
Fully automatic segmentation of heart chambers in cardiac MRI using deep learning.
Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD
Relationship between Tissue Factor Pathway Inhibitor and Aortic Stiffness assessed by MRI: The Multi-Ethnic Study of
Atherosclerosis (MESA)
Diagnostic accuracy of non-contrast magnetic resonance angiogram of infra-popliteal arteries prior to fibular-free
flap harvest
Withdrawn
Determinants of Exercise Calf Muscle Perfusion in Peripheral Arterial Disease (PAD)
4D Flow and 2D PC MRI: Impact of Volumetric Coverage and Three-Directional Velocity Encoding on Quantification of
Aortic Hemodynamics
Comprehensive non-contrast MR assessment of the iliofemoral arteries with visualization of vascular calcifications in
TAVR candidates – initial experience
Reproducibility of cuff-induced hyperemic popliteal artery flow analysis using phase-contrast MRI: Patients With
Intermittent Claudication Injected With ALDH Bright Cells (PACE) trial
Quantification and comparison of 4D Flow MRI derived wall shear stress and MRE derived wall shear stiffness of
abdominal aorta.
Evaluation of the Diagnostic Performance of Self-Navigated Whole-Heart Contrast-Enhanced Coronary MRA at 3T
Serial assessment of left atrial deformation in patients undergoing pulmonary vein isolation: a cardiovascular magnetic
resonance feasibility study
Ferumoxytol-Enhanced 4D MR Angiography with Retrospectively Defined Temporal Resolution
Hybrid One- and Two-sided Flow-Encodings Only (HOTFEO) to Accelerate 4D Flow MRI
Comprehesnive Evaluation of Aortic Disease by In-vivo 4D Flow MRI and 3D Printing of Patient-Specific Models: A
Feasibility Study
Rapid Imaging Of Peripheral Vascular Calcifications Using In-Phase, Two-Dimensional Radial Flash At 3 Tesla
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Abbasi, Siddique Abd-Elmoniem, Khaled Abdel-Gadir, Amna P 093
P 226, O 130
O 005
O 038, O 039, O 040, O 042, O 086, P 002, P 230,
Q 48, Q 67
Ammirati, Enrico P 250
An, Jing P 278, P 282, P 316, P 361
Anderson, Allen O 034
Anderson, Kevan P 206
Anderson, Todd P 083, P 284
Abdula, Goran P 229
Andres, Kristin O 010, O 083, P 241
Abdullah, Shuaib O 130
Andrews, Melissa O 085, O 093, P 333
Abidin, Nik Abouelnour, Amr Acevedo-Bolton, Gabriel Q 43
O 136
Q 54
Androulakis, Alexander Angel, Nathan P 067
O 128, P 196
Anita, Sri Q 52, T 11
Acikel, Volkan O 121
Annex, Brian Ackermann, Mary O 034
Antoniades, Charalambos P 224
Anwar, Mohammed O 059
Adam, Gerhard Addetia, Karima Addy, Nii Adhyapak, Srilakshmi Adluru, Ganesh Afilalo, Jonathan Agarwal, Prachi Agati, Luciano Ahlander, Britt-Marie Ahmad, Rizwan O 099, P 092, P 106, P 127
P 317, P 343
P 326, Q 30, W 31
P 046
O 111, P 223
O 075
P 356
Aoki, Ryosuke Q 40
Apitz, Christian O 116
Appelbaum, Evan O 130, P 144
Arai, Andrew O 008, O 061, O 087, P 099, P 108, P 173, P 279, Q 14, Q 17,
W 08, W 12
Arasaratnam, Punitha Q 21
P 096
Araszkiewicz, Aleksander W 20
P 312
Arcopinto, Michele P 164, P 166
P 331, P 335, W 22, W 29
O 075
Arena, Claudio O 093, P 333
Ahmadian, Rouzbeh P 365
Arestedt, Kristofer Ahmed, Nadeem P 231
Argento, Crocetta P 141
Ahmed, Nauman O 127
Argulian, Edgar O 134
O 056
Arheden, Håkan Akcakaya, Mehmet Akhtari, Shadi Akintuerk, Hakan Ako, Emmanuel Aksoy, Olcay Al hadad, Sudad Al-Mashat, Mariam P 244, P 296, Q 47
O 116
O 039, O 069
P 338, Q 59
O 032
Q 23
P 312
O 023, O 072, P 033, P 043, P 071, P 094, P 184, P 221,
P 222, P 240, P 300, Q 23, Q 61
Ariga, Rina Armstrong, Lynne Arnhold, Kristin O 035, P 035
T8
Q 64
Arnold, John O 132
Arnold, Madeline P 284
O 025
Arora, Garima P 130
Alaour, Bashir P 008
Arvidsson, Per O 023, Q 61
AlBadri, Ahmed P 082
Arya, Nikesh O 118
Albers, Erin P 174
Asfour, Ahmed O 033
Albert, Christine P 078
Ashworth, Michael O 040
P 049
Asimakopoulos, George Alehagen, Urban O 091
Aspelund, Thor Aletras, Anthony P 033, P 042, P 094, P 221, P 222, W 28
Al-Wakeel, Nadya Albery, Tamsin Ali, Aamir Aliotta, Eric Allen, Bradley Allsop, Joanna Almutairi, Haifa Alon, Lina Alpendurada, Francisco P 281, P 283, Q 52
P 026
P 170, Q 16, W 18
Assimopoulos, Stephania Atar, Dan Q 56
O 061
Q 05
P 094, P 221, P 222
Atkinson, David P 323
Attili, Anil O 123
P 177
Auger, Daniel P 047
Auger, Dominique P 290, Q 52
P 262
Augustine, Daniel O 127
P 290, Q 52, Q 56, T 11
Aupart, Michel Alway, Thomas P 088
Avanesov, Maxim Alì, Marco P 114
Avants, Brian O 126, P 045, P 215
O 047
P 092, P 106, P 127
P 055
P 228, P 269
Avery, Ryan P 148
Amano, Yasuo P 318
Awan, Hira O 134
Ambach, Stephanie P 273
Axel, Leon W 24
O 065, O 077, O 133, P 132, P 353, P 359
Ayad, Ihab O 113, P 259
Amadu, Antonio Matteo Ambale Venkatesh, Bharath Azarine, Arshid www.scmr.org
AUTHOR INXEX
Abanador-Kamper, Nadine P 153
55
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Azevedo, Clerio Q 31
Bernard, Stephen Babaee, Nafiseh P 332
Bernhardt, Peter O 026
Berry, Colin Babu-Narayan, Sonya Baessler, Bettina W 09, W 21
Bai, Wenjia Bairey Merz, C Noel P 209
Q 63
Berul, Charles P 211
O 003, O 012, O 043, P 082, P 126, W 25
Betts, Timothy O 035
O 124
Beuf, Olivier Balawon, Armida P 134
Bevilacqua, Marco P 271
Bhagirath, Pranav Balfour, Pelbreton O 036, P 009, P 075, P 129, P 231
Bertelsen, Litten Bakhos, Lara Balbo Mussetto, Annalisa P 077
O 058, P 006, P 058, P 059, P 249, Q 01
P 352, P 079
O 041
P 063, W 27
P 199
Bhat, Himanshu O 052, P 013
Ball, Stephen O 060
Bhatla, Puneet Ballantyne, Christie P 121
Bhatti, Sabha P 080
Bhuva, Anish O 037, O 042, O 086, P 002, P 230, Q 67
O 135, Q 35, Q 38, Q 39
Bi, Xiaoming O 018, P 016, P 218, P 350, Q 58, Q 62, W 02, W 15
Balzarini, Luca Banerjee, Rajarshi P 175, P 185
P 115, P 131, P 248, P 273
Biasiolli, Luca P 341, W 10
Barber, Nathaniel O 069, P 157, P 178
Barfuss, Spencer O 034
Bidhult, Sebastian W 28
O 062, O 127, P 118, P 219, P 239, P 269
Biederman, Robert O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7
Baritussio, Anna Barker, Alex P 170, P 232, P 345, P 346, P 357, P 365, Q 57
Bieging, Erik O 111, P 200
Barker, Piers P 187
Biglino, Giovanni Barnes, Neil P 134
Bigvava, Tamar P 076, P 110
Bijsterveld, Petra O 060, P 075
Barry, Jennifer P 206, P 303, Q 05
Bartone, Cheryl O 132
Baruah, Dhiraj Q 45
Basar, Burcu P 216
Bilal, Hasan Bilchick, Kenneth Birney, Ewan O 118, Q 02
Q 52
O 126, P 045, P 215
Q 63
O 056, P 019, P 051, P 054, P 062, P 238, P 244, Q 41
Bissell, Malenka P 227, P 341
Bashir, Yaver O 035
Biswas, Labonny P 206
Bassett, Paul Q 37
Blackman, Daniel P 337
Basha, Tamer Bastiaansen, Jessica P 258
Blaes, Anne P 133
Bateman, Timothy P 091
Blaisdell, Julie O 034
Battle, Bennett P 192
Blankenberg, Stefan O 099
Bauer, Juergen Baumbach, Andreas Bauml, Michael O 116
Blankstein, Ron O 130, P 226
P 118, P 239
Blaszczyk, Edyta Q 57
Q 20
Blazek, Stephan Baysoy, Engin P 208
Behairy, Noha Blom, Nico Q 66
P 162
P 289, P 344
Bluemke, David O 065, O 077, O 133, P 132, P 353
Behnke-Hall, Kachina O 116
Boccalini, Sara P 307, P 308
Beier, Susann P 103
Bogachkov, Abraham Belhajer, Zahra P 153
Bogun, Frank Bellm, Steven P 051, P 054, P 057, P 102, P 238, Q 41
Bellsham-Revell, Hannah Benefield, Brandon Benni, Monica P 161
P 095, P 101, W 38
P 270
Bohnen, Sebastian Bolger, Ann W 18, W 30
O 123
O 099
O 089, O 091
Bollache, Emilie P 345, P 357
Bonanno, Gabriele O 105, O 106
Bonetti, Federico P 137
Benveniste, Olivier P 254
Boniface, Karen O 040
Benza, Raymond
O 136
Boniface, Nicholas Berendsen, Floris O 084
Bonnet, Christopher P 136
Berg, Sophie O 056, P 051, P 054, P 057, P 062, P 102, P 238, P 244, P 296
Bonnet, Damien P 153
Bergau, Leonard P 362
Bonvin, Debora P 258
Berger, Alexander P 076
Borgna-Pignatti, Caterina P 137
Borgquist, Rasmus O 023
Benovoy, Mitchel Berger, Felix Berisha, Sebastian Berman, Daniel Bernard, Monique 56
O 087, Q 17
O 025, Q 18
P 329
O 003, O 012, O 022, O 043, P 082, P 218, W 15, W 25
P 274, Q 34
Botnar, Rene Bou Ayache, Jad Boubertakh, Redha O 100, Q 27
P 019, P 191, P 310, P 323, P 330, Q 11
W 18
P 031, P 047, P 134
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Boudriot, Enno O 098
Campbell-Washburn, Adrienne Boulet, Lindsey P 126
Camporeale, Antonia Bourque, Jamieson P 079
Cannao, Paola Maria
Boutouyrie, Pierre P 020
Cao, Jian Bowman, Alex O 048
Cao, Jie T3
Capelli, Claudio Boyce, Steven P 085
Captur, Gabriella Boyd, Austin P 365
Caravan, Peter Brachmann, Johannes P 202
Carberry, Jaclyn Bradley, Chris O 017
Carbone, Iacopo P 090
P 089, P 090, P 114, P 225
P 316
O 017, O 061, O 079
Q 02
O 065, O 077, P 041, Q 37, W 14
O 016
P 231
O 046, P 096
Braggion-Santos, Maria Fernanda P 340, Q 55
Carlhall, Carl Johan Brahmanandam, Vikram P 142, Q 12
Bramlet, Matthew O 114, T 13
Carlsson, Marcus O 023, O 072, P 033, P 043, P 071, P 094, P 184, P 221,
P 222, P 240, P 300, Q 61
Bratis, Konstantinos Brau, Anja Bravetti, Marine P 310
O 054, O 110, P 267
P 254
Bray, Janet P 077
Brener, Sorin O 033
Bricq, Stéphanie P 274, Q 34
Broder, Marike O 119
Brout, Dustin P 133
Brown, Julia Bruehl, Ruediger O 060, P 075
W 14
Brunengraber, Daniel O 113
Brunereau, Laurent O 047
Brunner, Fabian P 106
Brunner, Gerd P 121
Bruse, Jan Bryant, Jennifer Q 02
P 008, T 5
Bucciarelli-Ducci, ChiaraO 062, O 127, P 118, P 219, P 228, P 239, P 269, T 1
Bucius, Paulius Buckert, Dominik Budde, Ricardo Buddhe, Sujatha Bull, Sacha Bulluck, Heerajnarain Bulte, Jeff Bunck, Alexander Burchell, Amy Bustin, Aurelien Butcher, Charles Butler, Javed Butler, John P 064
O 058, P 058, P 059
P 307, P 308
P 174
Q 35
O 037, O 038, O 042, O 086, P 002, P 072, P 140,
P 230, Q 48, Q 67
P 262
W 09, W 21
P 228, P 264, Q 26
Caroline, Ita P 209
Carpenter, Alexander P 239
Carr, James O 034, O 090, P 001, P 005, P 017, P 038, P 116, P 155, P 168,
P 232, P 345, P 346, P 357, P 358, P 365, Q 13, Q 16, W 18, W 30, W 32
Carr, Maria Carrick, David Carroll, Timothy Carter, Martha P 231
P 095, P 101, W 38
P 309
Q 65
Casadei, Barbara O 035
Casale, Maddalena P 295
Case, James P 091
Castelletti, Silvia O 037
Castelvecchio, Serenella Catalano, Carlo Cater, George Cater, John Cates, Joshua Cazeneuve, Nicolas Cecelja, Marina P 090
O 046, P 096
P 120
P 103
P 149, P 200
O 047
Q 36
Celermajer, David P 298
Chabi, Marie Laure P 254
Chacko, Satish P 135, Q 20
Chai, Joshua W 10
Chai, Jyh-wen P 294
Chakravarti, Sujata Chamera, Elzbieta P 175
O 065, P 359
Chan, Angel P 265
P 088
Chan, Raymond P 117
O 079
Chang, Henry O 110, P 267
O 019, W 02
Chang, Hyuk-Jae O 135
Chang, Ian Byrne, Nicholas P 190
Chang, James Bönner, Florian P 105
Chang, Michael Chang, Sung A Calkoen, Emmeline O 090, Q 16, W 18
Caruso, Damiano Byrne, James Cai, Xiaoying O 068, O 089, O 091, P 011
P 319
P 024, P 162
Calvieri, Camilla P 090
Cameron, Peter P 077
Camici, Paolo P 250
Campbell, Michael P 187
Chang, Yu-pin P 220
O 022, P 218, W 15
P 133
Q 47
P 191
P 104, Q 08
P 294
Chaptinel, Jérôme P 027, P 074, W 16
Charnigo, Richard O 032
Charoensri, Nisarat P 297
Chatterjee, Neil Chattranukulchai, Pairoj www.scmr.org
AUTHOR INXEX
Bowman, Katherine P 205, P 216, Q 68, Q 69
W 38
O 044
57
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Chaturvedi, Rajiv Q 24
Church, Colin P 147
Ciolina, Federica O 046
Chazot, Alban O 045, W 16
Cheang, Mun O 038, P 157
Cirillo, Stefano P 271
Chelikani, Sudhakar P 207, P 209
Clarke, Kieran O 104, P 224
Chelliah, Anjali P 183
Clarke, William Chemaly, Elie O 073
Clement-Guinaudeau, Stephanie P 224
Chen, Albert O 015
Clemons, Alexander T 13
Chen, Clayton Chi-Chang P 294
Clerfond, Guillaume P 231
P 197, P 198, P 201
O 044, O 055, P 187, P 322, Q 06, Q 08, Q 10
Cluzel, Philippe P 254
Chen, Hanwei P 305, Q 49, Q 58
Clymer, Bradley P 029
Chen, Howard O 016
Cochet, Hubert P 197, P 198, P 201
Chen, John O 016
Coelho-Filho, Otavio Chen, Enn-Ling Chen, Liyong O 111, Q 60
Coenen, Adriaan W 07
P 308
Chen, On O 033
Cohen, Scott P 176
Chen, Stuart O 101
Colan, Steven O 030
P 065
Collins, Jeremy Chen, Wei Chen, Xiao O 126, P 215, P 319, P 325
O 034, P 005, P 017, P 038, P 116, P 155, P 168, P 232,
P 346, P 358, P 365, Q 13, Q 16, W 18, W 30, W 32
Chen, Y Iris O 016
Comyns, Julie T3
Chen, Yong W 01
Conn, Hannah O 087, Q 17
Chen, Yucheng O 031, P 034, P 125, P 139, P 159, P 272
Connelly, Kim Contijoch, Francisco O 015
P 055, P 329, W 13
Chen, Yuhua O 070, O 107, P 037
Chen, Yushu P 065
Contreras, Laurn P 123
Cook, Judy Cheng, Joseph P 217
Cook, Stuart Cheng, Wei P 159
Cook-Wiens, Galen P 082
O 073
Cooper, Annette P 056
Cooper, Leslie P 249
Cheng, Andrew Cheng, Ya-Jian Cheong, Benjamin Chetrit, Michael Chin, Calvin Chiodi, Elisabetta Chiribiri, Amedeo Cho, Goo-Young Cho, Soo Jin O 085, O 093, P 263, P 333
P 097
P 262
P 032, P 146, P 281, P 283, Q 63
O 075
Coppo, Simone O 105, O 106, P 074
P 032, P 235
Cordeiro, Marco P 104
P 137
Coristine, Andrew P 258
P 040, P 086, P 236, Q 15, W 14
Corneloup, Olivier P 197, P 198, P 201
P 288
Cornfeld, Daniel P 119
Cornhill, Aidan P 207
O 078, P 287
Corrado, Domenico O 062
Cortez, Angel P 262
P 288
Cossor, Waseem P 171
O 079
Costello, Benedict P 077
Choudhary, Preeti P 298
Couderc, Jean-Philippe P 275
Choudhury, Lubna P 155, P 168
Coulden, Richard O 011
Choudhury, Robin W 10
Cowan, Brett P 103
Choe, Yeon Hyeon Choi, Byoung Wook Choi, Hong-Mi Choudhary, Naila Chow, Kelvin Chowdhary, Varun P 119, P 342
O 022, P 218, W 15
O 049, P 028, P 073, P 079, P 325, Q 03
O 034, P 005
Cowan, Karen P 194
Cox, Andrew O 038
P 188
Cozzi, Andrea Chrispin, Jonathan O 065
Craft, Jason Christensen, Jason P 172
Croisille, Pierre O 114
Cross, Russell Chowdhury, Shahryar Christodoulou, Anthony Chua, Serene Chuang, Michael Chubb, Henry Chugh, Atul P 146
O 075, P 130, P 143, P 296
Q 28
P 132, P 353
Crowley, Anna Lisa Crum, Kimberly Cui, Sophia Culotta, Veronica P 089
O 132, Q 12
O 041, O 045, W 16
P 169
O 001, O 131, P 104, P 311, Q 33
P 279
P 215, W 03
O 038, O 042, O 086
Chung, Jaehoon P 135
Cummins, Ciara O 014
Chung, Yiu-Cho P 334
Cunningham, Chuck O 015
Chungsomprasong, Paweena P 165
Cupps, Brian 58
W 11
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
O 112
da Silva, Cynthia W 07
Dabaghyan, Mikayel P 212, W 04
Dabir, Darius O 004, O 102, P 111, P 255, P 314, Q 04
Didier, Juliette O 041
Dieringer, Matthias P 256, P 336, W 36
DiMaria, Joseph P 352, P 356
Dinjus, Dirk P 105
Damon, Bruce P 279
Dipchand, Anne Q 24
Damon, Stephen P 279
Dishart, Michael P 145
Darty, Stephen P 187, Q 10
Do, Hung O 007, P 100
T1
Dobson, Laura P 036, P 337, Q 11
Davies, Ceri P 031
Doltra, Adelina P 076, P 110
Davies, John P 072
Donekal, Sirisha Davis, Anne P 022
Dong, Wei Dastidar, Amardeep Dawes, Timothy Q 63
Dawkins, James O 070, Q 62
Dawson, Dana de Bourguignon, Charles De Cecco, Carlo O 133
O 002
Dorfman, Adam P 164, P 166
Dori, Yoav P 160
O 036
Dorrell, Lucy O 104
O 041
Dournes, Gael P 225, Q 65
Doyle, Mark P 197
O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7
Duan, Xuefei P 125
de Koning, Patrick P 024
Dufva, Melanie P 004
De Luca, Laura P 096
Duncan, James P 207
Duncanson, Lynette O 079
De Garate, Estefania O 062, P 118, P 219, P 269
de Marvao, Antonio Q 63, T 2
de Roos, Albert P 162
de Souza, Anthony Q 56
de Waha, Suzanne O 098, Q 19
Deering, Thomas P 210
Durrani, Amir P 204
Duvernoy, Claire P 060, P 150
Dweck, Marc P 235
Dwivedi, Girish P 291, P 292
Dyck, Jason O 009, O 049, P 073
Q 44
Dyckmanns, Nils O 058, P 058, P 059
Del Vecchio, Giovanni Carlo P 137
Dyverfeldt, Petter Dell’ Omodarme, Matteo P 310
Ebbers, Tino Dellegrottaglie, Santo O 063
Eckhaus, Michael Delling, Francesca P 244
Edelman, Robert P 166
Edupuganti, Mohan Mallikarjuna Rao Dees, Debra O 085, O 093, P 333
deFreitas, Roger DeLong, Amanda Deng, Jie O 074, Q 44
Deng, Wei Q 58
Deng, Zixin P 126, P 218, P 350, W 15
Dennie, Carole P 291, P 292
O 068, O 091
O 068, O 089, O 091, P 011
Q 68
P 069, P 306, P 358, P 366
P 192, P 193, P 248, Q 46
Eichhorn, Christian O 035
Eiriksdottir, Gudny O 061
Eitel, Charlotte Eitel, Ingo Q 19
O 098, Q 19
DeSa, Travis W 32
Ejsmont, Marta P 064
Desai, Ankit P 148
El Mozy, Wesam P 289
Q 19
EL Saiedi, Sonia P 289
Desch, Steffen Detterich, Jon O 120
El-Rewaidy, Hossam Deux, Jean-Francois P 222
Elagha, Abdalla P 085
ElBaz, Mohammed S. M. P 024
Elders, Bernadette P 162
Ellims, Andris P 077
P 354
Dey, Damini O 019, W 02
Dhakshinamurthy, Vijay Anand Dharmakumar, Rohan O 036
O 012, O 019, P 063, P 126, W 02, W 27, W 34
Di Giovine, Gabriella P 080
Elliott, Charles Di Leo, Giovanni P 114
Elliott, Perry Di Mario, Carlo P 290
Emmanuel, Sam Q 22
Endozo, Raymond Diamond, Tamara DiBella, Edward O 111, P 223, Q 60
Engblom, Henrik Engvall, Jan DiCarli, Marcelo P 226
Dick, Alexander P 291, P 292
Ennis, Daniel W 09, W 21
Enos, James Dick, Anastasia Dickerson, Jennifer Dickinson, Catherine O 132, P 335, W 22
O 060
Epstein, Frederick www.scmr.org
W 26
AUTHOR INXEX
D’Errico, Luigia Q 37
O 104
O 082
P 033, P 071, P 094, P 221, P 222, P 240
P 011, P 312
O 109, O 121, P 026, P 364
P 169
O 050, O 073, O 103, O 126, P 045, P 050, P 079,
P 215, P 319, P 325, P 352, P 356, W 03
59
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Er, Alicia T4
Erdei, Tamas P 324, Q 26
Erhayiem, Bara P 036, P 337, Q 11
Ericsson, Elisabeth P 312
Eriksson, Jonatan O 068, O 089, O 091
Finn, J. Paul O 051, O 113, O 121, P 007, P 015, P 259, P 338, P 363, Q 59
Fioravante, Luciana Firmin, David P 313, Q 53
O 048, O 050, P 035, P 304, Q 31, Q 56, Q 60, W 17, W 19
Fischer, André O 110
Fischer, Kady P 052
Fischer, Thomas Erixon, Hanna O 089
Erlinge, David P 094, P 221, P 222
Flamm, Scott Espinoza Barillas, Maria P 362
P 263, P 297
O 037, O 097, P 266
Flett, Andrew P 008
Eteiba, Hany P 231
Flögel, Ulrich O 057
Evans, Betsy P 337
Fogel, Mark Everett, Colin O 060, P 075
Exner, Derek O 006, P 066, P 194, P 233
Ezekowitz, Justin O 049, P 073
Faber, Ingrid W 07
Foley, James Fontana, Marianna Foote, Lucy Ford, Ian O 076, P 160
Q 11
O 037, O 038, O 040, P 230, Q 67
O 014
P 231
Facchetti, Rita O 063
Forman, Christoph O 112, P 313, Q 50
Fahmy, Ahmed W 06, W 26
Fornwalt, Brandon O 010, O 032, O 076, O 083, P 241
Q 60
Forsythe, Rachael P 056
P 126
Fair, Merlin Fairbairn, Timothy P 337
Foster, Glen Falk, Volkmar P 110
Foster, John P 129
Foucar, Charles O 090
Fan, Zhanming O 002, O 070, P 128, P 278, P 355, P 361
Fan, Zhaoyang O 018, O 022, P 016, P 126, P 218, P 305, P 350, P 355,
Q 49, Q 58, W 15
Farah, Victor P 138, P 247, T 12
Faranesh, Anthony P 205, P 208, P 216, Q 68, Q 69
Fox, Matthew P 177
Francis, Jane O 066, O 135, P 022, P 224, Q 38, Q 39
Franco, Veronica P 124
Francois, Christopher O 110
Farhad, Hoshang P 226
Francone, Marco Farrar, Christian O 016
Frandon, Julien Farrar, Genevieve P 154, P 186
Frank, Luba Farzad, Zohreh P 281, P 283
França Júnior, Marcondes Farzaneh-Far, Afshin Fasshauer, Martin O 001, O 131, P 135, P 311, Q 20, Q 33
O 080, O 129
Freed, Benjamin Freeman, Alexandra Fedaravicius, Augustinas P 064
French, Brent Fedson, Savitri P 107
Frieberg, Petter Feinberg, Loryn P 144
Friedrich, Matthias O 076
Frigerio, Maria Feindt, Jared Feliciano, Hélène P 027, P 258, W 23
Feng, Jiazuo O 130
Feng, Li O 105, P 185, W 24
Fenwick, Kate O 006, P 066, P 083, P 233, P 284
O 046, P 096
P 274, Q 34
O 123
W 07
Q 16, W 30
O 005
O 073, W 03
O 072
P 052, P 083, P 249, P 284
O 063, P 250
Frontera, Antonio O 127
Fu, Yun-ching P 294
Fuernau, Georg Q 19
Fuisz, Anthon P 085
Ferguson, Mark P 174
Fujii, Shinya P 253
Fernandes, Joao Filipe O 095
Fujii, Tomoki P 359
Fernandes, Juliano O 039, P 285, P 313, Q 31, Q 53
Fujiwara, Kensuke P 253
Ferranti, Joanna P 268
Fuller, Stephen P 225, Q 65
Ferrari, Victor P 280
Fung, Kenneth O 059
Ferraris, Federica P 271
Funk, Stephanie Ferreira, Pedro O 050, P 035, W 17, W 19
Ferreira, Vanessa O 035, O 066, O 104, P 022, Q 35
Ferreira Botelho, Marcos Feuchter, Patricia P 069, P 306, P 358, P 366
P 031, P 041
Field, Suzanne P 172
Figueroa, C. Alberto Q 36, Q 42
Filosa, Aldo P 295
Fine, Nowell O 006, O 078, P 066, P 083, P 194, P 233, P 234, P 284
Fink, Sarah 60
P 213
Furiasse, Nicholas Gale, Eric Galea, Nicola Gali, Ana Marta Gamberini, Maria Rita Q 64
P 001
O 016
O 046, P 096
P 340, Q 55
P 137, P 270
Gan, Li-ming O 103
Ganeshan, Balaji O 082
Gao, Fabao P 065
Gao, Hao P 009
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Gao, Song P 010
Goodarzian, Fariba Gao, Yi O 034
Gorbonosov, Michelle Gao, Yu P 007, P 363
Gorman, Joseph P 329, W 13
Garcia, Anne
T3
Gorman, Robert P 329, W 13
Garcia, Julio O 096, P 360
Gorre, Donovan P 112
Garg, Pankaj P 036, P 337, Q 11
Goswami, Robi Gasparini, Gabriele Gatehouse, Peter Goto, Yoshitaka P 080
Gottbrecht, Matthew O 103
Goubergrits, Leonid O 095
Goyal, Amita P 116
Gatzoulis, Michael O 026
Goyal, Sandeep Gaur, Lasya P 169
Grabau, Jonathan P 165
Gebker, Rolf P 260
O 117
O 026, O 048, O 088, Q 17, Q 52, Q 56, Q 60, T 11,
T 9, W 14
Gazzaz, Tamadhir O 033
P 076, P 110
P 070, P 087
P 210
O 010, O 083
Gralewski, Kevin P 158
Grant, Elena P 211
P 270
Gelder, David P 008
Grassedonio, Emanuele Gelfand, Eli P 144
Graves, Martin Gerbay, Antoine O 045
Greenway, Steven Q 24
Gergelé, Laurent O 041
Greenwood, John O 036, O 060, P 036, P 075, P 337, Q 11
O 013, O 053
Gregory, Thomas P 214, P 328
Gerstenblith, Gary Geva, Tal O 029, O 030, O 032, P 012
Ghadimi Mahani, Maryam P 164, P 166
Gharib, Ahmed O 005
Ghelani, Sunil Ghosh Dastidar, Amardeep Ghugre, Nilesh Giannattasio, Cristina Greiser, Andreas P 190
O 048, P 045, P 256, P 278, P 313, P 320, P 336, Q 52,
Q 53, Q 56
O 029, O 030
Grenier, Justin O 011
Greve, Anders O 061
Greve, Gottfried P 349
O 007, Q 05
Grieve, Stuart P 298
Grigoratos, Chrysanthos P 310
O 063, P 250
O 046
Gibbs, J. Simon Q 22, T 2
Gilad, Assaf Greil, Gerald O 062, O 127, P 118, P 219, P 228, P 239,
P 264, P 269, Q 26
Giannetta, Elisa Gieseke, Juergen W 14
O 004, P 111, Q 04
P 262
Griswold, Mark W 01
Grizzard, John O 131
Gross, David P 053
Gilbert, Kathleen P 154
Grosse-Wortmann, Lars Gilbertson, Janet O 040
Grotenhuis, Heynric Gilkeson, Robert O 132
Grothoff, Matthias O 098
Gillmore, Julian O 040
Groves, Ashley O 082
P 356
Grunseich, Karl P 207
Gucuk Ipek, Esra O 084
Gudnason, Vilmundur O 061
Guensch, Dominik P 052
Gina, Petroni Ginami, Giulia O 106, P 074, W 35
O 027, O 028, O 071, P 151, P 156, P 165,
Q 24, Q 25
Q 24
Ginks, Matthew O 035
Giri, Shivraman P 069, P 225, P 232, P 366
Giuliano, Pietro P 141
Guo, xiaojuan P 299
Giunta, Nicola P 141
Gupta, Dipti P 265
GIvertz, Michael P 226
Gupta, Sanjaya P 203
Glegg, Martin P 129
Gurajala, Ram P 354
Gleva, Marye P 204
Guron, Nita P 234
Gliganic, Kathleen P 048
Gustafsson, Ronny P 184
Gloer, Karen O 120
Gutberlet, Matthias Gnanappa, Ganesh Kumar P 298
Guttman, Michael Go, Yunyun T4
Gyllenhammar, Tom O 098, Q 66
O 122, P 213
P 071, P 240, P 300
Goddu, Beth O 056, P 051, P 054, P 057, P 062, P 102, P 238, P 244, P 296
Götte, Marco P 199
Godsave, Cattleya P 228
Haaf, Philip P 036
Goldberger, Jeffrey O 090, P 001, P 078, P 095, P 101
Haage, Patrick P 093
P 315, P 327, P 332
Haberkorn, Sebastian O 057, P 105
Gona, Philimon P 130
Habibi, Mohammadali O 065
Gonzalez, Jorge O 103, O 126, P 079, P 215, P 325, P 352, P 356
Hachmann, Pauline O 116
Golshani, Shokoufeh www.scmr.org
AUTHOR INXEX
Gasparetto, Taisa O 120
61
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Hadamitzky, Martin O 064
Haggerty, Christopher O 032, O 076, O 083, O 115
O 001, O 033, O 131, P 311, Q 33
Helbing, Willem P 152
P 097
Haig, Caroline P 009, P 231
Helfenstein, Jeffrey Hajnal, Joseph P 177, P 180
Hembree, Elliot Hakeem, Abdul P 115, P 131, P 273
Hendrich, Eva O 064
P 281, P 283
Heng, Ee Ling O 026, Q 56, T 11
Halliday, Brian Halpenny, Darragh P 265
Halperin, Henry O 122, P 213
Hamarneh, Ashraf P 072, P 230, Q 67
Hamilton, Craig O 081
Hamilton, Jesse W 01
Hamilton, Mark P 228, P 264, P 324, Q 26
Hamlet, Sean Han, Eric Han, Fei Hengstenberg, Christian Hennemuth, Anja Hennig, Pierre Henningsson, Markus Hernandez, Gabriela Herrey, Anna T3
O 064
W 24
P 336
P 310, P 323, Q 11
O 120
O 037, O 042, O 086, O 125, P 031, P 230, Q 67
Herzka, Daniel P 213
O 095
Herzog, Bernhard O 060
O 051
Heslinga, Friso O 010, O 083
Hammel, James O 051, O 108, O 109, O 113, P 007, P 015, P 363, Q 59
Hess, Aaron Hesselstrand, Roger W 14
O 068, P 227
P 071, P 300
Han, Yiying P 032, P 146, T 4
Han, Yuchi P 055, P 280, P 329, W 13, W 37
Heydari, Bobak O 006, O 078, P 066, P 233, P 234
W 10
Heydari, Bobby O 130, P 083, P 284, Q 21
Handa, Ashok Hansen, Michael O 008, P 205, P 211, P 216, P 313, Q 14, W 08, W 12
Harden, Stephen P 008, T 5
Harrild, David O 029, O 030
Hickey, Kelsey O 032
Higgins, Angela O 101
Higgins, David O 014
Harris, Matthew P 160
Hill, Peter P 085
Harris, Tamara O 061
Hinojar, Rocio O 014
Harris, William O 130
Hirohata, Makoto P 021
Hirsch, Alan P 359
Hlavacek, Anthony P 188
Harrison, James Q 28
Hart, Emma P 228, P 264, Q 26
Hartz, Jacob P 169
Ho, Jamie P 347
Harvey, Hayley P 227
Ho, Jean O 033
Hasenfuss, Gerd O 119, P 040, P 236, P 362
Hoffmann, Pavel P 094, P 221
Hoffmann, Udo O 130
Hashimoto, Hidenobu P 318
Hofman, Mark O 088
Hassell, Mariella P 036
Hofmann, Heinrich P 258
Hausenloy, Derek P 032, P 072, P 230, Q 67
Hogrefe, Kai O 036
Hashemi, Sassan O 094, O 115, P 189
Hauser, Jakob O 092
Hauser, Thomas O 101, P 144
Holdsworth, David Holland, Steven Q 35
O 005
Hawkins, Philip O 040
Holloway, Cameron Haydock, Paul P 008
Holmes, Jeffrey P 050
Hayes, Brenda P 187
Holst, Karen P 242
Haykowsky, Mark Hays, Allison O 067, O 104, P 191, Q 35
O 009, O 049, P 073
Hombach, Vinzens Q 01
O 013, O 053
Hombach, Vinzenz P 006
Hayward, Carl P 290
Homer, Kai Hayward, Christopher O 067
Homsi, Rami O 004, O 102, P 111, P 255, P 276, P 314, Q 04
Hayward, Martin O 040
Hood, Stuart P 231
Hoogeveen, Ron P 121
He, Xueping Q 58
He, Yang P 117
He, Yi O 002, P 361
P 052
Hor, Kan P 268
Horwood, Laura O 123
He, Zhuonan Q 58
Hoshino, Tsutomu P 018
Heather, Lisa O 024
Hothi, Daljit P 157
Hedjazi Moghari, Mehdi P 012
Howard, Luke Hegde, Sanjeet Heiberg, Einar 62
Heitner, John P 154, P 186
O 023, O 072, P 033, P 043, P 094, P 184, P 221, P 222,
P 245, Q 61, W 28
Howarth, Andrew Hsia, Tain-Yen Q 22
O 006, O 078, P 066, P 233, P 234, P 249, P 284,
P 287, Q 21
Q 02
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
P 307, P 308
Hsu, Chi Jen P 298
Hsu, Li-Yueh O 087, P 099, P 108, P 173, Q 17
Hu, Bob P 326, Q 30, W 31
Jao, Terrence O 007, P 098, P 100
Jariwala, Nikhil O 124, P 135
Jarvis, Kelly P 170, P 232
Jasmin, Nur Hayati T9
Hu, Peng O 051, O 108, O 109, O 113, O 121, P 007, P 015, P 025, P 259,
P 363, P 364, Q 59
Jayasekera, Geeshath Hu-Wang, Eileen P 017
Jenista, Elizabeth Huang, Feiqiong P 146
Jensen, Christoph Huang, Justyn O 067
Jerosch-Herold, Michael Huang, Pei-Ching P 014
Jesinger, Michael Huang, Sihong P 187
Jeuthe, Sarah Q 18
W 23
Jezzard, Peter W 10
Hullin, Roger Hundley, Gregory Hung, Yi-Hui Hussain, Tarique O 077, O 081, O 133, P 132, P 353
T4
P 190, P 330, Q 36, Q 42
Jefferies, John Jiang, Ke Jiang, Yun Jin, Ning Husser, Oliver O 064
Jing, Linyuan Hutt, David O 040
Jogiya, Roy Iantorno, Micaela O 013, O 053
P 243, P 261
O 044, O 055, P 187, P 322, Q 06, Q 08, Q 10
O 055
O 130, P 226, W 07
P 081
P 334
W 01
P 220, P 331, P 335, Q 31, W 22, W 29
O 032, O 083, P 241
P 040, P 086
Johansson, Edvin P 049
John, Anitha P 173
P 134
Ibrahim, El-Sayed O 123, P 060, P 150, W 06, W 26
Ichihara, Takashi P 087
John, Leonette P 070, P 087
Johnson, Kara Ichikawa, Yasutaka P 147
P 149
Iffrig, Elizabeth O 021
Johnson, Kenneth Iles, Leah P 077
Johnson, Kevin O 110
Illapani, Venkata Sita Priyanka P 360
Johnson, Martin P 147
Imran, Muhammad O 067
Johnston, Peter Ingle, R Reeve P 326, Q 30, W 31
P 262
P 326, Q 30, W 31
Jolly, Marie-Pierre O 081, P 045, Q 16
Iqbal, Mohammed O 059
Jones, Alexander O 092
Isaaz, Karl O 045
Jones, Daniel O 059
Iserin, Laurence P 153
Jordan, Jennifer O 081
Ishida, Masaki P 070, P 087
Jovanovic, Ana Ishimori, Mariko W 25
Ishimura, Rieko P 018
Judd, Robert Ito, Masaaki P 070
Jung, Denna Ittermann, Bernd W 14
Ivanov, Alexander O 001, O 033, P 311, Q 07
Jabbour, Andrew O 067, P 191, Q 56
Juan, Yu-Hsiang Junqueira, Flavia
Jögi, Jonas Q 43
P 014
O 001, O 044, O 131, P 311, Q 06, Q 33
O 120
O 117, P 285
Q 23
Kabra, Ashish P 260
Jablonowski, Robert P 033, P 221
Kabus, Sven P 032
Jackowski, Marcel O 052, P 013
Kachenoura, Nadjia P 254
Jacobs, Matthew O 087, Q 17
Kadish, Alan P 078
Jacoby, Christoph O 057
Kadiyala, Madhavi P 048
Jacot, Jeffrey P 163
Kaine, Joshua P 241
Kainz, Bernhard P 180
Jacquier, Alexis Jaeggi, Edgar Jafarkhani, Hamid Jagarlamudi, Ashadevi P 221, P 274, Q 34
O 071, P 151, P 156
Kallianos, Kimberly P 351
Kamper, Lars Q 54
P 093
O 134
Kanagala, Prathap Q 09
Jaijee, Shareen Q 22, T 2
Kancharla, Krishna P 085
James, Nielsen P 122
Kancherla, Kalyan P 085
James, Stephanie P 252
Kandolf, Reinhard O 098
James, Wai-Yee P 134
Kannan, Rajesh P 179
Janardhanan, Rajesh P 148
Kansal, Preeti P 345
Jang, Jihye Janich, Martin Jankauskas, Antanas P 019, P 057, P 238, P 244, Q 41
O 054, P 267
P 064
Kanski, Mikael Kantasis, Georgios Kanter, Kirk www.scmr.org
AUTHOR INXEX
Hsiao, Albert P 071, Q 23, Q 61
P 042, W 28
O 115
63
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Kantor, Paul Q 24
Kappanayil, Mahesh Kar, Julia P 179
W 11
Karamani, Vasiliki P 093
Karamitsos, Theodoros Karim, Rashid Karlsson, Lars Kim, Han O 001, O 044, O 055, O 131, P 104, P 187, P 311, P 322, Q 06,
Q 08, Q 10, Q 33
Kim, Heewon O 074
Q 28
Kim, Jung-Sun O 022
O 089
Kim, Kyung-Jin P 288
Q 69
Kim, Moon Young Karunaharamoorthy, Achudhan Q 57
Kim, Raymond Kashem, Abyaad P 354
Q 41
Kato, Atsuko O 028
Kato, Shingo P 102, P 238, P 244, Q 41, Q 47
Kato, Sojuro P 021
Katz, Marc O 033
Kaur, Gagandeep P 149
Kawaji, Keigo P 112, P 317, P 321
Kawakami, Taketo P 021
Kawel-Boehm, Nadine O 077
Kay, Jennifer P 352, P 356
Kaye, David P 077
Keegan, Jennifer P 304
Keeley, Ellen O 103
Keenan, Ellen O 029
Keenan, Katy W 14
Keith, Matthew P 204
Kelle, Sebastian P 076, P 110
Keller, Eric P 346, Q 16
Keller, Marc Kellman, Peter
P 132, P 353
Kim, Jooho O 104, P 224
Karmarkar, Parag Karuppasamy, Karunakaravel P 097
Kim, Jang-Young P 160
O 008, O 026, O 039, O 042, O 061, P 120, P 211, P 230,
P 237, P 246, P 256, P 277, P 282, P 293, P 313, Q 14,
Q 17, Q 67, W 08, W 12, W 14
P 119, P 342
O 001, O 044, O 055, O 131, P 104, P 187, P 311, P 322,
Q 06, Q 08, Q 10, Q 33
Kim, Steven Q 68
Kim, Sung Mok P 119, P 342
Kim, Young Jin O 022
King, Jordan P 149
Kingdom, John P 151
Kingdom, Theo P 151
Kinney, Aaron P 176
Kirby, Kevin O 048
Kissinger, Kraig O 056, P 051, P 054, P 057, P 062, P 102, P 144, P 238,
P 244, P 296
Kitagawa, Kakuya P 070, P 087
Kitzman, Dalane O 009
Klein, Christoph P 076
Klem, Igor O 001, O 131, P 104, P 311, P 322, Q 33
Klingel, Karin O 098
Kluenker, Folke O 102, P 255
Klug, Gert P 094
Knowlton, Joshua P 309
Kobashigawa, Jon O 018
Kober, Frank P 221
Kocaturk, Ozgur P 208, P 216, Q 69
Koenigkam Santos, Marcel Kelly, Catherine P 224
Koerner, Danielle Kelly, Damian O 036
Koh, Angela Kelm, Malte P 105
Koh, Woon Puay Kenny, Cliona P 252
Koktzoglou, Ioannis Keogh, Anne O 067
Kolandaivelu, Aravindan Kolipaka, Arunark P 340, Q 55
W 11
P 146
P 146
P 069, P 306, P 358, P 366
P 213
P 029, P 360
Kesavadas, Thenkurussi T 13
Kestenbaum, Samantha P 239
Komori, Yoshiaki Keymel, Stefanie P 105
Konecny, Filip O 095
Khalique, Zohya W 19
Kong, Lingyan P 316
Q 09
Konkle, Justin P 326
Khan, Jamal Q 50
Khanji, Mohammed P 047, P 134
Koops, Andreas P 106
Kharabish, Ahmed P 251, P 344
Kotlyar, Eugene O 067
Kheradvar, Arash Khettab, Hakim Kheyfets, Vitaly Kholmovski, Eugene Khoo, Jeffrey Kido, Teruhito Kido, Tomoyuki Kilner, Philip Kim, Daniel Kim, Hae Jin 64
P 351
Koul, Sasha P 020
Kovács, Sándor P 004
Kowalik, Grzegorz O 128, P 196
Kowallick, Johannes P 094, P 222
O 023
O 069, P 157
O 080, O 119, P 039, P 040, P 236, P 362
Kozerke, Sebastian P 061, P 086, P 302, Q 18
P 084, P 109
Kozor, Rebecca O 037, O 082, P 140, Q 48
P 084, P 109, Q 50
Krahn, Philippa P 206
O 088, P 152, W 19
Kraitchman, Dara P 262
O 036
O 111
P 119, P 342
Kramer, Christopher Krempien, Robert O 103, O 126, P 079, P 215, P 325, P 352, P 356
P 257
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
P 262
Lawton, Chris O 127, P 219, P 269, P 324, T 1, T 8
Krishnamurthy, Rajesh P 163, P 167
Le, Thu Thao P 032, P 146
Krishnamurthy, Ramkumar P 163, P 167
Le Goff, Caroline O 041
Krolikowski, Mary P 176
Lebel, Julie Krupinski, Elizabeth P 148
Lederman, Robert Kruse, Jane P 346
Ledoux, Jean-Baptiste Krüwel, Thomas O 129
Lee, Daniel Kubota, Takeyukii P 253
Lee, Jongmin Kudielka, Guido P 267
Lee, Sang Eun P 218, W 15
Kuehl, Karen P 173
Lee, Sang-Chol P 119
O 025, O 095, Q 18
Lee, Seung-Pyo P 288
Kuehne, Titus Kuetting, Daniel Kuhara, Shigehide Kulshrestha, Kevin O 004, O 102, P 111, P 255, P 314, Q 04
P 021
W 11
P 052
P 205, P 208, P 216, Q 68, Q 69
P 258
O 090, P 001, P 078, P 095, P 101, Q 13, W 38
P 277
Lee, Simon P 122
Lelieveldt, Boudewijn P.
P 024
Lensing, Shelly P 115, P 192, P 193, P 248, Q 46
Kumar, Vidhya P 220
Leon Jimenez, Javier Kumarasinghe, Gayathri P 191
Leong, Bao Ru Kumita, Shinichiro P 318
Lepor, Norman Kuruvilla, Sujith O 103
Leung, Steve P 081, P 241
O 095, O 119, P 040, P 171, P 182, P 236
Levelt, Eylem O 035, P 224
Kutty, Shelby Kvernby, Sofia Kwon, Deborah Kwong, Raymond Kydd, Anna Labedi, Mohamed Labib, Dina Ladouceur, Magalie LaFountain, Richard P 011
Levine, Jonathan P 297
Lewis, Andrew O 130, P 212, P 226, W 04
O 125
P 149
O 131, Q 08, Q 33
P 153
W 39
Lai, Wyman P 183
Lakhman, Yuliya P 265
Lalande, Alain P 274, Q 34
Lam, Adrian O 020
Lam, Willis P 339
Lamata, Pablo Lamb, Hildo Lamba, Nathan O 119, P 040
P 067
Q 31
Landes, Sofy P 082
Lang, Chim O 036
Lang, Roberto P 107, P 112, P 171, P 182, P 317, P 321, P 343
Langman, Craig P 017
Lantin-Hermoso, Regina P 163
Lapinskas, Tomas P 064
Lario, Chiara Valentina Larsen, Terje P 271
P 094, P 349
Larson, Peder Q 30
Lathra Mathew, George Q 31
Latson, Larry P 175, P 185
Latus, Heiner O 116
Latuscynski, Konrad Launer, Lenore Laurent, François Laurent, Stéphane Q 66
O 061
P 197, P 198, P 201
P 020
Lavalle, Steven T 13
Lawless, Claire P 129
P 097
P 155
O 024, Q 32
Li, Christine Li, Debiao P 343
P 032, T 4
O 033
O 003, O 012, O 018, O 019, O 022, O 043, O 070, O 107,
P 016, P 037, P 082, P 126, P 218, P 350, P 355, P 361,
Q 58, Q 62, W 02, W 15, W 25
Li, Linqing Li, Rongmao W 10
P 023
Li, Shuo P 010, P 023
Li, Wei P 069, P 306
Li, Xiaohu Li, Yan P 226
P 352, P 356
Liang, Jianke Q 58
Liao, Ronglih O 016
Liao, Ying-xiang P 294
Likhite, Devavrat P 223
Lim, Jessie Mei Lim, Ruth Lim, Tiong Keng Lima, Joao Lima da Cruz, Gastao Lin, Gigin Lin, Kai P 151, P 156
O 105
T4
O 065, O 077, O 133, P 132, P 353, P 359
P 323
P 014
P 005, P 017, P 038, Q 16, W 30, W 32
Lin, Linda P 298
Lin, Lu P 316
Lin, Yang P 334
Lindsay, Mitchell P 231
Ling, Lieng P 347
Lisicki, Craig P 354
Lisko, John O 100, P 068, Q 27
Litt, Harold P 152, W 37
Litwin, Sheldon Liu, Alexander Liu, Chia-Ying Liu, Hong www.scmr.org
AUTHOR INXEX
Krimins, Rebecca P 225, Q 65
O 035, O 066, P 022
O 077, P 132, P 353, O 133
O 031, P 034, P 139, P 159, P 272
65
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Liu, Jennifer P 265
Mahapatra, Srijoy Q 68
Liu, Jiayi P 355
Mahmod, Masliza P 224, Q 35
P 299
Mahnkopf, Christian Liu, Min Liu, Shizhen P 210, P 260
Liu, Xin P 305, Q 49, Q 58
Liu, Ying P 320
Liu, Yingmin W 22
Mahrous, Ahmed P 202
P 231
Maintz, David W 09, W 21
Malaisrie, S P 346, P 365
Malamateniou, Christina P 177, P 180
Liu, Yuan-Chang O 133
Malkin, Christopher Liuba, Petru O 072
Malley, Tamir Lloyd, David P 177, P 180
Mandawat, Aditya O 001
Lloyd, Michael O 020
Mandawat, Anant O 001
Lo, Wei-Ching W 01
Mandry, Damien Lof, John O 095
Manghat, Nathan Loggetto, Sandra P 285
Mangion, Kenneth Lohezic, Maelene P 180
Mangold, Stefanie P 225, Q 65
P 089, P 090, P 114
O 037, O 042, O 082, O 086, O 125, P 002, P 031,
P 041, P 140, P 230, Q 37, Q 48, Q 67
Longmore, Ryan P 203
Manisty, Charlotte Looft, Yana O 099
Manlhiot, Cedric Lopes, Luis Q 37
Lopes-Cendes, Iscia W 07
Lombardi, Massimo Lopez, David P 356
Lotz, Joachim O 080, O 119, O 129, P 039, P 040, P 236, P 362
Loudon, Margaret P 227, P 341
Lowery, Ray P 166
Lu, Jimmy P 164, P 166
Lu, Minjie P 277, P 282, P 293
Luecke, Christian O 098, Q 66
P 347
O 060
Maret, Eva P 312
Marieb, Mark P 207
Marini, Claudia P 022
Markenroth Bloch, Karin O 088
Markham, Larry P 279
P 027
Luining, Wietske Q 25
Lumish, Heidi O 130
Maron, Martin Lund, Gunnar O 099, P 092, P 106, P 127
Lydell, Carmen O 034, O 090, O 096, P 001, P 005, P 017, P 038, P 095,
P 101, P 116, P 155, P 170, P 232, P 345, P 346,
P 357, P 360, P 365, Q 13, Q 44, Q 57, W 30, W 32
Marrouche, Nassir P 238
O 128, P 149, P 196, P 200
P 229, P 237, P 246
Martinez, Alberto W 07
P 009
Martinoff, Stefan O 064
O 031, P 034, P 139, P 159, P 272
O 098, Q 66
O 006, O 078, P 066, P 233, P 234, P 249, P 287, Q 21
Marx, Christian W 35
Masterson, Conor P 176
P 290
Masuoka, Keiko Lysaker, Kirsti P 349
Matasar, Matthew Lüthje, Lars P 362
Mathew, George W 01
O 004, O 102, P 111, P 255, Q 04
Masci, Pier Giorgio Lyon, Alexander Ma, Dan O 070, Q 62
Maredia, Neil Lugand, Emeline Lurz, Philipp Q 25
Marbán, Eduardo Markl, Michael Luo, Yong P 009, P 129
Marchesseau, Stephanie O 102, P 111, P 255, P 276, O 004, P 314, Q 04
Luo, Xiaoyu O 130
P 228, P 264, Q 26, T 8
Manning, Warren O 056, O 075, O 101, P 051, P 054, P 057, P 062, P 102,
P 130, P 143, P 144, P 238, P 244, P 296, Q 41, Q 47
Luetkens, Julian Lundin, Magnus P 337
O 048, P 235, Q 52
Q 40
P 265
Q 52, T 11
Mathew, Jacob P 261
Ma, Xiaohai P 128, P 278
Mathur, Anthony O 059
Macdonald, Peter O 067, P 191
Mathur, Sujeev Macera, Annalisa P 271
Macgowan, Christopher O 071, P 030, P 044, P 151, P 156
Maciel, Benedito P 340, Q 55
Madathil, Sujana P 156
Madden, Marie Madyoon, Hooman Maestrini, Viviana Maffessanti, Francesco Q 42
Matich, Susanne O 120
Mattesi, Giulia O 062
Matthews, Julianne Q 27
Mavrogeni, Sophie P 249
W 13
Mayosi, Bongani Q 29
P 097
Mazal, Jonathan P 205, Q 68, Q 69
O 038, O 042, O 086
Mazhari, Nona O 116
P 182
Mazo, Paulo Magier, Adam P 273
Mazumder, Ria P 029, P 360
Magrath, Patrick O 121
Mazur, Wojciech O 132, P 273
66
P 313, Q 53
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
O 132
McAlindon, Elisa O 127, P 219
McCallum, Chloe O 024
McCann, Gerry McCarthy, Beth McCarthy, Patrick O 036, P 075, Q 09
Mikolich, J. Ronald Milazzo, Angela O 100, P 068, P 195, Q 27
O 063, P 250
Millasseau, Sandrine Miller, Christopher P 020
P 099, Q 43
P 220, Q 12
Miller, Jack O 024
P 346, P 365
Miller, Owen P 177
McClelland, Robyn O 077
Miller, Steven P 156
McConnell, Joseph O 130
Millet, Grégoire O 041
McCrindle, Brian Q 25
Min, James O 132
McCrohon, Jane O 067, P 191
Mionic, Marijana P 258
McCulloch, Andrew P 154, P 186
Miquel, Marc P 047
McDiarmid, Adam P 337, Q 11
Miquerol, Lucile Q 34
Q 37
McEntegart, Margaret P 231
Mirabel, Mariana McGann, Christopher P 223
Mirza, Omer McGee, Katherine P 345
Mita, Mitsuyoshi P 253
McGill, Laura-Ann P 035, W 19
Mitchell, Kevin P 204
Q 20
McGraw, Sloane Q 20
Mitlacher, Marcel P 202
McIntyre, Bethannie Q 26
Miyagawa, Masao P 084, P 109
P 356
Miyamoto, Takashi McKenzie, Robyn McLeod, Kristin O 118, Q 02
Miyazaki, Mitsue McMahon, Michael P 262
Mochizuki, Teruhito McManus, David P 130
Moffat, Kirsten McNeal, Gary McQuaker, Jacqueline P 160, P 189
Q 21
O 067, P 191
O 033
Mohammed, Nazia P 129
P 298
Mohammed, Shahid Mediratta, Anuj P 182
Mohiddin, Saidi Medrano-Gracia, Pau P 103
Moir, Stuart Medvedofsky, Diego P 343
Mojsejenko, Dimitri Mehra, Vishal P 099
Mongeon, François-Pierre Mehta, Bhairav W 01
Mekkaoui, Choukri Meloni, Antonella Menacho Medina, Katia Menicanti, Lorenzo Menini, Anne Menon, Prahlad Merchant, Naeem O 003, O 043, P 082, P 126
Metzler, Bernhard P 354
P 140
P 090
O 110, P 267
P 046
O 006, O 078, P 234, P 287, Q 21
O 038, O 042, O 086
W 05
O 025, P 110, Q 18
W 23
P 094, P 221
P 079, P 319, P 325, P 352, P 356
Meyer, David O 102
Michelakis, Evangelos Michels, Guido Mielniczuk, Lisa Q 63
O 049, P 073
W 09, W 21
P 291, P 292
Mikami, Yoko O 006, O 078, P 066, P 194, P 233, P 234, P 249, P 287, Q 21
Mikolich, Brandon P 080
O 026, O 038, O 039, O 042, O 065, O 077, O 086, O 125,
P 031, P 140, P 230, Q 43, Q 67, O 037, O 040, O 082,
P 002, P 041, P 072, Q 37, Q 48, W 14
Meyer, Craig Meyer, Hannah Monti, Lorenzo P 226
P 197, P 198, P 201
Moon, James P 077
Metrich, Mélanie Montaudon, Michel P 137, P 141, P 270, P 295
P 048
Messroghli, Daniel Q 51
O 032, O 076, O 083
Moon, Eunice Meredith, Ian Messner, Nadja W 13
O 065, P 031, P 041
O 052, P 013
Merchant, Tazim Merghani, Ahmed P 084, P 109, Q 50
Mohamed, Ambreen Medi, Caroline Mehta, Puja P 253
P 018, P 348
O 100, P 068, P 195, Q 27
Moore, Richard O 013, O 053
Moore, Ryan P 243, P 261
Moosa, Sulaiman Mor-Avi, Victor Morcos, Michael Mordi, Ify Morgenstern, Daniel Moriarty, John Moroni, Francesco Morris, Alan Morton, Geraint Mosca, Ralph Motwani, Manish Q 29
P 107, P 182, P 317, P 343
P 152
P 231
O 100, P 068, P 195
P 338
P 250
P 149, P 200
P 040
P 175, P 185
O 003, O 060, P 082
Moulin, Kévin
O 041, W 16
Mousseaux, Elie P 020, P 153
Muehlberg, Fabian Q 64
Mueller, Anna-Katharina P 336
Mueller, Edgar P 301
www.scmr.org
AUTHOR INXEX
Mazzaferri, Ernest 67
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
O 099, P 092
Nazir, Sheraz Q 09
Mukai, Kanae Q 54
Nehme, Ziad P 077
Mukhopadhyay, Anirban W 27
Neilan, Tomas P 226, W 07
T3
Neiman, David P 037
Muellerleile, Kai Mumford, Amy Muniz, Juan Carlos P 181
Neizel-Wittke, Mirja Murakami, Akimichi P 253
Nelson, Michael O 003, O 043, P 082, P 126
O 136
Neri, Maria Giovanna P 137, P 141, P 270, P 295
Murali, Srinivas Murphy, Ian P 358, W 18
Nerlerkar, Nitesh Q 51
Murphy, Theodore P 252
Nethononda, Richard Murtagh, Gillian P 155
Neubauer, Stefan Murthy, Venkatesh Musa, Tarique Muscogiuri, Giuseppe Muthupillai, Raja Muthurangu, Vivek O 135
P 036, P 337, Q 11
P 225, Q 65
O 085, O 093, P 263, P 333
Nezafat, Maryam O 069, O 092, P 157, P 178
Nezafat, Reza P 208
Muto, Makoto Q 40
Mutoh, Makoto P 253
Myerson, Saul O 068, P 227, P 341, Q 35
Månsson, Sven P 049
Müllerleile, Kai P 127
Münch, Frédéric O 025
Münch, Julia P 127
Nabi, Faisal O 001, O 131, P 121, P 311, Q 33
Nadar, Mariappan P 313
Nadjiri, Jonathan O 064
Naehle, Claas Nagata, Motonori Nagel, Eike Nairooz, Ramez Nakajima, Takatomo Nakamori, Shiro Nakamura, Masashi Nakano, Yosuke Nambi, Vijay Napan, Sirikarn P 276
P 070, P 087
O 014, P 040, P 310
P 115
P 253, Q 40
P 070
P 084, P 109, Q 50
P 253, Q 40
P 121
T7
Narang, Akhil P 107
Narayan, Hari P 160
Narayan, Srinivas P 190
Nardi, Barbara P 080
Naresh, Nivedita P 050
Narous, Mariam P 194
Narula, Dhiraj P 078
Nash, Martyn O 017
Nasiraei-Moghaddam, Abbas Nasis, Arthur Nasser, Sarah P 113, P 315, P 327, P 332
O 082
P 076, P 110
Natsuaki, Yutaka P 322
Natsume, Takahiro P 087
Nauffal, Victor P 359
Nayak, Krishna Nazarian, Saman Nazemoroaya, Azadeh 68
O 007, O 108, P 098, P 100
O 065, O 084
P 113
Q 35
O 024, O 035, O 066, O 068, O 104, O 135, P 022,
P 035, P 224, P 227, P 341, Q 32, Q 35, Q 38, Q 39
Newby, David Newsome, Simon Mutlu, Senol P 105
P 056
P 235, P 281, P 283
P 019, Q 11
O 056, P 051, P 054, P 057, P 062, P 102, P 238, P 244,
Q 41, W 14
Ng, Jason O 090, P 001, P 095, P 101
Ng, Justin P 095, P 101
Ngamkasem, Hataichanok Ngo, Long Nguyen, Christopher Nguyen, Kim-Lien Nickander, Jannike Nicoloff, Nicola O 039
P 051, P 054, P 057, P 102
O 018, O 022, O 070, P 037, P 218, Q 62, W 15
O 113, P 025, P 259
P 245
P 068, P 195
Nielles-Vallespin, Sonia O 008, O 050, P 035, Q 14, W 08, W 12, W 17, W 19
Nieman, Koen Nightingale, Angus Nijveldt, Robin P 307, P 308
P 118, P 228, P 239, P 264, Q 26
O 088, P 036
Nitatori, Toshiaki P 018
Nixon, Jane O 060
Noda, Chikara Noel, Cory Nordin, Sabrina P 132, P 353, P 359
P 163, P 167
O 039, P 002, Q 48
Nordlund, David P 094
Nordmeyer, Sarah O 025
Norris, Stuart P 103
Nowicki, Stefan P 129
Nozohoor, Shahab P 184
Ntsekhe, Mpiko Ntsinjana, Hopewell Ntusi, Ntobeko Nutting, Arni Nyktari, Evangelia Nyns, Emile Nystrom, Michelle O h-Ici, Darach O’Brien, Kendall O’Donnell, Christopher Q 29
Q 02
O 104, Q 29, Q 35
P 188
Q 56
Q 24
P 326, W 31
Q 18
P 211
P 130, P 143
O’Dwyer, Eoin O 104
O’Halloran, T. P 144
O’Hanlon, Rory P 252
O’Neill, Mark O’Regan, Declan Q 28
T 2, Q 22, Q 63
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
O’Rourke, Noelle P 129
Parker, Scott Obara, Makoto P 318
Parks, W. James O 094, O 115
P 172, P 279
Q 66
Parra, David Obianyo, Chinwe Q 37
Pasque, Michael Odille, Freddy P 267
Patel, Amit P 084, P 109
Patel, Hitesh Ogele, Emmanuel P 168
Patel, Mehul Ogimoto, Akiyoshi P 084, P 109
Ohyama, Yoshiaki O 133, P 132, P 353
Ogawa, Ryo Okene, Erica Oksuz, Ilkay Patel, Mita Patel, Vimal W 11
P 107, P 112, P 171, P 182, P 317, P 321, P 343
P 290
P 277
P 107, P 112, P 321
Q 37
O 020
Paterson, Ian O 009, O 049, P 073, Q 03
W 27, W 34
Paton, Julian P 228, P 264, Q 26
Oldman, James O 125
Patten, Monica P 127
Oldroyd, Keith P 231
Paul, Erin P 183
Oliva, Jose P 145
Paul, James Olivieri, Laura P 169, P 173, P 211
Omens, Jeff P 154, P 186
Oral, Hakan O 123
Paul, Jan Paul, Thomas O 119
Pauly, John P 217
P 224
Ordovas, Karen Q 54
Pavlides, Michael Ormerod, Oliver P 227
Peacock, Andrew Ormiston, John P 103
Pednekar, Amol P 186
Pedretti, Stefano Ortiz, AK Oshinski, John O 020, O 021, P 214, P 328
P 129
P 006, Q 01
Pedrizzetti, Gianni P 147
O 085, O 093, P 263, P 333
O 063
Q 61
W 06
Pedrotti, Patrizia O 063, P 250
Ostenfeld, Ellen P 043, P 300
Peebles, Charles P 008, T 5
Oswal, Abhishek P 341
Osman, Nael Pellegrini, Costanza Pellerito, Raffaele Otazo, Ricardo O 105, W 24
Otton, James O 067, P 191
Pena, Elena Oudit, Gavin O 049, P 073
Pennec, Xavier Ouyang, Cheng P 015
Overall, William P 326, Q 30, W 31
Ozsoy, Cagla Pacaud, Daniele Pacchia, Christina Pagano, Joseph Pahlm, Ulrika Paiman, Elisabeth Palazzuoli, Alberto Palkowski, Gregori Pennell, Dudley P 284
Pepper, John P 149
Perazzolo Marra, Martina O 062
Perera, Divaka P 086
P 043
Perin, Emerson P 359
P 067
Peritore, Angelica P 250
P 239
Pernow, John P 222
Q 29
Perry, James P 154, P 186
O 009, O 049, P 073, Q 03
Peters, Brigitte Palumbo, Pierpaolo P 096
Peters, Dana Pan, Wei P 163
Petersen, Steffen P 115, P 131, P 192, P 193, P 248, Q 46
Pang, Jianing O 002, O 018, O 022, O 107, P 037, P 361
Pang, Wenjie W 14
Parekh, Keyur Parikh, Paras Q 02
O 048, P 035, P 235, P 281, P 283, P 290, Q 31,
Q 52, Q 56, T 11, T 9, W 17, W 19
Pepe, Alessia P 049
Pantaleon, Clemence P 271
P 291, P 292
P 208
Palmér, Malin Pandey, Tarun O 064
O 047
Q 44
P 095, P 101
Petrie, Mark Petrini, Marcello Petrose, Lia Piccini, Davide Piechnik, Stefan Pierce, Iain P 137, P 141, P 270, P 295
Q 56
O 116
P 207, P 209
O 065, O 077, P 031, P 041, P 047, P 134
P 231
P 089, P 114
O 053
O 105, O 106, P 056, P 074, P 185, P 188, W 23
O 039, O 066, O 104, P 022
O 048, P 304
Park, Hyo Eun P 288
Piersson, Albert T 10
Park, Jin Joo P 288
Pieske, Burkert P 076, P 110
Park, Jun-Bean P 288
Pilla, James P 342
Pinto, Gustavo P 285
Pitcher, Alex P 227
Pitrolo, Lorella P 295
Park, Sung-Ji Parker, Michele O 044, O 055, P 104, P 187, P 311, P 322, Q 06,
Q 08, Q 10, Q 33
www.scmr.org
AUTHOR INXEX
Oberueck, Christian O 121
P 055, W 13
69
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Pizarro, Carmen P 276
Plein, Sven O 060, P 036, P 075, P 086, P 337, Q 11, Q 15
P 009, P 129, P 147, P 231
Radunski, Ulf O 099, P 092
Plodkowski, Andrew P 265
Rafiq, Isma Q 36, Q 42
Plotnik, Adam P 338
Ragin, Ann O 034
Pofi, Riccardo O 046
Rahsepar, Amir P 116
Pohost, Gerald P 097
Raina, Sameer P 115
Pollock, Eks P 124
Rajagopalan, Archa Pollock, Sam P 158
Rajappan, Kim Polsani, Venkateshwar Pontana, Francois Pontnau, Florence P 121, P 210, P 260
Rajpurohit, Naveen P 153
Ramadan, Ahmed P 206, P 303
Ramamurthy, Senthil Pop-Busui, Rodica P 060, P 150
Raman, Subha V.
P 297
Porayette, Prashob Porter, John Positano, Vincenzo Q 21
O 035
Rajewska-Tabor, Justyna P 339
Pop, Mihaela Popovic, Zoran W 20
P 210, P 260
P 344
O 094, P 189
O 132, P 124, P 142, P 220, P 275, P 335, Q 12,
Q 31, T 3, W 22
P 151, P 156
Ramanan, Venkat O 039, O 069
Ramirez de Arellano, Ignacio Rodríguez P 137, P 141, P 270, P 295
Ramlall, Manish O 007, P 206, Q 05
W 33
P 072, P 230, Q 67
Post, Wendy O 133
Ramos, Nadine Pothineni, Naga Venkata K P 115
Rangarajan, Vibhav Pottala, James O 130
Range, Felix P 105
W 22, W 29
Ranjan, Ravi O 128, P 196
Potter, Lee Powell, Alexander L. Powell, Andrew Prasad, Sanjay P 357
O 029, O 030, O 032, P 012
O 005
P 135, Q 20
Rao, Parachuri P 046
Rapacchi, Stanislas O 113
O 010, O 083
Raphael, Claire O 048, Q 52, Q 56
O 048, O 067, P 235, P 281, P 283, P 290, P 339, Q 52,
Q 56, T 11, O 050
Rasche, Volker P 006, Q 01
Powell, David Prato, Frank O 019, W 02
Rashid, Shams P 025
Rastin, Sanaz O 025
Prieto, Claudia P 323
Ratcliffe, Laura Printz, Beth P 186
Rathod, Rahul Prothmann, Marcel P 256, P 336, Q 64, W 14, W 36
Ratnayaka, Kanishka P 228, P 264, Q 26
O 029, O 030
P 211, P 216, Q 68, Q 69
Pucheux, Julien O 047
Rattan, Mantosh Pulini, Stefano P 141
Rauhalammi, Samuli P 231
Pun, Shawn P 265
Rave-Fränk, Margret O 129
Puntmann, Valentina O 014, O 067
Rayarao, Geetha Puranik, Raj P 298
Rayner, Jennifer Purini, Maria Cristina P 285
Razavi, Reza Pursnani, Amit P 069, P 366
Reant, Patricia P 161, P 177, P 180
P 261
P 138, P 247, T 12, T 6, T 7
O 135, Q 35, Q 38, Q 39
P 161, P 177, P 180, Q 15, Q 28
O 037, P 230, Q 37, Q 67
Recht, Hannah Q 13
W 20
Reddy, Sahadev P 145
Qazi, Saadia P 143
Redheuil, Alban P 132, P 254, P 353
Qi, Shun P 320
Redwood, Simon Pushparajah, Kuberan Pyda, Magorzata Qi, Xiuling Qian, Zhen Qiu, Bensheng Quarta, Antonella Quarto, Cesare Quattrocchi, Giuseppina Quellhorst, Laura Quinlan, Marina Q 05
Reed, Galen P 210, P 260
Reemtsen, Brian P 305, Q 49
Reese, Timothy P 086
P 326, Q 30, W 31
P 259
O 052, P 013
P 270
Rehwald, Wolfgang O 001, O 044, O 055, P 322, Q 06, Q 08, Q 10, Q 65
Q 56
Reichek, Nathaniel O 079, P 048
P 250
W 21
Q 22, T 2
Reid, Anna Reinstadler, Sebastian Renne, Stefania Q 43
Q 19
P 295
Quinn, Rachel P 169
Resta, Maria Chiara P 270
R. Avendi, M. P 351
Restrepo, Maria O 115
O 124
Revstedt, Johan O 072
Rabbat, Mark Radermacher, Michael 70
Radjenovic, Aleksandra P 006, Q 01
Rich, Adam W 22
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
O 024, O 135, P 224, P 227, Q 32, Q 35, Q 38, Q 39
Riesenkampff, Eugenie O 027, O 028, Q 25
Righetti, Irene W 07
Rigolet, Aude P 254
Rigsby, Cynthia O 074, O 096, P 170, Q 44
Rimoldi, Ornella O 063
Ripley, David P 036, P 075, P 337, Q 11
Ritter, Christian O 129
Robinson, Joshua O 074, O 096, P 170
Robson, Matthew O 066, P 035, Q 62, W 10
Rochitte, Carlos P 335, W 22
Saini, Brahmdeep Sallee, Denver O 094, O 115
P 130
Salusky, Isidro P 259
Salvatori, Cristina P 141, P 270
Samar, Huma P 136, T 6
Samineni, Swetha O 088
P 224
Samnøy, Stig F.
Rogers, Toby O 103, O 126, P 028, P 050, P 079, P 319,
P 325, P 352, P 356, W 14
Salton, Carol Rodgers, Chris Roest, Arno P 197, P 198, P 201
Salerno, Michael Rodenburg, Manouk O 062, O 127, P 118, P 219, P 228, P 239, P 264,
P 269, Q 26, T 1, T 8
P 070, P 087
Salel, Marjorie Sammut, Eva Rodrigues, Jonathan P 151, P 156
Sakuma, Hajime P 085
P 086, Q 15
P 349
Samuels, Petronella Q 29
Samyn, Margaret P 176
P 024, P 162
Sancaktar, Orhan Q 45
P 205, P 216, Q 68, Q 69
Sandberg, Sarah P 204
O 063, P 250
Sandhu, Vaneet W 25
Rohan, Stephen P 264
Sandri, Marcus O 098, Q 66
Romano, Simone P 135
Sanghvi, Mihir P 031
Romeo, Maria Antonietta P 137
Sankaralingham, Marimuthu P 129
Roghi, Alberto Rommel, Karl-Philipp Q 66
Santelli, Claudio Roos-Hesselink, Jolien P 307, P 308
Santos, Juan Rose, Michael O 096, P 170
Sardanelli, Francesco Rosen, Stuart P 290
Rosmini, Stefania O 038, O 040, O 042, O 086, P 002, P 230, Q 67
Sarikouch, Samir Saru, Raluca P 302
P 326, Q 30, W 31
P 089, P 114
O 116
P 307, P 308
Ross, Joanne O 067
Sasaki, Jun Ross, Patrick O 120
Sasaki, Nao P 181
W 23
Satou, Gary O 113, P 259
Rotman, Samuel Rottbauer, Wolfgang O 058, P 006, P 058, P 059, Q 01
Satriano, Alessandro Roubille, François P 052
Sattar, Naveed Roujol, Sébastien P 019, P 238, P 244, Q 41
Saudek, David Roux, Charles Rowin, Ethan Roy, Christopher Rubenstein, Jason Ruden, Emily Rudolph, André Rueckert, Daniel Ruijsink, Bram Ruiz-Cabello Osuna, Jesús María P 254
Scandling, Debbie P 226
Scardino, Claudia P 030, P 044
Q 45
P 142
P 256, Q 64
Q 63
P 161, P 330, Q 36
W 33
Scatteia, Alessandra Schaarschmidt, Frank Schad, Lothar Schaechter, Andi Schapira, Jay Scheiderer, Kelly Schelbert, Erik P 181
O 006, O 078, P 066, P 083, P 233, P 234, P 284
P 129, P 231
P 176
O 132, P 335, Q 12, W 22, W 39
P 080
O 062, P 118, P 219, P 269
W 09, W 21
W 05
P 078
W 25
T3
P 120, O 061, O 132, P 133
Rutherford, Mary P 177, P 180
Schenke, William Q 68, Q 69
Rutz, Tobias O 106, P 074
Schievano, Silvia O 118, Q 02
RV, Leena P 286
Schild, Hans Rådegran, Göran P 300
Schmacht, Luisa Sabe, Marwa P 297
Schmidt, Andre Sabe, Sharif P 297
Schmidt, Anna P 073, P 083, P 284
Sabharwal, Nikant P 224
Schmidt, Ehud O 122, P 212, P 214, P 328, W 04
Sabzevari, Kian O 125
Schmidt, Michaela Sado, Daniel Saeed, Ibrahim Q 37
Schmitt, Matthias P 091, P 203
Schmitt, Vanessa Sagi, Janaki P 166
Schnackenburg, Bernhard Sahn, David P 152
Schneider, Jurgen www.scmr.org
AUTHOR INXEX
Rider, Oliver P 314, O 004, O 102, P 111, P 255, P 276, Q 04
P 256, P 336
P 340, Q 55
O 112, P 313, Q 50, W 18
Q 43
Q 01
O 099, P 076, P 110, W 09
P 224
71
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Schnell, Susanne O 096, P 170, P 232
O 103, P 079, P 325, P 352, P 356
P 152
O 048, O 082
Shemin, Richard P 338
Schranz, Dietmar O 116
Sherzai, Ayesha P 350
Schroeder, Marie O 015
Sherzai, Dean P 350
Schroeder, Samuel P 029
Shetye, Abhishek P 225, Q 65
Schofield, Rebecca Schuler, Gerhard Schulz-Menger, Jeanette Shi, Wenzhe Q 63
P 249, P 256, P 257, P 336, Q 57, Q 64, W 36
Shie, Nancy P 052
Shirasaki, Keisuke Schwid, Madeline Shome, Joy Q 13
O 105, O 106, P 074, W 23
Schär, Michael O 013, O 053, P 262
Schüler, Johannes Scott, Andrew Shufelt, Chrisandra Sierra-Galan, Lilia O 050, P 035, W 17, W 19
Sigurdsson, Sigurdur O 061
Sculpher, Mark P 075
Simon, Marc Seed, Mike O 027, O 028, O 071, P 030, P 044, P 151, P 156, P 165, Q 25
Simonetti, Orlando P.
Seehase, Matthias O 119
Simpson, John Seemann, Felicia P 043
Simpson, Scott P 089, P 090, P 114
Seguro, Florent Q 54
Sindhura, Alapati Sehmi, Joban Q 52
Singh, Amita O 074, W 01
Singh, Anil O 059, P 031
Singh, Anvesha O 049
Singh, Sheldon Sellwood, Joanne P 224
Singhal, Priyanka Semaan, Edouard P 346
Sinn, Martin Semple, Scott P 056
Sinusas, Albert Semsarian, Chris P 298
Sirker, Alex Senel, Mirac O 099
Sjöberg, Pia Sekowski, Viktor Serafim da Silveira, Juliana Sermesant, Maxime P 280
P 229, P 237, P 242, P 245, P 246, Q 70
Sikdar, Khokan Sekhri, Neha O 003
Sigfridsson, Andreas P 365
Seiberlich, Nicole P 253
P 086, Q 15
P 249, P 256
Scotti, Alessandro Secchi, Francesco Q 09
O 098, Q 66
Schuster, Andreas O 080, O 095, O 119, O 129, P 039, P 040, P 236, P 362
Schwitter, Juerg P 335, Q 12, Q 31, W 22, W 39
Q 02
Q 21
P 120
O 132, P 053, P 331, P 335, Q 12, Q 31, W 22,
W 29, W 39
P 177, P 180
P 172
P 193, Q 46
P 182, P 317
P 145
O 036, Q 09
P 206
P 118, P 269
P 092
P 207
P 230, Q 67
O 072, P 184
Skondros, Evangelos P 088
Skowasch, Dirk P 276
P 093
Slavin, Glenn P 268
Shah, Amee P 183
Sleeper, Lynn O 029
Shah, Dipan O 001, O 131, P 121, P 311, Q 33
Slesnick, Tim O 094, O 115, P 189
Seyfarth, Melchior Shah, Moneal Shah, Ravi O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7
O 130, Q 41, O 135, P 102, W 07
Slicker, Julie Slomka, Piotr P 176
O 019, W 02
Shah, Sanket P 309
Smacchia, Maria Paola P 295
Shahid, Mohammed P 055
Smart, Suzanne P 220
Shahir, Kaushik Shahzad, Rahil Shambrook, James Q 45
Smink, Jouke P 321
O 084
Smith, Gillian P 290, Q 52, T 11
P 008, T 5
Smith, Karen P 077
O 061
Smith, Peter Shandas, Robin P 004
Smyke, Matthew Shang, Quanliang O 095
Socolow, Joshua P 210
Sodickson, Daniel Shanbhag, Sujata Shannon, Wooden Shao, Jiaxin Sharif, Behzad P 025, P 364
O 003, O 012, O 019, O 043, P 082, W 02, W 25
Sohns, Jan Solana, Ana Beatriz Soleimanifard, Sahar Q 16
W 22, P 335
O 033
O 105, P 175, P 185
O 080, O 119, O 129, P 039
P 183
O 013, O 053
Sharland, Gurleen P 177
Sharma, Aditya P 356
Solomon, Joseph Sharma, Ravi O 133
Soltys, Joseph Sharma, Sanjay O 038
Soma, Siva O 136
Song, Shlee P 350
Shaw, Jaime 72
Shaw, Peter Sheehan, Florence Schoepf, U. Joseph O 003, O 043, O 075, W 25
P 055
P 091, P 203
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Q 68
Suinesiaputra, Avan Sonnex, Emer O 011
Suksaranjit, Promporn Soriano, Brian P 174
Sun, Jiayu Sorrell, Vincent O 010, P 081, P 241
Soslow, Jonathan P 172, P 279
Sosnovik, David O 016, O 052, P 013
Soto-Lopez, Maria-Elena P 280
Soulat, Gilles P 020, P 153
Speidel, Nathaniel Christopher Speier, Peter Spottiswoode, Bruce Sprigings, David Sprinkart, Alois Martin Spruijt, Onno Srivastava, Shubhika Staab, Wieland Steeds, Richard Steele, Russell Stehning, Christian Steigner, Michael Steingart, Richard Steinman, Theodore Swart, Laurens P 307
O 036
Swoboda, Peter P 036, P 337, Q 11
O 004, P 111, Q 04
Sydow, Karsten P 106
O 088
Syed, Mushabbar O 124
P 122
Sykes, Jane O 032
Steding-Ehrenborg, Katarina Steeden, Jennifer O 048, P 316, Q 16, Q 52, Q 56
Q 22
Stearns, Evan Sörensson, Peder Ta, Allison Tachi, Masaki Tahir, Enver P 127
P 222, P 229, P 237, P 245, P 246, Q 70
P 108
P 318
P 092, P 106, P 127
P 253
P 021
O 036, Q 43
O 075
O 067, O 099, W 09
O 130, P 226
P 265
Q 47
P 212, W 04
Q 66
Stoll, Victoria Säring, Dennis Q 37
P 228, P 324
Takeshima, Hidenori Stiermaier, Thomas Stojanovska, Jadranka Szantho, Gergely Takahashi, Hirotake Stevenson, William Stoeck, Christian Syrris, Petros O 019, W 02
O 048, Q 52, T 11
P 043, P 300, Q 61
O 080, O 119, O 129, P 039
Stochitoiu, Ioana Symmonds, Karen O 069, O 092, P 157
Steinmetz, Michael Stobo, Jon P 253
P 164
P 243, P 261
Statton, Benjamin O 114
Suzuki, Teruhiko P 060, P 150
O 112
Starc, James O 039
Sutton, Brad Swanson, Scott O 080, O 129, P 039
Stalder, Aurelien O 062
Sutcharitchan, Pranee O 018, P 301, P 313
P 301, P 313
Stahnke, Vera-Christine P 225, Q 65
Susana, Angela Swanson, Sara P 064
Staeb, Daniel P 223
O 031, P 159, P 272
T 13
O 080, O 119, O 129, P 362
Stabinskaite, Agnieta Suranyi, Pal P 031, P 154, P 186
Talmud, Phillippa Tan, Ru San Q 37
P 003, P 032, P 146
Tanami, Yutaka P 132
Tang, Haw Chiaw P 003
Tang, Maxine P 062
Tang, W.H. Wilson Tao, Qian Tautz, Lennart Tavolaro, Sébastian P 297
O 084, P 067
W 24
P 020
Tayal, Upasana O 050, P 281, P 283, Q 52
O 071, P 151
Taylor, Andrew O 092, O 118, P 077, Q 02
P 129
P 061
Taylor, Michael P 243, P 261
O 123, P 060, P 150
Taylor, William O 021
O 068, P 227
Teixeira, Tiago P 249
Stone, Ian P 134
Teixido-Tura, Gisela Strange, Julian O 062
Teo, Soo Kng P 003
Thai, Ngoc P 145
Strauss, Bradley Strecker, Ralph Q 05
P 313, Q 53
Thalén, Simon Stroer, Sebastian P 020
Thavendiranathan, Paaladinesh Stromp, Tori P 241
Thiele, Holger Stub, Dion P 077
Thomas, Daniel Stuber, Matthias Stump, Claire Su, Shi Su, Yi Subramanian, Sharath Suever, Jonathan Suh, William P 132, P 353
Q 70
O 132
O 098, Q 19
O 004, O 102, P 111, P 255, P 314, Q 04
O 041, O 105, O 106, P 027, P 074, P 258, W 35
Thomas, Sheena P 224
P 045
Thompson, Diane O 136, P 138, P 247, T 12, T 6
P 305, Q 49
P 003
Q 12, Q 31
O 010, O 032, O 076, O 083
P 338, Q 59
Thompson, Richard Thomson, Louise Thorgeirsson, Gudmundur Thornhill, Rebecca Thul, Josef www.scmr.org
AUTHOR INXEX
Sonmez, Merdim O 003, O 009, O 011, O 049, P 073, Q 03
O 003, O 043, P 082, W 25
O 061
P 291, P 292
O 116
73
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Tian, Yikui O 073
Van Assche, Lowie Tichelbaecker, Tobias P 362
van den Boogaard, Pieter Timmis, Adam O 059
van der Geest, Rob Timoh, Tendoh P 108
van der Graaf, Maurits Ting, Samuel P 331
van Heeswijk, Ruud Todoran, Thomas P 225
van Ooij, Pim Tokarczuk, Pawel Q 22, T 2
Tom, Kusum P 145
Tomlinson, George Q 24
Tonegawa, Reina P 253, Q 40
Vannan, Mani Varga-Szemes, Akos P 257
Varghese, Juliet Trauzeddel, Ralf Q 57
Treibel, Thomas O 037, O 038, O 040, O 042, O 086, P 002, P 140,
P 230, Q 48, Q 67
Treutlein, Melanie W 09
P 262
O 010, O 083, P 241
Q 09
P 210, P 260
P 188, P 225, Q 65
W 29, W 39
Vasanawala, Shreyas Vassiliou, Vassilis P 217, P 307, P 308
O 048, O 067, P 235, P 290, P 339, Q 52, Q 56, T 11
Velasco Forte, Mari-Nieves P 190, P 330
Venancio, Thiago W 07
Venuti, Giuseppe P 269
Truong, Uyen P 004
Vermes, Emmanuelle Trusty, Phillip O 115
Viallon, Magalie O 041, O 045, W 16
O 019, P 063, W 02, W 27, W 34
Vieira, Miguel S. P 236, P 330, Q 11, Q 36, Q 42
O 056
Vigneron, Daniel Tsaftaris, Sotirios Tsao, Connie Tse, Zion P 212, P 214, P 328, W 04
Vijayakumar, Sathya Tsuge, Shinsuke P 087
Villa, Adriana Tudisca, Chiara P 141
Villa, Chet Tufvesson, Jane P 033, P 221, P 222
Vincenti, Gabriella O 047
Q 30
P 196
P 086, Q 15
P 243
O 106, P 074
Tullus, Kjell P 157
Vita, Tomas P 226
Tumkosit, Monravee O 039
Vittori, Claudia O 063
Tunnicliffe, Elizabeth P 035, Q 62
Vittorio, Timothy O 079
T5
Vogel, Mika P 307
Tyler, Damian O 024
Voges, Inga Tymchak, Wayne O 049
Volpe, Gustavo Töger, Johannes O 023, Q 61
Uddin, Akhlaque P 337
Ugander, Martin P 229, P 237, P 242, P 245, P 246, Q 70
Twigg, Ceri Underwood, Richard P 088
Unnikrishnan, Nishad T 11
Uno, Mio P 070, P 087
Unterberg-Buchwald, Christina O 080, O 119, O 129, P 039, P 362
von Deuster, Constantin von Knobelsdorff-Brenkenhoff, Florian von Loesch, Eckhart Thassilo von Morze, Cornelius von Roeder, Maximilian O 116
P 340, Q 55
P 061
P 256, P 257, P 336, Q 57, Q 64
O 080
Q 30
Q 66
Vorasettakarnkij, Yongkasem O 039
Vorobiof, Gabriel P 097
Uppu, Santosh P 122
Wada, Akira P 275
Urbinelli, Lindsay P 261
Wage, Ricardo Urbonaite, Laura P 064
Wake, Nicole P 175, P 185
Uretsky, Seth O 134
Walker, John Malcolm O 039, O 069
Vaid, Haris O 006, P 066, P 233
Walker, Simon P 281, P 283, P 290, P 304, Q 60, T 9
P 075
Valadkhani, Arman P 229
Wallace, Daniel Valente, Anne Marie O 032
Wan, Ke Valeri, Gianluca P 270
Wanambiro, Kevin P 307, P 308
Valeti, Uma P 133
Wang, Chao-Hung P 014
Vallone, Antonino P 295
Wang, Da P 364
Wang, Harris P 073
Vallurupalli, Srikanth P 131, P 248, P 273
Valsangiacomo-Buechel, Emanuela Valverde, Israel van Amerom, Joshua 74
O 088
Vanezis, Andrew P 347
P 340, Q 55
P 346, P 357
Vandsburger, Moriel P 268
Trad, Henrique P 199
O 041, P 027, W 23
van Zijl, Peter Totman, John P 162
O 084, P 024, P 036, P 067
van Rossum, Albert Toro-Salazar, Olga Traber, Julius O 055
O 088, P 152
Wang, Hui P 190
Wang, Jing P 177, P 180
Wang, Jiun-Jie W 25
O 031, P 034, P 139, P 159, P 272
P 112, P 263, P 321
W 37
P 014
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Wang, Kuocheng P 294
T 13
White, James O 006, O 078, P 066, P 073, P 083, P 194, P 233, P 234,
P 284, P 287, Q 21
O 067
White, Richard O 017
White, Robert P 149
Wang, Wei O 122
White, Steven O 037, O 040, P 072, P 230, Q 67
Wang, Wenchuan P 355
Whitehead, Kevin P 158, P 160
Wang, Yi O 109
Whitman, Teresa O 006, O 078
Wang, Yining P 316
Wichmann, Julian P 225, Q 65
Wang, Zhankui P 320
Wielopolski, Piotr P 308
Wang, Zhe O 109
Wien, Joshua O 017
Wijesurendra, Rohan Wang, Louis Wang, Vicky Wang, Zhinuo Jenny Ward, Jay P 212, W 04
Will, Albrecht P 029, P 360
P 092
O 035, O 066
O 064
Warntjes, Marcel P 011
Williams, Ronald Washburn, Adrienne P 208
Wilmink, Lena O 099
P 017
Wilson, Brent O 111, P 223
Wasse, Haimanot Wassilew, Katharina Watanabe, Eri Watanabe, Kouki Waterhouse, Deirdre P 138, P 145, T 12, O 136, P 136, P 247, T 6, T 7
O 048, P 110, Q 56
Wilson, Catherine P 239
P 226
Winterfield, Jeffrey O 124
Wintersperger, Bernd O 112
Q 50
P 252
Wisotzkey, Bethany Witschey, Walter P 174
P 055, P 158, P 329, W 13, W 37
Waters, Dexter O 006, P 066, P 233
Watkins, Hugh P 341, Q 35
Wolff, Steven O 054, O 134
O 122, P 212, W 04
Wong, Jia ing P 146
Watkins, Ronald P 231
Wong, Joyce Watts, Evan P 131
Wong, Timothy Weale, Peter P 056
Woo, Joyce P 171
Webster, Mark P 103
Wood, John O 120, P 123
Wechalekar, Ashutosh O 040
Woodard, Pamela Weeks, Richard P 046
Woolfson, Peter Weerackody, Roshan P 031
Wragg, Andrew Watkins, Stuart Wehner, Gregory Wei, Janet Wei, Zijun O 010, O 076, O 083
O 003, O 043, P 082, P 126
P 305, Q 49
Wright, Graham Wright, Matthew Wu, Bailing W 05
Wu, Can Weinrich, Julius P 127
Wu, Colin Weinsaft, Jonathan P 265
Wu, Edwin W 25
Wu, Holden Weingärtner, Sebastian Weisman, Michael Weiss, Robert Weissman, Gaby O 013, O 053
P 085
Well, Lennart P 106, P 127
Weller, Daniel P 319
Welsh, Aimee Welsh, Paul Weltman, Arthur Wu, Kevin P 088
O 132, P 120
P 204
Q 43
O 059
O 007, P 206, P 303, Q 05
Q 28
P 277, P 293
O 096, P 232
O 133, P 132, P 353
P 078
O 121, P 026
P 214
Wu, Yi-Ying P 294
Wu, Ziyue O 108
Wundrak, Stefan P 006, Q 01
Wuttge, Dirk P 071
P 231
Xanthis, Christos P 042
P 352
Xia, Xiaojuan Q 45
Wendell, Dave O 044, Q 06
Wendell, David O 055, P 187, P 322, Q 08, Q 10
Xie, Guoxi Xie, Yaoqin P 275
P 305, Q 49, Q 58
P 010, P 023
Weng, Zhen P 117
Xie, Yibin Werner, Beat O 088
Xu, Lingyu P 073
P 206
O 117
Xu, Robert Westenberg, Jos O 088, P 024, P 036, P 162
Xu, Ziqian Westwood, Mark O 039, P 031, P 041
Werner, Heron Wetzl, Jens Whelan, Carol Whitaker, John Xue, Hui O 112
Yadav, Nirbhay O 040
Yak, Nicolas Q 28
Yamada, Akimasa www.scmr.org
AUTHOR INXEX
Wang, John O 018, O 022, O 070, P 037
P 065
O 008, P 216, P 313, Q 14, W 08, W 12
P 262
P 206
P 070, P 087
75
From Innovation to Impact in Cardiovascular Care
AUTH O R I N D E X
Yamada, Fumi P 318
Yamrozik, June O 136, P 136, P 138, P 145, P 247, T 12, T 6, T 7
Yan, Fei P 305, Q 49
Yancy, Clyde O 034
O 091
Zaliunas, Remigijus P 064
Zambelli, Daniel Zapf, Antonia Zareba, Karolina Yang, Dan O 031, P 034, P 139, P 159, P 272
Yang, Eric P 121, P 311
Zemrak, Filip Yang, Hsin-Jung O 019, W 02
Zeng, Mu Yang, Jie P 010, P 023
Zenge, Michael Yang, Qi Yang, Yang O 022, P 016, P 218, P 350, Q 58, W 15
O 103, P 028, P 050, P 079, P 319, P 325, P 352, P 356
P 067
P 299
Zhang, Jiming Zhang, Li Yao, Jialu P 117
Zhang, Ruzhi O 005
Zhang, Shelley Zhang, Shuo Yazdanparast, Ehsan W 33
Zhang, Tao Ye, Yufeng Q 58
Yee, Eric P 194
Zhang, Tianjing Yee, Raymond O 078
Zhang, Xiaoyong Yellon, Derek P 072
Zhang, Yan Yerly, Jérôme O 105, P 027, W 35
Zhang, Zhicheng Yildirim, Dursun P 208
Zhao, Lei Yilmaz, Sevim O 025
Zhao, Li Yim, Deane Yin, Hong Yoganathan, Ajit Yokoyama, Kenichi Yoo, Shi-Joon O 027, O 028
O 070
P 313, W 18
O 075
O 120
Yazdani, Saami P 275
O 065, O 077, P 031, P 041
Zhan, Yang Yanofsky, Samuel P 291, P 292
P 089
O 080, O 129, P 039
Zeppenfeld, Katja Yang, Yuanhua Yassin Kassab, Lin Zhao, Shihua O 093, P 333
P 303
P 065
P 212, W 04
P 032
P 217
O 031, P 034, P 125, P 128, P 159, P 272, P 278, P 299,
P 316, P 320, P 361
P 305, Q 49
P 277, P 282, P 293
P 023
P 128, P 278
P 325
P 277, P 282, P 293
P 320
Zhao, Xiaodan P 003
O 115
Zheng, Jianmin P 320
P 018
Zheng, Jie P 065
O 027, O 028, O 071, P 151, P 156, P 165, Q 24, Q 25
Zhong, Liang P 003
Yoon, Yeonyee P 288
Zhong, Xiaodong O 050, P 210
Yoshida, Takami P 021
Zhou, Xiangzhi P 018, P 348
Yoshida, Takegawa Young, Alistair P 259, P 338, P 363, Q 59
O 017, O 079, P 031, P 048, P 103, P 154, P 186
Youssof, Emile O 045
Yu, Chung-Yao O 067, P 191
Yu, Shaode Yu, Sunkyung 76
Zajac, Jakub P 023
P 164, P 166
Zhou, Xiao Zhou, Yafeng Zhou, Zhengwei Zhou, Ziwu Zhu, Meng Yuan Zhu, Yanchun P 210
P 117
O 070, P 037
O 051, P 007, P 015, P 363, Q 59
O 071, P 151, P 156
P 010, P 023, P 305, Q 49
Yuanchang, Ou P 046
Zidere, Vita P 177
Yuecel, Seyrani O 004
Zoellner, Frank Yushkevich, Paul P 055
Zorzi, Alessandro O 062
Zabel, Markus P 362
Zviman, Menekhm O 122
W 05
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
E X H I BITO R DI R EC TO RY
13703 W. Colfax Ave., Suite 300
European Association of Booth #22
Cardiovascular Imaging (EACVI)
Golden, CO 80401 USA
2035, route des colles
Phone (303) 273-5344
Sophia Antipolis 06903 FRANCE
[email protected]
Phone +33 6 8987 2038
Webwww.3dsystems.com/healthcare
Fax +33 6 9296 8646
3D Systems offers healthcare-centric 3D printing and 3D visualization
technology. The company’s surgical tools include accurate 3D printed
anatomical models, advanced virtual reality simulators, direct metal
printing for implants and instrumentation, virtual surgical planning
(VSP*) and personalized 3D printed surgical guides. 3DS is developing
true patient-specific healthcare solutions, one by one or at scale,
designed to change the future of personalized medicine.
[email protected]
3D Systems
Bracco Diagnostics
Booth # 11
Booth # 7
259 Prospect Plains Rd
Webwww.escardio.org
The EACVI is the leading international network in Cardiovascular Imaging
worldwide. Its mission is “to promote excellence in clinical diagnosis,
research, technical development and education in Cardiovascular
Imaging in Europe”. It is a unified platform of experts and a knowledge
provider in CMR, Echo-cardiography Nuclear Cardiology and Cardiac CT:
live events and distance learning – certification - Journal membership
– Grants - EuroCMR congress - recommendations. Learn more at www.
escardio.org/EACVI.
Monroe Township, NJ 08831 USA
GE Healthcare
Phone (609) 514-2343
Fax (609) 514-2514
Bracco Imaging offers a product and solution portfolio for all key
diagnostic imaging modalities: X-ray Imaging (including Computed
Tomography-CT, Interventional Radiology, and Cardiac Catherization),
Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound
(CEUS), Nuclear Medicine through radioactive tracers, and
Gastrointenstinal Endoscopy. The diagnostic imaging portfolio is
completed by a range of medical devices and advanced administration
systems for contrast imaging products.
Cardiovascular Imaging Solutions LTD
Booth #3
9900 Innovation Drive
Booth # 8
Incurator, Bessemer Building, Imperial College
London SW7 2AZ United Kingdom
Phone (44) 0 7885 906770
Wauwatosa, WI 53226 USA
Phone (414) 721-2620
Fax (414) 918-8138
[email protected]
Webwww.gehealthcare.com
For over 10 years, Heart Imaging Technologies has offered worldwide
access to diagnostic-quality DICOM images using nothing but a
web browser. Now your web browser is also your CMR workstation
(volumes, VENC, T1/T2, etc.), your structured reporting system (382
data elements), and your admission ticket to a searchable database,
real-time collaboration, and multi-center trial organization tools. Share
your de-identified images, and reports, with your colleagues across the
country and around the world!
Webwww.cmrtools.com
Booth #2
Heart Imaging Technologies, LLC
Booth #4
5003 Southpark Drive
#250 815 8th Ave SW
Durham, NC 27713 USA
Calgary, AB T2P 3P2 Canada
Phone (919) 323-3001
Phone (403) 453-2061
Fax (866) 457-3694
Fax (403) 338-1895
[email protected]
[email protected]
Webwww.heartit.com
Webwww.circlecvi.com
For over 10 years, Heart Imaging Technologies has offered worldwide
access to diagnostic-quality DICOM images using nothing but a
web browser. Now your web browser is also your CMR workstation
(volumes, VENC, T1/T2, etc.), your structured reporting system (382
data elements), and your admission ticket to a searchable database,
real-time collaboration, and multi-center trial organization tools. Share
your de-identified images, and reports, with your colleagues across the
country and around the world!
Circle Cardiovascular Imaging Inc. develops and markets cardiac
post-processing software that allows for the evaluation and analysis
of MR and CT images. Available for clinical and research use, the
stand-alone software provides full DICOM and PACS connectivity.
Circle operates worldwide and its products (cvi42, cmr42, ct42, and
report 42) have been approved for the Canadian, American, Australian,
Korean and European markets. Circle’s goal is to contribute to quality
in cardiovascular imaging and research.
www.scmr.org
EXHIBITOR DIRECTORY
Circle Cardiovascular Imaging Inc.
77
From Innovation to Impact in Cardiovascular Care
E X H I BITO R DI R EC TO RY
HeartVista, Inc.
Booth #16
4984 El Camino Real, Suite 102
Medis Medical Imaging Systems, Inc.
Booth #19
9360 Falls of Neuse Road, Suite 103
Los Alto, CA 94022 USA
Raleigh, NC 27615 USA
Phone (650) 800-7937
Phone (919) 278-7889
[email protected]
Fax (919) 847-8817
Webwww.heartvista.com
Webwww.medis.nl
HeartVista develops high-end acquisition solutions with modern user
interfaces to perform quick, comprehensive cardiac MRI examinations.
Its real-time and advanced acquisition and reconstruction methods
significantly reduce overall exam time and enable imaging difficult
patients. Many of these imaging methods do not require breath-holds
or cardiac gating. The included real-time sequences have high temporal
and spatial resolution and can be used to visualize the motion of
anatomy or blood flow.
Since 1989 Medis medical imaging systems has been a leading
provider of analytical software for the quantification of cardiovascular
images.
Imricor
Booth #10
At this year’s SCMR we will demonstrate our new workflow-centric
imaging platform Medis Suite, a multimodality, single reporting patient
analysis platform, from which our well-known and high-quality analysis
solutions (Apps) can be launched. These include the further extended
QMass and QFlow, as well as solutions for myocardial characterization,
strain imaging, CT-volumetric plaque analysis, image-based physiologic
assessment of coronary lesions, etc. Please visit booth #19 & #20.
400 Gateway Blvd.
Burnsville, MN 55337 USA
NeoSoft/NeoCoil, LLC
Phone (952) 818-8417
N27 W23910 A Paul Rd
Fax (952) 818-8401
Pewaukee, WI 53072 USA
[email protected]
Phone (262) 522-6142
Webwww.imricor.com
Fax (262) 347-1251
Imricor specializes in developing medical devices that are compatible
with magnetic resonance imaging. Our MR-enabled™ products are
designed to provide doctors the ability to perform interventional
procedures under real-time MRI guidance. While we are applying our
patented technology to an array of applications, our first MR-enabled
solutions are for use in MRI-guided cardiac ablation procedures. We
are also collaborating with medical imaging companies to establish
interventional MRI suites in medical centers around the world.
[email protected]
Journal of Cardiovascular Booth# 24
Magnetic Resonance (JCMR) Web www.neosoftllc.com / www.neocoil.com
NeoSoft’s suiteHEART software is a fast, comprehensive, and intuitive
analysis tool for structured reporting of cardiac MRI examinations
including function, flow, tissue characterization, and T2*. Learn from
cardiac MRI Industry leaders via mini fellowship training, onsite training,
or remote support. Since 2004, NeoCoil and NeoSoft have led the
industry with many first to market products: 16 element flexible coils,
MR conditional android tablet, and wireless MRI hearing protection –
entertainment system. Please visit www.neosoftllc.com
Cardiovascular MR Unit
Philips Healthcare
Royal Brompton Hospital
Building QR-0119
Sydney Street
Veenpluis 4-6, 5684 PC Best, The Netherlands
London, SW3 6NP
Phone
+31 40 27 64061
United Kingdom
Email
[email protected]
Tel +44 207 351 8825
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and wellbeing company, focused on improving people’s lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2014 sales of EUR
21.4 billion and employs approximately 108,000 employees with sales
and services in more than 100 countries. The company is a leader in
cardiac care, acute care and home healthcare, energy efficient lighting
solutions and new lighting applications, as well as male shaving and
grooming and oral healthcare. News from Philips is located at www.
philips.com/newscenter.
Fax +44 207 351 8816
Email
[email protected]
Web www.jcmr-online.com
JCMR, the official journal of the Society for Cardiovascular MR,
is an open access, online journal that publishes articles on all
aspects of basic and clinical research on the design, development,
manufacture, and evaluation of magnetic resonance methods applied
to the cardiovascular system. The only journal devoted exclusively to
cardiovascular MR, JCMR aims to provide an international forum for
communicating the latest findings and reviews on the burgeoning field
of cardiovascular MR imaging and spectroscopy.
78
Booth #17
Booth #13
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
E X H I BITO R DI R EC TO RY
Philipsweg 1
Society for Cardiovascular Magnetic
Resonance (SCMR)
Maastricht 6227AJ, The Netherlands
19 Mantua Road
Phone043-3281328
Mt. Royal, NJ 08061 USA
Fax043-3281329
Phone (856) 423-8955
[email protected]
Fax (856) 423-3420
Webwww.piemedicalimaging.com
[email protected]
Pie Medical Imaging, a company with over 25 years of experience
in quantitative analysis software for medical images, offers a wide
range of software packages for cardiovascular analysis of MR images.
With our CAAS MRV software Functional analysis of the left and right
ventricles, Viability, Edema and First Pass Perfusion analysis can be
performed. CAAS MR (4D) Flow software allows for quantification of
blood flow, velocities, wall shear stress and detailed visualization of
hemodynamics.
Webwww.scmr.org
Precision Image Analysis
Booth #15
The Society for Cardiovascular Magnetic Resonance (SCMR) is
a professional association whose vision is to be the recognized
representative and advocate for physicians, scientists, and
technologists who work in the field of cardiovascular magnetic
resonance. It endeavors to be the principal international, independent
organization committed to the further development of cardiovascular
magnetic resonance through education, quality control, research, and
training.
Booth #12
303 Parkplace Center, Suite G-131
Springer
Kirkland, WA 98033 USA
233 Spring Street
Phone (425) 822-8199
New York, NY 10013 USA
Fax (425) 519-9971
Phone (212) 460-1500
[email protected]
Fax (212) 460-1575
Webwww.piamedical.com
[email protected]
Precision Image Analysis (PIA) provides an innovative image postprocessing analysis service for use in diagnostic medical studies,
including CT and MRI. The HIPAA compliant, cloud-based architecture
enables images to be uploaded, monitored, tracked, and analyses
retrieved remotely. Precision Image Analysis expertly-trained analysts
deliver consistently reproducible results in a timely manner.
Webwww.springer.com
PIA can help improve scanner throughput, decrease internal training
time and save money. Visit www.piamedical.com today.
Siemens Healthcare
Booth# 23
Booth #1
40 Liberty Boulevard
Malvern, PA 19355 USA
Phone (610) 448-4500
Webhttp://usa.healthcare.siemens.com/
Siemens Healthcare develops innovations that support better patient
outcomes with greater efficiencies, giving providers the confidence
they need to meet the clinical, operational and financial challenges of a
changing healthcare landscape. As a global leader in medical imaging,
laboratory diagnostics, and healthcare information technology, we
have a keen understanding of the entire patient care continuum--from
prevention and early detection to diagnosis and treatment.
Booth #9
BioMed Central is an online STM publisher of more than 270 peerreviewed, open access journals. Our portfolio of journals spans all areas
of biology, biomedicine and medicine, with many journals publishing
content related to medical imaging and cardiovascular systems.
Examples of such journals include: Journal of Cardiovascular Magnetic
Resonance, Cardiovascular Ultrasound, BMC Medical Imaging, Journal
of Therapeutic Ultrasound and BMC Cardiovascular Disorders. All
original research articles published by BioMed Central are made freely
accessible online immediately upon publication. Authors publishing
with BioMed Central retain copyright of their work under the Creative
Commons Attribution License, which allows articles to be re-used and
re-distributed without restriction provided the original work is correctly
cited. BioMed Central is owned by Springer Nature, and also hosts the
SpringerOpen platform.
Toshiba America Medical Systems, Inc Booth #6
2441 Michelle Drive
Tustin, CA 92780
Phone (800) 421-1968
Fax (714) 734-0362
[email protected]
Webmedical.toshiba.com
Toshiba America Medical Systems, Inc understands today’s healthcare
business and delivers diagnostic imaging and interventional solutions that put customers first. Toshiba markets, sells, distributes, and
services throughout the U.S. It is committed to listening to customers and giving them a voice through patient-focused technology and
superior customer service.
www.scmr.org
EXHIBITOR DIRECTORY
Pie Medical Imaging B.V.
79
EXIT
L-UP
ROL OR
DO
S
BAR
80
EXIT
L-UP
ROL OR
DO
ONS
STATI
FE
FA
S
FE E
S
S
6
S
HYATT REGENCY CENTURY PLAZA HOTEL
CALIFORNIA BALLROOM
LOS ANGELES, CALIFORNIA
EXIT
S
FA S
S FA
NS
TATIO
EE S
EXIT
FE
FA
S
F
8
10
5
S
6
S
S
S
1
11
20'
7
12
20'
13
8
S
S
S
14
S
EXIT
9
S
FA S
S FA
10
POSTER
AREA
/ C OF
BAR
S
S
7
9
FA
2
S
20'
S
S
3
S
1
11
20'
12
170 - D/S Poster Boards
98 - S/S Poster Boards
438 Sides
20'
13
20'
20'
20'
FA
S
S
S
S
14
S
S
15
S
S
4
16
2
S
S
FA
FA
19
S
20
EXIT
21
S
S
3
S
170 - D/S Poster Boards
98 - S/S Poster Boards
438 Sides
20'
20'
20'
S
ENTRANCE
S
20'
18
20'
20'
17
22
S
S
S
S
S
23
ge
S
15
Sta
24
S
S
S
/ CO
4
16
EXIT
FE
FA
BAR
20'
17
S
20'
18
FFE
ES
TAT
ION
S
S
S
S
S
EXIT
FA
FA
19
ROLL
DOO-UP
R
S
20
EXIT
S
21
22
S
S
S
23
Sta
ge
24
E X H I BITO R FLOO R PL A N
EXIT
/ C OF
S
5
S
S
ENTRANCE
S
S
/ CO
EXIT
FE
FA
BAR
From Innovation to Impact in Cardiovascular Care
HYATT REGENCY CENTURY PLAZA HOTEL
CALIFORNIA BALLROOM
LOS ANGELES, CALIFORNIA
19th Annual Scientific Sessions • January 27-30, 2016
FF
From Innovation to Impact in Cardiovascular Care
CO N V ENTIO N C ENTER FLOO R PL A N S
HYATT REGENCY CENTURY PLAZA
HYATT REGENCY CENTURY PLAZA
2025 Avenue of the Stars
LosCalifornia
Angeles, CALevel
90067
USA
T: +1 310 228 1234
F: +1 310 551 7548
E: [email protected]
centuryplaza.hyatt.com
FLOOR PLAN
Plaza Level
12.12
FLOOR PLANS
Plaza Level
PLAZA TERRACE
www.scmr.org
12.12
81
Precession
powered by WebPAX Technology
“Opinion is good, but evidence is better...”
CloudCMR
World-wide
collaboration using any
Web Browser!
With any distant colleague!
30,000+
Scans with Finalized de-identified structured reports!
SCMR Booth # 4
National Institutes of Health, Bethesda, USA
2000 ms
0 ms
siemens.com/cmr
Cardiovascular MRI
Efficient, reliable, ready.
Add a new layer of pixel-based diagnostic information to cardiac diagnoses.
Based on HeartFreeze Inline Motion Correction (Siemens unique), MyoMaps
provides pixel-based myocardial quantification, on the fly.
Now you can better detect global, diffuse, myocardial pathologies (T1 Map).
Or better depict cardiac edema (T2 Map) and improve early detection of iron
overload (T2* Map).
• Designed to evolve visual assessment to pixel based quantification of
tissue characteristics
• Based on Siemens-unique HeartFreeze Inline Motion Correction
• Guide cardiovascular therapy, starting earlier and more efficiently
MyoMaps – now available on the powerful software platform syngo MR E11.
Leading.
With
MAGNETOM.
Delivering
Catheters
and other Devices
for
MR-Guided
Interventions
Electrophysiology
Structural Heart
Renal Denervation
Oncology
The Advantage-MR EP Recorder/Stimulator System and Vision-MR Ablation Catheter have been approved for use in human clinical investigations in Europe.
All other Imricor products are not yet approved for use in humans.
Download the Mobile App Now!
Search: SCMR 2016
( in the Apple App Store or Google Play )
Enter: http://m.core-apps.com/scmr2016
( in your mobile browser )
Or
Scan: the QR code below
ViosWorks
A S T O N I S H . C H A N G E T H E C A R D I A C I M A G I N G PA R A D I G M .
ViosWorks* extends cardiac MR assessment beyond the anatomy by bringing
automatic quantitative data & deep learning to cardiac imaging in a fraction of
the time of conventional cardiac scans. Providing whole-heart cardiac anatomy,
function, and flow in 1-free breathing, 8 minute scan with cloud-based,
real-time processing of images.
Visit us at the GE Healthcare booth and at
www.viosworks.gehealthcare.com
*Not yet commercially available
From Innovation to Impact in Cardiovascular Care
N OTES
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
www.scmr.org
87
From Innovation to Impact in Cardiovascular Care
N OTES
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
88
19th Annual Scientific Sessions • January 27-30, 2016
From Innovation to Impact in Cardiovascular Care
N OTES
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
____________________________________________________________________________________________________________________________
www.scmr.org
89
Gaylord National Resort & Convention Center at National Harbor
Washington, DC
FEB R U A R Y 1 – 4 , 2 0 1 7